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Abstract  
Current technologies focus on the use of single drug delivery carriers delivering a single drug 
species, or multiple species, in a compromisingly loaded or damaged state. Here we aim to 
develop controlled liposome (vesicle) clusters as potential multi-drug carriers for applications in 
nanomedicine. Specifically; applications include but are not limited to, combinational therapeutics 
and for the simultaneous delivery of prodrug and complementary activating enzyme. To this end, 
we are utilising a platform where different liposomes can be connected through DNA linkers, in 
hope to deliver multiple species in close proximity whilst keeping the individual cargos separate. 
Liposome clusters can be formed using complementary lipid-DNA conjugates integrated into a 
vesicle’s surface. To ensure strong directional liposome bridging, a patch of localised DNA allows 
the assembly of size-limited clusters through the directionality of the adhesive interactions. 
Studies have localised DNA through phase coexistence, mixing saturated (DPPC) and 
unsaturated (DOPC) lipids with cholesterol, forming lo patches of saturated lipid surrounded by a 
ld phase of unsaturated lipids. However, these studies displayed poor saturated lipid-DNA 
partitioning to the lo ordered patches, allowing a lack of specificity in directional interactions 
between functionalised domains. To enhance saturated lipid-DNA lo partitioning, 10 mole percent 
(mol%) cardiolipin (CL) was added. CL increases the free energy required for a saturated lipid to 
insert into the ld phase, increasing DNA partition coefficient to the lo phase by an order of 
magnitude. Here, a new four component phase diagram incorporating 10 mol% CL was plotted 
using liposomes with diameters of ~100 nm, an appropriate particle magnitude required for 
cellular uptake. Förster Resonance Energy Transfer (FRET) was implemented to map out the 
four component phase diagram as vesicle size was below optical microscopy limits. Results 
showed similar phase topology to the analogous three component diagram with the addition of 
potential lo-HII phase coexistence. 
Using the new phase diagram in conjunction with lipid-DNA conjugates, dynamic light scattering 
(DLS) displayed size limited tethered clusters <200 nm in diameter could be achieved. This 
Indicated 10 mol% CL and phase diagram position limits the average number of tethered vesicles 
to single figures. Moreover, DNA-lipid bridging stability was examined using van’t Hoff analysis, 
where aggregates were shown to be stable at homeostatic temperature, pH and salt 
concentration. Furthermore, through the implementation of DNA i-motifs, small clusters were 
shown to be able to disassemble at pH 3, forming ~single vesicles, and to reassemble when the 
pH was raised to pH 7.4.  
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Introduction 
Nanotechnology is a term used to describe developments of materials that are within a size range 
of 1 nm to a few hundred nanometres. The broad magnitude of nanoparticle (NP) size results in 
nanoparticles (NPs) scaling from small atomic clusters, to large complex self-organising 
molecular systems such as nanodiscs, liposomes, viral based nanoparticles, polymersomes, 
carbon nanotubes, bucky balls and dendrimers [1]. Nanotechnology and its bottom up design 
approach allows for fine tuning and enhancement of a materials’ electrical, magnetic, mechanical, 
and optical properties. With these enrichments, nanoparticles are at the forefront of new 
innovative science, helping give rise to the large scale multidisciplinary research that occurs 
today. Through this interdisciplinary research, new innovative products are being produced 
across industry: carbon nanotubes are being woven to replace steel for lighter, stronger and 
corrosion free car chassis parts [2]; nanoparticle doped coatings gave rise to smart materials 
including switchable privacy glass windows; e-readers and pollution removing paint to name but 
a few [3], [4]. However, it is within medical research, specifically nanoparticle drug delivery 
systems, where this project focuses.  
With over 350 thousand people in the UK in 2014 being diagnosed with cancer and over 
150 thousand deaths in 2014 due to cancer, large organisations of researchers are looking 
towards developing more effective treatments [5]. In this space, drug delivery will play a vital role 
in forming new cures in place of ineffective palliative care treatments [6]. For example, lung cancer 
alone shows there is a high demand for new technology, with 12% of all lung cancer patients’ only 
have the option of palliative chemotherapy [7]. On its own palliative chemotherapy is a treatment 
for the short term prolonging of life and minimisation of symptoms not a cure [6]. Through 
proceeding with treatment, the chemotherapy agents preferentially destroy the cancerous tissues 
but this is in competition between healthy cells. Palliative treatment therefore leads to a significant 
loss of quality of life through inducing nausea, vomiting, fatigue, mouth sores, hair loss and an 
increase in the chance of infection [5]. It is then evident that drug delivery must play a key role in 
providing more effective treatments in tackling disease while ensuring a better quality of life.  
Nano-drug delivery carriers offer many benefits to both the patient and drug species. Principally 
they enhance the therapeutic index of cargo drug while protecting the patient from unintended 
interactions leading to side effects; thereby lowering drug toxicity [8]. Nanomedicine can control 
the bio-distribution and protect against reticuloendothelial system removal [9], [10]. Additionally, 
nanomaterials have two routes open for a targeted drug delivery. Firstly, passive targeting can be 
achieved through taking advantage of the enhanced permeability and retention (EPR) effect [11]. 
Secondly, the addition of targeting ligands on the material’s surface offers an active target cell 
approach. Interestingly, in order to enhance the EPR effect and the circulation half-life of 
nanomaterials, a “stealth” coating can be applied. Regardless of method, once targeted a 
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nanomaterial can deliver its cargo through various mechanisms. Two such routes include; 
diffusion from the nanomaterials into the cell or a triggered rapid release from an external stimuli 
e.g. temperature or pH [12].
From this brief synopsis it can be seen multiple approaches and methods are offered by the 
scientific community for dealing with drug delivery. The specific strategies however are dependent 
upon the individual drug species, as each drug has a preferred administration route and 
environment in which it is stable. Current nanocarriers have therefore been reviewed here to give 
an insight into the breadth and advancement of drug delivering nanocarriers. 
1.1 Nanocarrier drug delivery materials 
In short, the employment of drug delivering nanocarriers is to transport locally high concentrations 
of drug species to a target area, to induce a therapeutic effect while minimising exposure to non-
target areas. Other benefits from using carriers can come from tuned parameters for targeted 
stimulated responsiveness. Whatever the intended extra effects, carriers can be categorised into 
two factions; solid and soft nanoparticles.  
1.1.1 Solid nanoparticles 
Many examples of solid nanoparticles are demonstrated in literature, including silver, silica and 
gold nanoparticles and quantum dots (Q-dots). Silver nanoparticles are commonly incorporated 
within plasters and on computer keyboards, where both applications take advantage of silver NPs 
antimicrobial properties [13], [14]. However the effect of silver NPs entering the environment are 
in much debate with regard to their long-lasting toxic effects [15]. Mesoporous silica on the other 
hand, has been widely adopted into the field of drug delivery, where silica offers chemical stability, 
a reasonable biocompatibility and capacity to undergo surface modification [16]. That being said 
there are issues with silica phosphorus reactivity and resulting haemolysis leading to a promotion 
in melanoma growth [17], [18]. Moving forward, similar silica NP advantages apply to Q-dots. In 
addition though, Q-dots have a major benefit of being able to replace fluorescent dyes as contrast 
agents [19]. When imaged Q-dots are brighter and less susceptible to photobleaching than 
standard indicators, while also providing a route to deliver photothermal therapy to a patient [19]. 
While there are many advantages to using Q-dots, the inorganic semiconductor is cytotoxic, 
limiting their biological use [20]. 
For the purpose of this review, a more in-depth appraisal has been made of gold nanoparticles 
(GNPs), with their selection being due to their use in the clinic today [21]. Depending on their 
application gold nanoparticles can be tagged with ligands and/or can be formed into many 
different shapes, the most obvious being a sphere. Spherical nanoparticles offer a straightforward 
synthesis with diameters ranging between 2-100 nm [22].  
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To functionalise a GNP, ligands are attached through a thiol group. An example of this attachment 
can be seen through the addition of paclitaxel; a mitotic inhibitor which prevents mitosis (cell 
division) in chemotherapy [23]. Once attached the ligand is biologically inactive, therefore at the 
target site it must be again detached from the particle in order to be activated. To detach the 
ligands intracellular glutathione has been discussed to partially displace any thiol groups, thereby 
removing the original ligand [24]. Furthermore, gold-thio nanoparticles are widely used in gene 
delivery [22], whereby DNA is modified with a thiol group. In summary Figure 1.1 displays a 
scheme illustrating thiol attachment ligand types and GNP shapes. 
Additionally, gold nanoparticles have also been developed to interact with an applied outside 
electromagnetic radiation source, which can be used to induce localised heating. This property is 
unavailable to larger diameter nanoparticles (10-100 nm), whose surface area to volume ratio is 
smaller than that of the small diameter nanoparticles (5 nm) [22]. The surface to volume ratio 
plays an integral part in the wavelength of light absorbed due to the level of surface plasmon 
available. Larger spherical gold nanoparticles only absorb between 520-550 nm in the visible 
region, to which biological tissue is opaque [22]. Smaller nanoparticles, nanorods and shells have 
developed to have strong surface plasmon resonance. These materials have been shown to 
absorb radiation within the near infrared region (800-1200 nm), enabling deeper tissue 
penetration, making GNPs such as these ideal candidates to be used within photothermal cancer 
therapy [22], [25]. 
Unfortunately, solid gold nanoparticles are not without their disadvantages. Not all drugs species 
can be modified with thiol attachment group(s) without loss of functionality of the therapeutic. 
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While GNPs can provide localised drug delivery, the ligands are not localised to any specific 
side of the NP, and therefore cannot be linked with another NP in a directional manner. This is
not to say there are no examples of solid NPs having localised functionalities, an example to the 
contrary would be silica NPs in combination with Pickering emulsions and microfluidic 
devices [26]. However these silica NPs are more commonly found within electronic e-readers 
rather than in medical applications [27].  
Furthermore, when functionalised GNPs are used in patient treatment the ligands themselves 
are not protected from their environment, thereby making it possible for the exposed drugs 
to be degraded. Additionally the attachment thiols themselves are in much debate in 
literature with regard to their toxicity [28]. However, a broader issue associated with the use of 
GNPs is their environmental impact. Once excreted they could expose their toxic effects to 
plants and animals, which in turn could enable them to enter the food chain [29].  
1.1.2 Soft nanoparticles 
Soft NPs are often made from self-organising organic molecular building blocks gathering 
together to form complexes of ordered and thermodynamically stable structures, held together 
through non-covalent interactions. For example, lipids and polymers self-assemble in liposomes 
and polymersomes respectively; and through their own individual complexity they build a richer 
catalogue of nanoparticles that are available for use within drug delivery. The self-assembly of 
these building blocks is made possible through an enthalpic energy cost being balanced by an 
entropic energy gain, driven by the hydrophobic effect of amphiphilic molecules [30], [31]. The 
hydrophobic effect is driven through a hydrophobic molecule disrupting water’s three-
dimensional hydrogen bonding network. At the surface at, for example a lipid chain, water forms 
a solvation shell which limits the translational and rotational entropy of the water molecules, 
making for an unfavourable interaction in terms of free energy. Through lipids self-assembling 
however, this interface between the hydrophobic region and water is minimised and so reduces 
the disruptive effect of the lipid.  
Figure 1.2 – 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) lipid with two 16 carbon 
long lipid chains/tails and a phosphocholine hydrophobic head group [32].  
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With an extensive library of lipids varying in both shape and size polymorphism is observed, with 
the end self-assembled structure dependent upon lipid(s) used. There are four main 
categoriesof lipids that are characterised through their molecular geometry [33]. To predict what
structures lipids form during self-assembly, a Critical Packing Parameter (CPP) can be 
calculated from the geometric parameters of the individual lipids, this is outlined in Equation 1.1. 




Where v is the volume of the hydrophilic head group, lc is the critical length of the hydrophobic tail 
(fully extended) and a0 is the area of the hydrophilic head group. The results from Equation 1.1 
can be compared to tabulated data to predict what lipid structures are formed. 
Table 1.1 – Critical packing parameter influencing the formed self-assembled 
structure [34]. 
The resulting arrangements within Table 1.1 can be rationalised through considering packing 
space. Cone shaped lipids with large polar head groups and smaller hydrophobic tails form 
spherical micelles. The small volume of the tails allows the tails to pack together tightly, 
complementing the larger space required for the bulky head groups to pack together. Extended 
micelles form when the volume of the surfactant’s hydrocarbon region is increased, distorting the 
packing arrangement which prevents the formation of a typical spherical micelle [33]. Further 
increasing the volume of the hydrocarbon region through additional chains/tails allows the 
formation of bilayers. Lipids are commonly found taking on a “cylindrical shape” where upon self-
assembly the lipids arrange themselves to be perpendicular to the plane of the bilayer [33]. The 
final lipid shape that will be considered in this review has a small cross-sectional head group in 
comparison with its tails; leading to the head groups being at the trailing end of the cone shape. 
As a result these lipids pack in an inverted micelle formation, where the head groups pack into 
the core of the  micelle,  leaving  the bulky tail groups  exposed to the  water [33]. In response  to
CPP Lipid “Shape” Self-Assembled Structure 
<1/3 Cone Micelles 
1/3–1/2 Truncated Cone Extended Micelles (Rods) 
~1 Cylinder Planar bilayers 
>1
Inverted Cone / 
Wedge 
Inverted micelles (HII) and 
cubic phases 
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this packing, the HII phase forms a bulk phase to minimise water contact. It is worth noting 
environmental triggers can enable polymophorism, for example, a trigger could include changing 
the charge on a lipids head group [35]. 
1.1.2.1 Polymersomes 
Block copolymers can be used to make a synthetic fluid polymer membrane. Amphiphilic block 
copolymers consist of one long chain of polymer with sections of contrasting hydrophobicity. 
When the chains are placed within an aqueous environment they may self-assemble to form 
hollow spheres with an internal aqueous compartment, termed polymersomes [36]. The aqueous 
core can be used to store therapeutic molecules which contrasts with hard NPs. This 
incorporated internal storage shields the contents from the external environment which 
could lead to the denaturing or inhibition of a therapeutic. Polymersomes have thick 10 - 50 nm 
membranes which are attributed to the high molecular weight of the initial building blocks [37]. 
The thick membrane of a polymersome offers great stability, mechanical strength and long 
cargo retention times. Analogous to solid nanoparticles, polymersomes can be surface 
functionalised for drug delivery to provoke therapeutic effects. Modification is possible through 
the addition of a motif to the polymer chain. A cartoon displayed within Figure 1.3 exhibits 
some conceivable multiblock polymer compositions and the resulting hypothetical assembled 
configurations. 
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Figure 1.3 – Polymersomes membrane conformations where the initial building block of 
the polymersomes becomes more complicated. The complexity of the copolymer from 
diblock, triblock to more theoretically possible multiblock co-polymers in membrane 
assemblies has been illustrated [38]. 
From the cartoon in Figure 1.3 it can be seen that it could be possible to tune the polymersome 
to have contrasting internal and external surface areas. It is likely that, to produce structures such 
as these, large functional groups would have to be used to encourage partitioning to the outside 
of the polymersome, where steric hindrance would be significantly reduced opposed to internal 
partitioning. What is clear from this cartoon, is that polymersome structures offer more in the way 
of tuneable parameters which the hard NP could not. The higher degree of structural freedom 
afforded to the polymersomes aids the ability to produce particles more specifically adept to 
targeting and delivering therapeutics for/to an individual disease. For example through adding a 
monoclonal antibody to polymer chains, the subsequent polymersomes have been able to cross 
the blood brain barrier, to deliver therapeutic peptides [38]. 
Additionally soft polymersomes offer an easier and safer route to the preparation of NP than gold, 
removing the need to use powerful reducing agents [22]. Moreover, polymersomes are quickly 
prepared with respect to GNPs, where GNPs can take weeks to form. Regrettably, polymersomes 
are still not without their flaws; namely, biocompatibility and slow diffusion rates of the 
polymer [36]. The slow phase separation impedes heterogeneous surface formation to ~a month, 
limiting polymersome’s capacity to form directionally linked materials [36]. 
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1.1.2.2 Micelles 
Therapeutic delivering micelles can be formed using polymers, lipids and surfactants alike. Once 
assembled into micelles, the hydrophobic core offers a better environment for partitioning of low 
water soluble drugs than the aqueous core of a polymersome or liposome. Micelles are therefore 
capable of transporting hydrophobic species in hydrophilic conditions, making them distinctive 
from other the NP drug carriers discussed so far. 
A micelle’s suitability for the transport of hydrophobic species is nevertheless a blessing and a 
curse. While there is a demand for the delivery of a wealth of lower water solubility therapeutics, 
there is a larger demand for the safe delivery of more biologically suitable hydrophilic drugs. Again, 
there are also further issues regarding the biocompatibility of the polymers used and the circulation 
time of the NP. To address the latter the NP would need to be doped with a stealthing agent such 
as propylene glycol (PEG), which would extend the NP circulation time by impeding immune 
system detection [39]. Nevertheless, a more sophisticated drug delivery unit analogousto a micelle
in terms of hydrophobic therapeutic delivery, has been developed. These new delivery units are 
called nadenanodiscs (ND). 
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1.1.2.3 Nanodiscs 
A ND is made from a sandwich of lipids that are wrapped in a protein “belt”; where the belt reduces 
the hydrophobic line tension at the ND boundary. The protein is derived from a high density 
lipoprotein Apolipoprotein [40]. Apolipoprotein derivatives function as membrane scaffold proteins 
that have a high affinity towards lipids, with common examples including MSP1D1 and MSP1D1-
deltaH5 [41]. The protein length determines the size of the final NP where its length is the 
circumference of the stabilising belt [41]. While both NDs and micelles have been discussed to 
carry hydrophobic species, the lipid bilayer inherent to NDs has been debated to resemble a 
biological membrane, affording greater stability to other therapeutic proteins being delivered [42]. 
NDs have similar issues to micelles through a somewhat limited hydrophilic drug delivery 
capacity. Additionally, the preparation of NDs is not trivial, requiring specialised skills to formulate 
a ND, where opposingly, micelles spontaneously form in water as long as the concentration is 
above the Critical Micelle Concentration (CMC). 
1.1.2.4 Liposomes 
Liposomes/vesicles are spherical shells built through the self-assembly of lipid building blocks, 
resulting in a lipid membrane encapsulating an aqueous core, similar to a polymersome. 
Scientists researching liposomes take inspiration from nature where amphiphilic lipids are seen 
in cellular membranes. Lipids present the cell with inherent valuable properties including the ability 
to be deformed by external forces and self-repair all while preventing leakage from the cell [43]. 
These powerful natural lipid membrane properties are therefore incorporated into liposomes, 
making vesicles ideal bio delivery tools. Due to these properties liposomes are at the forefront of 
novel biomedical encapsulation applications for the delivery of drugs, contrast reagents and 
catalysis [44].  
Liposomes have distinct advantages over their therapeutic delivering NP equivalents. These 
advantages include; the delivery both hydrophobic and hydrophilic species through their 
hydrophobic centred bilayer and aqueous core respectively, with the additional benefit of being 
made of biological molecules, granting enhanced biocompatibility over block copolymers. 
Furthermore, the relatively fast diffusion of lipids over their polymer counterparts enables fast 
phase separation (discussed further in section 1.2 page 11). Through phase separation it has 
been shown that a liposome’s functionalised surface can be localised to form a heterogeneous 
Janus particle. This permits Janus liposomes, with the aid of a molecular linker, to form binary 
size limited liposome A bound to liposome B clusters. In contrast, without phase separation 
polymersomes when tagged with an appropriate molecular linker, would bind together to form a 
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large mass of aggregated polymersomes. In summary Janus liposomes offer new potential routes 
to faster and more effective treatments in the field of multiple drug delivery. 
1.1.3 Multiple nanocarriers 
Four new treatment routes can be explored through the possibility of simultaneous transportation 
and delivery of therapeutic species, these include; prodrug, combinational and theranostic 
delivery. Also, simultaneous transportation offers new routes into targeted delivery where links 
between liposomal carriers can be disturbed in the presence of an intended stimulus.  
Currently, DaunoXome, Doxil, ONCO-TCS and DepoCyt are typical liposomal therapies on the 
market, however, these systems all encapsulate one drug species per product and these are 
daunorubicin, doxorubicin, vincristine and cytarabine respectively [45]. In order to further enhance 
the potency of these approved treatments, combinational therapies were developed. Agrawal et 
al. encapsulated both 6-mercaptopurine and daunorubicin into the same vesicles to provide a 
more effective treatment of leukaemia [46]. In the study it was found that the two mechanistically 
different drugs offered a higher cytotoxicity against Jurkat and Hut 76 T-cell lymphoma when 
coupled together in the same vesicle, than either drug applied singularly [46]. This in turn suggests 
that a cocktail of the two drugs has the potential to provide a higher therapeutic efficiency. 
Unfortunately it was found that 6-mercaptopurine has a poor 1.5% loading efficiency and therefore 
that specific treatment was described as being unsuitable for use [46], [47]. Although it was 
unsuitable, this study showed the idea of combinational delivery of multiple drugs not being 
something new to the world of nano carriers. Where this project seeks to lead on from the work 
presented by Agrawal et al. is to form separate AB tethered dimer carriers, where separation of 
drugs would offer the potential for better therapeutic tailoring. Tethered vesicles would remove 
the need to add two drugs to the same liposome. In turn vesicles would have a higher maximum 
loading efficiency, as each vesicle can be engineered to suit its cargo’s requirements. A further 
effect of separating out the loading of therapeutics over multiple liposomes is the prevention of 
cross reactions between species. 
The ability to prevent cross reactions and tune therapeutic loadings is key to the advancement of 
theranostic treatments. Rapid detection of disease is often paramount, especially when fast action 
will strongly influence the effectiveness of a treatment and the resulting outcome. Theranostic 
treatments bridge the gap between detection and prescription through delivering diagnostic 
imaging agents/biosensors, with the corresponding therapeutics. A key change and benefit to 
using the technique, is that there would be drastically reduced lag time which would ultimately 
increase survival rates [48], [49]. 
As an example of a hard theranostic material, hybrid gold-iron NPs are currently being used to 
detect and remove tumour cells that have been shed into the vascular system from a primary site; 
which if left unchecked leads to metastasis. The Circulating Tumour Cells (CTC’s) are tagged 
using a S6 aptamer, which are themselves attached to the gold coated Fe3O4 (s) NP  using a thiol 
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coupling group [50]. The tagged CTC’s could then be imaged through the fluorescently labelled 
aptamer. The hybrid NP then presents the user with two functionalities, separation and ablation. 
The iron oxide is magnetically sensitive and so in the presence of a magnetic field the CTC’s can 
be isolated or imaged through magnetic resonance imaging (MRI) instruments, allowing early 
stage CTC detection [51], [52]. A further benefit of the NP is the gold coating, whilst already 
contributing an attachment route for the aptamer, gold is able to induce localised heating through 
the absorbance of infrared radiation. The induced localised heating then selectively ablates the 
CTC through the gold [50]. However, this specific treatment still has the disadvantages of solid 
NPs discussed in section 1.1.2 page 4, which are not present when using vesicles. 
Where tethered liposomes show further potential over their hard NP counterparts is in the delivery 
of prodrugs. Prodrugs are the therapeutic equivalent to a fibre glass application kit. The resin 
(pharmacologically inactive therapeutic) and the activating agent are transported and packaged 
separately until the point of application. Current prodrug treatments require in vivo enzymatic and 
or chemical transformation before the parent inactive drug can exert its therapeutic effect [53]. 
Tethered liposomes can offer an alternate approach where the parent drug and activator are kept 
separate whilst being delivered. Upon being supplied to the target the activator and therapeutic 
would combine leading to treatment. Through tethering the carriers together there will be an 
increased probability of delivering both species simultaneously to the same cell, inducing the 
wanted pharmaceutical effect. 
In summary, vesicles present a favourable solution to forming size limited clusters required for 
combinational, theranostic and prodrug delivery treatments. The driving force behind a vesicles’ 
diversity and pharmaceutical usefulness, in regards to the outlined treatments, rests in lipid phase 
behaviour. 
1.2 Liposome phase behaviour 
Liposomes/vesicles have been shown to form multiple phases dependent upon the lipids from 
which they are made and temperature they are at. Homogenous vesicles are usually described 
as being in a liquid disordered (ld) or more solid gel (lgel) phase [54]. As a rule of thumb, a vesicle’s 
phase is dictated by the saturation of the lipid carbon chains. In other words, saturated chains 
closely pack together forming a more solid phase than unsaturated lipids [54]. The combination 
of saturated and unsaturated lipids within vesicles can lead to the formation of rafts/domains. A 
domain within a liposome is the heterogeneous arrangement of lipids on the surface of a vesicle, 
which is a result of phase separation [55]. Essentially, comparable lipids concentrate together so 
that lipids with saturated and unsaturated tails separate from one another to form separate 
patches. 
It is widely known that mixtures of lipids can form ld, liquid ordered (lo) and many lgel phases, with 
mixtures of phases being able to coexist. It is important to note the phase of the membrane 
significantly impacts the structural properties of the vesicle [56]. A liquid gel phase is more solid 
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than a liquid disordered phase, where lgel phase vesicles have a distorted spherical morphology 
and both a slower lipid diffusion rate and cargo release rate. When phases coexist the size of 
each coexisting phase ranges typically from nanometres to micrometres, with size being 
dependent upon lipid type, quantity and the preparation method of the liposome [57]. Each lipid 
type has an individual transition temperature, bending modulus and length [58]; with lipid 
transition temperatures being largely reliant on the length of the hydrophobic tail, level of 
saturation within the tail and the type of head group [59]. The mixing of dissimilar lipids in a vesicle 
introduces a higher interfacial energy cost than having a vesicle made up of one lipid type, leading 
to separation.  
When below the transition temperature, lipid mixtures no longer have enough thermal energy to 
overcome the interfacial energy cost required to maintain a homogeneous structure. This 
promotes the lowest melting lipids to de-mix and coalesce together once they come into contact 
with one another, through Brownian motion. Through coalescence, small domains of the lowest 
melting lipid form in competition with an entropic energy cost [60]. Each formed domain has an 
associated line tension (an energy per unit length of boundary) that exists at the edge of the 
domain [61]. Multiple small domains have a greater interface than a large domain, therefore to 
reduce the interfacial tension across the multiple domains they further coalesce 
together [61], [62].  
1.2.1 Binary systems 
For binary lipid systems, phase diagrams define a liposome’s local lipid concentration and 
morphology with respect to temperature. Phase diagrams in combination with the Gibbs phase 
rule, Equation 1.2, give a prediction of the degrees of freedom when phases coexist for a stated 
number of components.  
Equation 1.2 -   𝑭 = 𝑪 + 𝟐 − 𝑷 [63] 
Where F is the number of degrees of freedom available for number of P coexisting phases, C is 
the number of components. The phase rule however cannot give any information about the 
amount/size of each phase present. To do this the lever rule must be applied. To examine the 
lever rule more closely a lipid phase diagram has been displayed in Figure 1.4. 
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Figure 1.4 – A modified example of a binary phase diagram for DPPC:DLPC liposomes. 
Circles represent differential scanning calorimetry (DSC) gathered data and diamonds 
display Fluorescence Resonance Energy Transfer (FRET) data. The solid line displays the 
phase boundaries [64]. 
The graph in Figure 1.4 shows the x-axis representing the mole fraction of DPPC, in other words 
it describes the fraction of saturated lipid. At high concentrations of DPPC and at low 
temperatures, it would be expected the lipids would be in an lgel phase due to the liposome mainly 
consisting of saturated lipids below the lipid melting temperature. Alternatively, at low 
concentrations of DPPC and at a high temperature it would be expected that the liposomes would 
be in an ld phase due to the increase in unsaturated lipids. In between the pure ordered gel phase 
and pure liquid phase there exists a region where a liposome’s surface will have the properties of 
both i.e. the membrane has become phase separated. In this region, the fraction of lipids in the 
gel phase and fraction in the liquid phase can be calculated through the lever rule.  
In Figure 1.4 a binary phase separated liposome has been recorded through point “x”. It is 
important to note when calculating the mole fraction of each phase that the temperature and mole 
fraction of DPPC remains constant. A horizontal isotherm/tie line running through point x parallel 
to the x-axis has been drawn (red line Figure 1.4). When the red line intersects the phase 
boundaries (solid black lines) two perpendicular lines (blue) of ld and lgel can be drawn down to 
the x-axis. It is through these three points, A, B and X that the mole fraction of each phase can 
be calculated using Equation 1.3 and Equation 1.4. 









Using the knowledge gained from binary lipid mixtures enables ternary phase systems, more 
relevant to the project, to be further discussed. 
1.2.2 Ternary systems 
The addition of cholesterol to binary lipid systems affects the packing arrangement of lipids, 
thereby strongly changing a liposome’s properties, making cholesterol of high interest within the 
literature. When cholesterol is applied to a lipid membrane it will preferentially enter the close 
packed highly ordered gel phase, disrupting the close packing arrangement [65]. Cholesterol’s 
rigid fused ring structure cannot pack as tightly as saturated lipids increasing the lipid diffusion 
coefficient and membrane mechanical flexibility [65]. In contrast, cholesterol within ld domains aids 
the membrane to become more rigid through restricting chain conformations [66]. In other words, 
cholesterol limits the degrees of freedom in chain confirmations in the ld phase. By reducing the 
degrees of freedom the lipid tails can adopt, cholesterol decreases the lateral diffusion coefficient 
of the unsaturated lipids and increase mechanical rigidity of the liposome; making the liposome 
less deformable [65]. The addition of cholesterol to the binary phase diagram enables the 
possibility of the liposome’s surface to become liquid ordered (lo), rather than just being gel or 
liquid disordered. Cholesterol addition is therefore favourable when designing heterogeneous, 
drug delivering liposomes, where cholesterol maintains the flexible fluid shell while making the 
liposomes less leaky. Cholesterol further benefits this project by driving the ld-lo phase separation 
required to form Janus vesicles. However, in order to make controlled heterogeneous liposomes 
when a third component is added to the binary system, a new phase diagram with updated tie 
lines is required.  
1.2.2.1 Ternary phase diagrams 
Lipid ternary phase diagrams have been plotted and updated using complementary techniques 
in an effort to achieve more accurate data with which to construct the phase diagram [67], [68]. 
The most researched phase diagram consists of liposomes being made from 
DOPC:DPPC:cholesterol components. The initial attraction for using PC lipids within research is 
that they are found naturally in biological cell membranes [69]. Specifically, DPPC was selected 
because it already had a wealth of literature describing its behaviour within bilayers. Furthermore, 
unsaturated DOPC was selected due to it having the same head group as its saturated lipid 
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counterpart, thus nulling the potential effect of a different head group on phase separation [68]. 
By varying the ratios of lipid as previously discussed for binary systems, and using suitable 
fluorescent dyes, the separate lipid domains were viewed via confocal fluorescent microscopy as 
shown within Figure 1.5. 
Figure 1.5 – An early ternary phase diagram for giant vesicles of DOPC:DPPC:Cholesterol 
at 30 oC. The microscopy images display bright ld DOPC rich domains, distinguished 
through Texas Red dipalmitoyl-phosphatidylethanolamine (TR DPPE) partitioning. Scale 
bars represent 20 µm [68].  
From Figure 1.5 it can be seen that the apexes of the triangle represent 1 mole fraction of that 
specific lipid and the dashed lines display 10% change in lipid mole fraction. The shaded area on 
the phase diagram outlines the ld and saturated lipid phase coexistence region, which was 
mapped through monitoring TR DPPE dye phase separation in the confocal images. Even though 
the dye has saturated carbon chains, TR DPPE has been shown to preferentially partition to the 
ld phase. This counterintuitive partitioning, is due to the bulky labelling fluorophore disturbing the 
lo phase packing lipids around it, leading to TR DPPE partitioning into the ld phase [70]. That note 
a side, experiments such as these formed the basis to monitor phase separation reversibility. 
These confocal images display both the melting and formation of lipid domains [71]. 
While giant unilamellar vesicles (GUVs) are useful in characterising vesicle structures on a micro 
scale, it is perhaps not appropriate to extrapolate the data to the nanoscale due to the increased 
effect of curvature on the membrane. With potential changes to the phase diagram induced by 
making nano vesicles, a new phase diagram using the same components but on the nanoscale 
would be required to model nano phase separated vesicles. 
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Phase diagrams where liposomes are on the nanoscale have been developed using quantitative 
Florescence Resonance Energy Transfer (FRET) techniques rather than using confocal 
fluorescence microscopy. Steady-state Probe-partitioning Florescence Resonance Energy 
Transfer (SP-FRET) also exploits probe partitioning between phases as seen in confocal 
fluorescence studies [72]. The basic principles behind SP-FRET can be best understood when 
discussed alongside Figure 1.6. 
Figure 1.6 – SP-FRET fluorescent probe partitioning: green being the donor probes and 
red the acceptor probes [72]. 
Figure 1.6 displays that there are three possible SP-FRET signals that can be produced 
depending on the dye and probes partitioning preferences. In a single phase system where no 
domains have formed, probes are homogenously distributed across the surface of the liposome. 
When domains form, membrane probes can partition in one of two ways; either they can coexist 
in the same domain, or separate out among the saturated lipid and ld phases depending on the 
probe type. To model phases and phase changes, FRET signals are recorded where a change 
in the FRET signal is due to the change in distance between the probes. This technique is limited 
to measuring small distances, where the largest accurately measured distance ~10 nm, limiting 
the domain sizes that can be measured [73]. 
Using FRET a fully mapped updated nano-version of the ternary phase diagram of 
DOPC:DPPC:cholesterol was suggested [67].  
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Figure 1.7 – The suggested later phase diagram of liposomes composed of 
DOPC:DPPC:cholesterol by J.T. Buboltz et al. Yellow dashed line in region B displays the 
previous lo and ld phase boundary presented for the same liposome systems by 
S.Keller et al. Region A displays the boundary at which cholesterol crystallises in the
membrane, and region C displays the compositions where the membrane is in a lgel phase. 
This phase diagram was conducted from data collected at 25 oC [67]. 
The phase diagram for nano vesicles presented by J.T. Buboltz et al. does potentially show a 
difference between the nano and giant liposome model systems. However, this could also be 
rationalised as a discrepancy between the analytical phase boundary detection techniques. 
Regardless of this the authors argue that the difference between zone B and the previous ld-lo 
phase model by S.Keller et al. is through the preparation of their samples by Rapid Solvent 
Extraction (RSE) [67]. RSE relies upon rapid drying under vacuum and immediate hydration, 
rather than slower electro-cell vesicle preparation [67].  
This review concludes that the two ternary phase diagrams cannot be compared for two reasons: 
The liposomes used by S.Keller et al. in phase boundary experiments are giant unilamellar 
vesicles (GUVs), with diameters in the range of 10-50 µm. Whereas in RSE prepared liposomes 
diameters are not quoted, but it can be assumed that they are on the nanoscale. Secondly the 
temperatures at which the phase diagrams have been recorded at are different. S.Keller et.al. 
quotes a phase diagram at 30 oC and J.T.Buboltz et.al. quotes a phase diagram at 25 oC. As 
previously discussed an increase in temperature promotes lipids into the ld phase making lo 
domains smaller in size [74]. Furthermore, the GUVs have more membrane material which drives   
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faster nucleation of domains where in small vesicles nucleation will be slower. Therefore 
preparation time could be key in determining whether domains form for particular compositions. 
This review will limit itself to the study of three component DPPC:DOPC:cholesterol lipid 
systems, due to the components being relevant to this project, and this project only adding a 
fourth lipid component, cardiolipin (CL), at a low constant 10 mol%. At this low percentage, it 
was assumed that any significant phase behavioural changes would be avoided (see section 
1.4.1 page 27). It is of note however that a four component lipid system has been mapped by G. 
W. Feigenson et al. using a mixture of 
distearoylphosphatidylcholine:dioleoylphosphatidylcholine:1-palmitoyl,-2-
oleoylphosphatidylcholine:cholesterol (DSPC/DOPC/POPC/cholesterol) lipids [75].  
1.2.2.2 Tie lines 
Similarly to binary lipid systems, tie lines in three component phase diagrams are used to 
calculate how much of a liposomes surface is phase separated. Unlike a binary system ld-lo tie 
lines do not run parallel to the x-axis, instead moving from the three phase triangle to the critical 
point, where the three phase tringle must exist to comply with phase diagram thermodynamics. 
To determine the tie lines of a ternary lipid phase diagram a number of techniques have been 
used including x-ray scattering and nuclear magnetic resonance (NMR) 
techniques [76], [77], [78]. The methods behind each technique will not be considered here. 
However, both NMR and x-ray spectroscopy have shown good agreement to the direction of the 
guide tie lines shown Figure 1.8. 
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Figure 1.8 – Ternary phase diagram displaying tie lines moving across the DOPC/DPPC 
axis at 15 oC. The fine dotted lines with open diamonds display the NMR data collected by 
S.L Veatch et.al. the diamonds signifying the ld and the lo phase boundary [78]. The black
triangle displays a suspected three phase region where ld, lo and the lgel (So) coexist [78]. 
The red lines and circles display the data gathered through the x-ray study [76]. All other 
lines can be ignored for the purpose of this review. 
The overall direction of the tie line is of high importance; however, the exact angle is not required 
when building heterogeneous liposomes. The requisite for an utmost accurate angle not being 
necessary can be best described in conjunction with Figure 1.9. 
Figure 1.9 – A modified S. Keller phase diagram with an incorrectly drawn tie line (red) and 
the experimentally determined tie line (blue).  
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Through use of the lever rule in combination with the tie lines present within Figure 1.9, the blue 
line will predict that sample x will have a smaller liquid ordered domain than would be predicted 
with the red tie line. This example displays that without correctly mapped and oriented tie lines, 
vesicle structures would be difficult to predict. Moving across to the right of the experimentally 
measured blue tie line enables phase separation to be controlled in a manner similar to the 
cartoon in Figure 1.10. 
Figure 1.10 – Three Janus liposomes with increasing concentrations of saturated lipid 
across the experimentally measured (blue) tie line presented in Figure 1.9 when vesicles 
are left to equilibrate. 
1.2.2.3 Measuring domain Size 
Rather than using the lever rule to approximate potential domain sizes, different techniques have 
been implemented to measure them, with methods being dependent upon vesicle size and the 
suspected domain sizes. Lipid-fluorescent dyes coupled with confocal fluorescence microscopy, 
enabled images of >micrometre sized vesicles to be taken. The resulting images permit a scale 
bar to be used as a ruler to measure domain size. However, care has to be taken when 
interpreting these domain size measurements, due to the lack of consideration towards 
membrane curvature. These intrinsic inaccuracies can be accounted for though corrections being 
applied in image analysis. Criticisms aside, the raw measured data will give a good approximation 
to the respective domain size. Nevertheless, confocal fluorescence microscopy is limited with 
respect to the size of liposome it can image, due to its inherent use of light. The Abbe diffraction 
limit (d) (Equation 1.5) prevents the resolution of <~200 nm structures [79].  




This limit is dependent on the numerical aperture of the lens (2nsinθ) and the wavelength of light 




refractive index of the imaging medium [79]. A larger angle and refractive index leads to a greater 
numerical aperture, granting a better resolution. In addition, smaller wavelengths of light 
contribute to a better resolution through greater refraction. With a microscope’s average 
numerical aperture being 0.2-1.4 the maximum resolution of 520 nm beam of light is ~370-
260 nm [79]. Therefore nanometre sized domains on nano sized vesicles cannot be imaged using 
visible light microscopy as the vesicles are under the maximum resolution [80]. Phase separation 
on vesicles with nanometre diameters, required for cellular uptake, necessitates the application 
of other techniques.  
Nanometre domain size measurements have been carried out for binary systems using a FRET 
based method, where the fluorescent tags phase separate in the ld and lgel phases [80]. More in 
line with this project’s aims, the same techniques were used to investigate 
DOPC:DPPC:cholesterol liposomes [80], [81].  
Initially the FRET based model for calculating domain sizes considers that there are two FRET 
pathways; either energy can be transferred across the bilayer in the same monolayer or 
transversely through the bilayer. Due to the large separation between the probes through 
(perpendicular to the membrane plane) the bilayer, FRET will be more predominant parallel 
across the membrane. As a result, low fluorescence is recorded from inter-monolayer FRET, 
outputting significantly less acceptor fluorescence intensity. This is in accordance with FRET’s 
Förster radius (Ro) dependence (discussed in section 2.1.3.1 page 45). The resulting FRET 
efficiencies therefore describe lateral probe partitioning. Through phase separation saturated and 
unsaturated lipid probes de-mix, raising inter probe separation, reducing FRET efficiency. From 
FRET efficiency an average probe separation was calculated [80], leading to the formation of an 
extended DOPC:DPPC:cholesterol phase diagram [81].  
Figure 1.11 – DOPC:DPPC:cholesterol ternary phase diagram with ld-lo phase region fitted 
with suggested domain sizes (shaded area). The dashed line represents the suggested 
extension of the two phase ld-lo region, when the domain size model was applied [81]. 
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The authors acknowledge that there is a major limiting factor of the model outlined. Through the 
inverse sixth power relationship in FRET calculations, the model can only consider domains 0.5-
10 nm in diameter. When domains are in the range of 10 nm the model calculates equivalent 
energy transfer profiles. Even with this addressed, the authors plot domains >10 nm, which are 
high in error due to the loss in resolution at large distances [81]. It is of note that no definitive 
calculated errors are quoted. Furthermore it is debated the model cannot distinguish one domain 
size from another for large domains [80]. Finally it is discussed that the model assumes the 
smallest domains are always saturated lo domains; this assumption limits the models wide 
potential use, preventing the ability of calculating ld nanometre domain diameters [80].  
Once vesicle surface heterogeneity had been achieved and demonstrated it was desirable to 
functionalise a vesicles surface to generate a Janus particle. However homogeneous vesicle 
functionalisation will first be discussed.  
1.3 Homogeneous DNA functionalised liposomes 
Research investigating DNA integration into both hard and soft colloidal systems has been 
examined for new gene therapy treatments, and more pertinently to this project, DNA connected 
colloidal superstructures [82]. In regards to this project, both hard and soft colloids have been 
shown to hybridise together, with the complementary DNA strands present on opposing 
particles [43]. In both cases the use of DNA offers many advantages namely; high specificity 
through the ATGC base pair coding for programmable assembly of aggregates and a 
programmable reversible aggregation, dependent upon surrounding conditions (discussed in 
section 1.5 page 38) [43]. It is of note that there are further benefits of using vesicles over their 
hard counterparts beyond their intrinsic biocompatibility; specifically, vesicles are structurally 
deformable. The inherent deformability affords the lipid membrane flexibility, reducing the strain 
on the helical DNA bridges, thereby providing an enthalpic gain over rigid particles [83] . While 
not directly linked with this project, DNA has also been shown to aid the fusion of vesicles [84]. 
Hard colloidal particles cannot mimic this behaviour, preventing the ability to tailor small scale 
reactions through vesicle cargo mixing. DNA vesicle integration consequently has a richer 
diversity of techniques and potential products over the hard colloidal alternative. Moving forward 
this review will only consider vesicles and DNA mediated cluster formation. 
DNA directed lipid clusters have many applications beyond the realm of drug delivery. A 
substantial area of interest lays in mimicking biology’s ability to compartmentalise cellular 
chemistry on micrometre and sub-micrometre length scales, using multi step reactors. These self-
assembled reactor clusters would grant control over chemical processes, allowing for the 
maintenance of small quantities of active compounds at high concentrations [85], [86]. 
Furthermore, multi-step reactions in chemically incompatible environments (e.g. acidic and 
alkaline pH, or oxidising and reducing environments) could be achieved as the reactants move 
through each localised compartment [86]. 
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The first experiments documenting tethered vesicle superstructures used homogenous liposome 
compositions in combination with commercially available cholesterol DNA (chol-DNA) lipids [43]. 
Upon vesicle formulation chol-DNA was applied, enabling the cholesterol moiety to anchor itself 
within the hydrophobic part of the bilayer, resulting in the DNA strands being randomly distributed 
out from the surface of the liposome. Figure 1.12 demonstrates when complementary cholesterol 
DNA is applied to separately prepared liposomes and then mixed, the DNA hybridises linking the 
two different liposomes together [43]. 
Figure 1.12 – An equator confocal microscopy image of two different populations of POPC 
liposomes tagged with complementary DNA (chol-DNA 10 mers) hybridised together. The 
colours (red and green) represent the different liposome types using a 
5.0 ×10-3 ssDNA/lipid in a 38 mM Na+ solution [43]. 
To image the hybridised vesicles the groups of liposomes were tagged with two different 
fluorescent probes: 1,2-dipalmitoyl-sn-phosphoethanolamine-N-[lissamine rhodamine B sulfonyl] 
(Rh DPPE (red)) and Oregon Green 1,2-dihexadecanoyl-dn-glycero-3-phosphoethanolamine 
(Oregon Green 488 (green)) in conjunction with confocal microscopy. 
To enhance the hybridisation seen in Figure 1.12 between vesicles, further similar experiments 
were imaged. Figure 1.13 displays the resulting level of hybridisation between vesicles when the 
DNA loading was decreased and salt concentration was increased from 5.0 ×10-3 ssDNA and 
38 mM Na+ to 1.3 ×10-3 ssDNA and 47 mM Na+ respectively.  
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Figure 1.13 - An equator confocal microscopy image of two different populations of POPC 
liposomes tagged with complementary DNA (chol-DNA 10 mers) hybridising together. The 
colours (red and green) representing the different liposome types in a 
1.3 ×10-3 ssDNA/lipid, 47 mM Na+ solution [43]. 
Even though the number of DNA strands was dropped, Figure 1.13 shows that salt shielding the 
negative phosphate back bone of the DNA has a profound effect on increasing levels of 
hybridisation. 
While showing promise in terms of cluster size controllability, the data presented in Figure 1.12 
and Figure 1.13 display a lack of specificity, where red and green liposomes are shown to be 
homogenously aggregating. This mono-aggregation should not be possible when considering the 
inherent DNA specific coding. To accommodate this observation the authors recognise that the 
cholesterol anchor and with it DNA linker, must be exchanging between liposomes [43]. The 
swapping mechanism was also discussed to be potentially enhanced by sucrose being present 
within the buffer, where cyclic sugar based molecules have been demonstrated to extract 
cholesterol from membranes [87]. Sucrose’s structure is partially non polar (~25% of its surface) 
[87]; and therefore sucrose molecules could potentially cluster around non polar cholesterol, 
reducing the free energy difference between being anchored in the hydrophobic part of the bilayer 
and the aqueous solution [43]. 
1.4 Heterogeneous DNA functionalised liposomes 
1.4.1 Cholesterol DNA conjugates 
Being able to understand and control phase separation over a liposomes surface, grants the 
ability to localise functionality to a particular hemisphere of a vesicle. In the literature, phase 
25 
separation selectivity has been exploited to localise DNA conjugates to form Janus particles with 
“sticky” patches of DNA. Through using complementary DNA sequences, directional bridges 
between liposomes enable the formation of size limited clusters. 
To overcome the previous cholesterol membrane switching issue, two new DNA vesicle bridging 
techniques were devised: The first utilised two cholesterol moieties with partially matching DNA 
sequences in the same liposome which hybridise together. The partial hybridisation still enables 
one longer sequence to heterogeneously bind together with a complementary vesicle [88]. The 
second method involved one DNA sequence being attached to two cholesterol moieties, thereby 
again doubling the anchorage to the bilayer through an increase in cholesterol lipid 
interactions [88]. The three methods discussed so far can be summarised in Figure 1.14. 
Figure 1.14 – DNA-cholesterol membrane binding methods. A displays cholesterol bound 
to a single DNA bridging group and C displays its cartoon representation when inserted 
into the membrane. B and E display the structure and a cartoon representation of two 
cholesterol moieties attached to DNA inserting into the membrane. Finally D shows a 
cartoon of two cholesterols both with a DNA sequence capable of binding together, with 
one sequence being longer than the other to allow for heterogeneous liposome 
bonding [88]. 
In ld-lgel phase separated vesicles, the partitioning of the chol-DNA was monitored using 
complementary DNA fluorescent dye conjugates. Subsequent DNA hybridisation enabled the 
detection of cholesterol DNA partitioning when combined with confocal fluorescent microscopy. 
Literature discusses that both the single and double cholesterol anchors predominantly partition 
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to the ld phase when the liposomes contain 1,2-dilauroyl-sn-glycero-3-phosphocholine: 1,2-
dimyristoyl-sn-glycero-3-phosphorylethanolamine (DLPC:DMPE) lipids in a one to one ratio. This 
result was rationalised through impurities within lipid bilayers always entering the most disordered 
phase, due to a high free energy cost of entering a highly ordered saturated gel phase [88]. In 
other words, it is rare for molecular additives to have a lower free energy cost when inserting into 
phases with a higher molecular ordering [88]. This behaviour contrasts with untagged cholesterol 
partitioning, whereby, cholesterol would normally enter a more saturated lipid domain. To 
understand this behaviour the cholesterol umbrella model must be discussed. Briefly, this model 
suggests cholesterol’s small polar headgroup is insufficient in size to shield its large hydrophobic 
body from water. Fortunately when cholesterol is in a bilayer, neighbouring lipids manoeuvre their 
hydrophilic head groups towards cholesterol’s hydroxyl group, which in turn covers the exposed 
hydrophobic body of cholesterol [89]. Specially in regards to cholesterol partitioning, a lipids ability 
to minimise cholesterol’s water exposure is linked with the level of saturation in the lipid tail. 
Unsaturated lipids have less degrees of freedom and understandably, pack poorly with 
cholesterol, when compared to their saturated counterparts, resulting in poor coverage of 
cholesterol. Thus, untagged cholesterol preferentially partitions in domains rich with saturated 
chains, over those with mono- or polyunsaturated chains [89]. Furthermore, the need for the 
stabilising umbrella effect is likely minimised when cholesterol’s small hydroxyl group is used to 
attach the bulky hydrophilic DNA moiety. 
In ternary lipid systems, confocal images displayed the level of cholesterol DNA partitioning to be 
dependent upon whether a single cholesterol moiety or the bi-cholesterol DNA conjugates were 
applied. For the latter, the double anchored DNA cholesterols partitioned preferentially to lo 
domains. Through the fluorescence intensities of labelled DNA, it was calculated that the 
concentration of double anchored DNA in the lo phases was double that of the ld phase [88]. For 
single cholesterol DNA conjugates there was a 10-20% preference of cholesterol entering the lo 
phase [88]. This observation was rationalised through DOPC in the ld phase having unsaturated 
carbon bonds, increasing the difficulty of cholesterol entering the domain. The rigid structure of 
cholesterol has a reduced number of degrees of freedom in the ld phase over the lo phase [90]. 
Explicitly, this is an entropic based argument where cholesterol has limited degrees of freedom 
or n conformations within the ld phase, and qn possible conformations with q >1 in the saturated 
lipid region [88]. Similarly, the double anchored cholesterol DNA’s partitioning can also be 
explained using the method described, with the addition of the assumption that conformational 
freedom between the two cholesterols is not coupled. The adapted model describes the first 
cholesterol entering the ld bilayer in n configurations, with the second cholesterol also having n 
configurations. The cholesterol anchors can therefore enter the ld domain in n2 configurations. 
When applying the same logic to the lo domain the cholesterols can enter the bilayer in q2n2 
configurations [88].  
Putting cholesterol partitioning theory aside, through being able to coordinate and enrich a lo 
domain with DNA using the two cholesterol anchors, a heterogeneous liposome is converted to a 
Janus particle. The localisation of DNA affords the user the potential to build AB tethered vesicle 
structures rather than forming large uncontrolled aggregates as previously outlined. However, 
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though using a cholesterol membrane anchor, a significant proportion of DNA still partitions to the 
ld phase of the membrane, removing the binary specificity required for controlled size limited 
aggregation [88].  
To influence a stronger partitioning of the cholesterol DNA conjugates, a membrane composition 
in the centre of the DOPC:DPPC:cholesterol ld-lo coexisting phase was adapted to include the 
highly unsaturated lipid, CL. It was hoped that CL would mprove DNA partitioning to a specific 
phase and thus a create a more definitive binary Janus liposome. In these experiments 10 mol% 
unsaturated DOPC was replaced with CL. In essence, a lipid with two unsaturated symmetric acyl 
chains was exchanged for a lipid with four highly unsaturated symmetric acyl chains as outlined 
in Figure 1.15. 
Figure 1.15 – A comparison of unsaturated lipid chemical structures: A – 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC). B - cardiolipin. 
Due to CL’s highly unsaturated nature it strongly resides within the ld  phase, influencing both lipid 
and cholesterol partitioning [91]. CL inclusion is thought to increase lateral packing stress of lipids 
within the bilayer. In other words, the increased stress generated through CL inclusion creates a 
localised negative curvature force within the membrane [91]. It was hypothesised that the 
increased lateral stress in the hydrophobic region of the bilayer, may lead to an increase the 
cholesterol DNA free energy cost of packing into the ld phase. As a result CL would enhance the 
partition of cholesterol DNA conjugates into the lo domain, promoting directional DNA bridging 
between vesicles [91]. 
When implementing CL inclusion experimental data displayed that the exchange of 10 mol% 
DOPC with CL had a significant effect on the partitioning of both single and double cholesterol 




anchored DNAs [91]. Additionally double anchored chol-DNA was shown to provide superior lo 
partitioning, displaying an order of magnitude difference between the ld and lo phases [91]. 
However, introducing CL to the phase diagram creates a four component system rather than three 
component one. In order to minimise changes in DOPC:DPPC:cholesterol phase behaviour, CL 
content was maintained at 10 mol%. This nevertheless is an estimate and CLs addition to the 
phase diagram would ideally need to be mapped, this in turn could allow selectivity in vesicle 
composition to drive separation. Rather than exploring this avenue to vesicle binding, the authors 
examined replacing cholesterol conjugates with lipid-DNA based conjugates to gain greater DNA 
partitioning control.  
1.4.2 Lipid-DNA conjugates 
It was initially hypothesised that DNA tagged lipids (lipid-DNA) would provide an opportunity to 
create an improved Janus liposome. The lipid moiety was suspected to be able to grant stronger 
bilayer interactions than cholesterol, increasing DNA anchorage to the bilayer, preventing DNA 
liposome swapping. Furthermore, the lipid acyl chain would also potentially offer a more robust 
DNA partitioning to the lo phase, than seen in cholesterol mediated anchorage. However, DNA 
tagged lipids were not commercially available; consequently lipid-DNA had to be formed using a 
phosphoramidite approach undertaken in house. This process was broken up into a two-step 
synthesis, the schematic of which is displayed within Figure 1.16. 
Figure 1.16 – Reaction scheme for creating a DNA tagged saturated lipid using the 
phosphoramidite approach [84]. 
The preparation of lipid-DNA involved a functional group substitution whereby the chlorine in 2-
cyanoethyl N, N-diisopropylchlorophosphoramidite was removed and the “lipid tail” of 
1,2-O-dioctadecyl-rac-glycerol was attached, forming a lipid phosphoramidite. The lipid 
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phosphoramidite was then dissolved in dichloromethane and attached as the “last base” to the 
DNA oligomer, generating the lipid-DNA conjugate [84]. 
Initial data from the inclusion of lipid-DNA conjugates within DOPC:DPPC:Cholesterol 
membranes, displayed a significant two to three times higher partitioning into the lo phase over 
the ld domains [91]. Additionally, the incorporation of 10 mol% CL into DOPC:DPPC:cholesterol 
vesicles, strongly influenced the partitioning of lipid-DNA conjugates. Using confocal fluorescence 
microscopy coupled with DNA fluorescence tagging, the Janus surface of the CL containing 
liposomes was imaged, whilst also enabling the relative fluorescence intensities to be plotted. 
Figure 1.17 – An example of a confocal image of a DOPC:CL:DPPC:cholesterol liposome 
sliced through its equator. The green line represents an example of an intensity profile 
drawn through the coexisting phases. The red Rh-DOPE fluorescent dye displays the ld 
phase and the blue A647-DNA conjugate dye displays the DNA functionalised surface of 
the Janus particle in the lo phase [91]. 
From the fluorescence intensities (an example of which is plotted in Figure 1.17) it was inferred 
that the addition of CL had resulted in an order of magnitude increase in lipid-DNA partitioning to 
the lo phase, over the ternary mixture of DOPC:DPPC:cholesterol [91]. Lipid-DNA conjugates in 
conjunction with CL provided a route to form improved directional size limited clusters, where 
work discussed previously using cholesterol-DNA conjugates had failed or had been shown to be 
not as affective [43].  
Further samples combining CL addition with lipid-DNA were made and imaged through 
fluorescent microscopy. These new samples demonstrated the abundance of interactions size 
limited clusters can form when DNA is effectively localised to individual vesicles and domains. 
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Figure 1.18 – Janus liposomes adhering together through complementary DNA 
hybridization with varying salt concentrations shown through confocal fluorescent 
microscopy images. The red fluorescent dye (Rh-DOPE) depicts the ld phase and green 
fluorescent dye (NBD-DPPE) displays lo regions functionalised with DNA [91]. 
Other than displaying the benefit of CL and lipid-DNA addition, Figure 1.18 illustrates evidence 
for a further advantageous effect between DNA adhesion plaques that helps promote size limited 
cluster formation. Due lipids forming soft deformable membranes, adhesion plaques of DNA can 
be flattened and misshapen. This membrane malleability results in the DNA plaques flattening 
together, encouraging DNA hybridisation initially limited by liposome curvature. Furthermore, flat 
adhesion plaques lead to only the ld phase, with very dilute lipid-DNA present, being on the 
exposed periphery of the cluster; limiting any further hybridisation with other vesicles [91].  
Once directional DNA bridges between vesicles were successfully formed and imaged, a loose 
model for DNA vesicle adhesion was created to account for the differences in the number of 
hybridised vesicles in Figure 1.18. The model takes into consideration both the strength of the 
DNA hybridisation between strands; which considers salt concentration and temperature, and the 
surface concentration of DNA/receptors within the phase [91]. 
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Figure 1.19 – Model displaying how surface concentration of DNA/receptors affects 
nanoparticle adhesion against the strength of e.g. DNA bonds [91]. 
Through interpreting the model, it can be seen that lots of short/weak bonding DNA sequences 
on the surface of the liposome would be required for liposome adhesion. Alternatively, few very 
long strongly hybridised DNA sequences would also result in liposome binding. The model also 
displays that in low salt concentrations, hybridisation and aggregation will be poor. The model 
therefore predicts that external stimuli can control both DNA hybridisation and dissociation, 
subsequently governing any liposome aggregation. Through DNA’s switchable and reversible 
nature, a switchable device tailored towards therapeutic drug delivery is conceivable. In an effort 
to make this device a reality, work studying the dissociation of DNA-liposome clusters is 
imperative. 
1.4.3 Dehybridisation of DNA 
Liposomes tethered together through DNA have been demonstrated to reversibly aggregate and 
disassemble through a change in temperature as shown within Figure 1.20. 
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Figure 1.20 – Screenshots taken from a video of thermally driven assembly and 
disassemblyof DNA bridged liposome clusters [43]. 
Initially at cooler temperatures the vesicles shown within Figure 1.20 cluster together, forming a 
white flocculate that scatters incident light (a). Through heating DNA begins to dehybridise 
causing vesicles to break away from the initial large cluster (b). Additional heating then drives 
further dispersion of vesicles from the initial plaque (c). During the cooling cycle the opposite 
trend is recorded where liposomes bind together to form visible flocculates (d-f).  
To melt DNA, the thermal energy of the solution needs to be greater than that of the hydrogen 
bonds between the ATGC base pairs connecting the strands together. To weaken this hydrogen 
bonding and lower the melting temperature of the DNA (Tm), salt concentration can be 
decreased. DNA has base pairs connected to sugars which in turn are all connect through 
a negatively charged phosphate backbone. The weak hydrogen bonding base pair recognition 
system of DNA is only possible with sufficient positive salt ions, screening the negative 
phosphate charge. To ensure DNA tethered vesicles with intended biological use are stable at 
37 oC it is appropriate to measure/calculate DNA melting temperatures.  
This review will now consider a few approaches to calculating and measuring Tm of DNA. 
Classically when calculating Tm two equations can be used: the first being the Wallace rule.  
Equation 1.6 - 𝑻𝒎 =  𝟐( #𝑨 + #𝑻 ) + 𝟒( #𝑪 + #𝑮) [92] 
Where Tm is the melting temperature of DNA in degrees Celsius #A #T #C #G are the respective 
numbers of base pairs in the DNA sequence. The Wallace rule has limited potential use, it is 
discussed that it is best applied when calculating sequences 14-20 base pairs long in a sodium 
chloride  solution  equal to 1 mol dm-3, [93], [94].  Furthermore  the Wallace  rule  in its  simplicity
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does not consider DNA concentration, changes in salt concentration or any nearest neighbour 
interactions, therefore making it inaccurate and inappropriate to use. A more accurate method
for calculating the Tm involves an equation termed the nearest neighbour empirical formula 
(Equation 1.7) [95]. Its improvement over the Wallace rule is due to both the sequence of base 
pairs and the environmental salt concentration being taken into consideration. 
Equation 1.7    𝑻𝒎  =  (𝟏𝟎𝟎𝟎∆𝑯)/𝑨 +  ∆𝑺 +  𝑹𝒍𝒏 (𝑪/𝟒)  −  𝟐𝟕𝟑. 𝟏𝟓 +  𝟏𝟔. 𝟔 𝒍𝒐𝒈[𝑵𝒂+]    [95] 
ΔH is the sum of nearest neighbour enthalpic interactions; A is a small constant to correct for 
helical initiations; ΔS is the sum of nearest neighbour enthalpic interactions (where ΔH and ΔS 
are found tabulated in data books); R is the molar gas constant; C is the concentration of the oligo 
and [Na+] is the concentration of salt (sodium ions) [93]. 
However, for complex DNA-liposome tethering it is more appropriate to use an experimentally 
driven method to measure the Tm of DNA rather than calculate it. Through experimentally 
measuring Tm, potential liposome effects that could change the melting temperature are recorded, 
leading to better modelling of vesicle aggregate systems. Additionally through measuring the Tm 
both ΔH and ΔS can be more accurately calculated as a function of concentration [96].  
DNA is widely known for having distinct ultraviolet (UV) absorption peaks at 260 and 280 nm, 
where the ratio of the absorbance’s at these wavelengths is used to determine DNA purity [97]. 
Absorbance at the UV range has been discussed to be due to π to π* electronic transitions of the 
base pairs. These transitions are only available when the DNA is in its free form; once hybridised 
DNA absorbance is significantly reduced [98]. In line with this, heating and cooling cycles of DNA 
have shown to exhibit a UV absorbance sigmoidal transition curve. Transition curves were 
smoothed and the upper and lower baselines were normalised to f=0 and f=1 were f is the fraction 
of unbound bases [96]. The centre of the curve where f= 0.5 represents the Tm of the DNA. To 
extract the Tm the first derivative was taken and plotted with the peak maximum being the Tm. A 
similar experimental procedure can be implemented to calculate Tm of DNA liposome 
aggregations but at 320 nm with melting curves being attributed to scattering [96]. 
To extract entropy and enthalpy data, a series of van’t Hoff plots for DNA tethered vesicles was 
produced through raising the concentration of DNA/vesicle. Such plots have been outlined in 
Figure 1.21. 
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Figure 1.21 – An example of van’t Hoff plots for the melting data of non-Janus DNA bridged 
POPC, POPG vesicles, implementing cholesterol DNA conjugates. The graph shows DNA 
concentration on the vesicle surface plotted against inverse temperature. 
Diverting from the main narrative of this review, it would appear that there is a mistake on the 
graph presented in Figure 1.21. Specifically, the DNA concentrations plotted would not be feasible 
if the x axis label is to be believed. Nevertheless, a derivation of the traditional van’t Hoff equation 
for modelling DNA hybridisation was made by the authors, describing the effect of liposome 
intermembrane forces on DNA melting [96]. The van’t Hoff equation and its liposome derivative 
are shown in Equation 1.8 and Equation 1.9 respectively. 
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 Equation 1.8 - 𝑻𝒎 =  
∆𝑯𝟎
∆𝑺𝟎+𝒌𝑩𝒍𝒏 (𝑪𝑻 𝟒⁄ )
 [98], [99] 
 Equation 1.9 - 𝑻𝒎 =  
∆𝑯𝟎+𝑼𝑭
∆𝑺𝟎+𝒌𝑩𝒍𝒏 (𝑪𝑻 𝟒⁄ )
 [96] 
Where ΔH and ΔS are the enthalpy and entropy change per molecule between single and double 
strands of DNA, KB is the Boltzman constant, CT is the total concentration of DNA strands and UF
is the work done by intermembrane forces [96]. In conjunction with the van’t Hoff plot and 
Equation 1.9, the gradient and intercept are R/(ΔH +UF) and ΔS/ΔH respectively, enabling ΔH 
and ΔS to be calculated where R is the molar gas constant. The model developed to estimate UF 
displayed that intermembrane forces do play an important roll for short DNA sequences, with 
longer sequences reducing the effect of intermembrane pressures [96]. Thirty BP sequences 
were shown to be adequate in providing tethering without significant intermembrane forces. The 
authors further discuss that intermembrane forces are not just unique to liposomes but also 
significant to other NPs tethered using DNA [96]. 
Lipid-DNA conjugates have so far been shown to have melting temperatures dependent upon 
DNA length, salt concentration, nearest neighbour interactions and the attached NP. This review 
will now examine how modified DNA sequences can make for programmable dehybridisation.  
1.5 DNA i-Motifs 
In nature DNA extensively exists in its B-form double helix state, but it is well researched that 
DNA can form other secondary structures including; three way junctions, triplexes and 
quadruplexes [100], [101]. i-motifs are an example of a C-quadruplex, where cytosine-rich DNA 
sequences intercalate (i) together to form a self-hybridising strand of DNA [102]. A cartoon of 
regular B-form DNA attached to C-quadruplex DNA has been shown in Figure 1.22. 
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Figure 1.22 – A cartoon of the Watson-Crick duplex structure and the C-quadruplex 
intercalated DNA structure.  
DNA i-motif sequences are responsive to pH’s in acidic conditions, the added protons afford 
cytosine to become hemiprotonated at the N3 position (Figure 1.23), forming cytosine–cytosine 
hydrogen bonded base pairs. The resulting hybridisation produces stronger intra-strand BP 
interactions over inter-strand cytosine-guanine bonding [102]. The preference of C-rich DNA to 
intercalate with itself in acidic conditions dehybridises Watson-Crick duplex DNA, creating a 
switch.  
Figure 1.23 – Hemiprotonated DNA cytosine–cytosine hydrogen bonding in acid 
conditions [103]. 
An i-motif structure can form as two variants which are dependent upon the positioning of the 
outermost cytosine–cytosine bonding base pair [104]. The position of the base pair more 
specifically relates to whether the cytosine is in a 3’ or the 5’ site in the DNA [105]. Resulting 
structures from cytosine’s 3’ and 5’ positioning were determined through NMR and are shown in 
Figure 1.24. Figure 1.24 also shows wide and narrow grooves still being present in the hybridised 
molecule, where the small groves are thought to be a major stabilising factor enabling CH⋯O 
hydrogen bonding. 
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Figure 1.24 – (a) An NMR determined structure for an example 3’ based cytosine system, 
(b) a schematic diagram for an example 3’ based cytosine system, (c) an NMR determined
structure for an example 5’ based cytosine system, and (d) a schematic diagram for an 
example 5’ based cytosine system [106]. 
The pH sensitivity of i-motif formation is spread from pH’s 7 to 3, where the exact pH is dictated 
by the surrounding conditions and the addition of stabilising and destabilising features in the DNA 
sequence [106]. i-motifs still have phosphorus and sugar backbones making them susceptible to 
salt conditions as seen for the Watson-Crick duplex. Low salt concentration results in limited 
shielding of the negative phosphate groups, introducing intrarepulsion of DNA preventing 
intrahybridisation. Furthermore, guanine or thymine insertion into the cytosine sequence makes 
DNA i-motif formation unfavourable, through reducing the stabilising hemiprotonated cytosine–
cytosine hydrogen bonding [105]. 
Previous studies have attached i-motif sequences to GNPs, via a thiol attachment, in an effort to 
develop a targeted drug release mechanism in cancer therapy. At homeostatic pH (~7.4) i-motifs 
form duplexes, however when in a low pH environment, for example, in close proximity to 
diseased tumour tissue or in an intracellular endosomal/lysosomal compartment, it is hoped the 
i-motif will present a triggered response. Using a complementary hybridised sequence with
doxorubicin, a model anticancer drug, was stably intercalated into the duplex [107]. Upon reducing 
the pH down to ~5.1, cytosines became hemiprotonated promoting intrahybridisation and DNA 
dissociation, subsequently releasing doxorubicin [107]. This mechanism is displayed in 
Figure 1.25.  
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Figure 1.25 – Cartoon displaying the pH controlled loading and release of doxorubicin 
(DOX). At normal physiological pH (7.4), DOX is intercalated in the DNA duplex which is in 
turn attached via a thiol group to the GNP. In an acidic environment (pH < 5.1), DNA 
dissociates releasing DOX. Inset showing the formation of an i-motif [107]. 
Through exploiting the i-motif pH switching mechanism, as demonstrated by D. Zhou et al., a 
biologically relevant triggered release could be implemented in vesicle therapeutic nanocarrier 
design. Once incorporated into NP flocculates, i-motifs could promote the destabilisation of NP 
bridges for a triggered response. In other words, lipid-DNA i-motifs can be tailored towards a 
targeted delivery technique, whereby a flocculation of NPs can be broken up in the presence of 
an acidic site; for example within tumours [108]. Furthermore, by using lipids instead of GNPs and 
thiol attachment groups, there is a higher degree of control in regards to in transit therapeutic 
protection and therapeutic loading. Additionally, the employment of lipid based drug delivery 
technology ensures the benefits previously discussed in section 1.1.2 page 4. 
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1.6 Aims 
Three themes run through the papers reviewed here. The first demonstrates the potential of 
liposomes as therapeutic nanocarriers over their hard and soft counterparts. The second 
illustrates DNA being used as a responsive tether to directionally link dimer AB liposomes 
together, rather than form uncontrolled clustering. And finally, DNA i-motif incorporation was 
discussed in reference to yielding a potential triggered vesicle dissociation mechanism.  
These three topics were directed towards the overarching project goal of developing directionally 
linked Janus DNA connected vesicle clusters, to form the basis of a new therapeutic drug delivery 
platform. It is hoped that this platform will be then be taken forward and tailored towards “real 
world” treatments. However, to produce the initial drug delivery platform four key stages need to 
be fulfilled in this project:  
1. Map a four component phase diagram of DOPC:DPPC:cholesterol:CL using 100 nm
diameter liposomes where cardiolipin is set at 10 mol%.
2. Incorporate lipid-DNA into vesicles and measure hybridised vesicle flocculate melting
temperatures, ensuring platform stability and DNA suitability.
3. Examine resulting size limited DNA hybridised vesicle flocculate size through DLS, in
conjunction with the newly plotted phase diagram.
4. Integrate lipid-DNA i-motifs within vesicles and measure a pH triggered response.
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Experimental procedures 
This chapter examines the instrumentation, materials and methods used/carried out throughout 
this project. Additionally, a brief scientific introduction is given to each instrument used. 
Instrumentation and theory 
Thermocouple 
A type K thermocouple was implemented to ensure the temperature of key stages in vesicle 
preparation was maintained above the highest lipid melting temperature. Furthermore, a 
thermocouple monitored the temperature within the fluorometer when conducting FRET 
experiments. Within a K type device alumel and chromel alloys are fused together, where: alumel 
is 95 % nickel, 2 % manganese, 2 % alluminium, 1 % silicon and chromel is 90 % nickel 10 % 
chromium [109]. Due to the Seebeck effect, when the fused junction between the dissimilar metals 
is heated a temperature gradient is formed across the wires. This temperature increase allows 
the movement of charge carriers to diffuse from the heated junction to the cold second 
junction [63]. The voltage difference generated was then applied to a calibration table [110]. The 
gradient between the two junctions is dependent upon the temperature of both junctions, therefore 
the reference junction was held at the calibration reference temperature of 0 oC, achieved through 
using an ice bath.  
Ultraviolet-Visible (UV-vis) spectroscopy 
When conducting the phosphorus assay to determine phosphorus content of samples, and DNA 
thermal-melt experiments, UV-visible spectroscopy was applied to measure the change in light 
absorbance. 
Light absorbance is due to electron excitation from the highest occupied molecular orbital 
(HOMO) to the lowest unoccupied molecular orbital (LUMO). This band gap between the HOMO 
and LUMO has an associated energy and a resulting associated excitation wavelength (λmax). 
Raising analyte concentration promotes the number of HOMO to LUMO excitations, increasing 
light absorbance. When calculating absorbance a reference is measured at the same wavelength, 
matching the solvent and cuvette type, to account for any absorbance that was not due to the 
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analyte [111]. The reference and sample signals can then be used to calculate the analyte’s 
absorbance. 




Where lo is the reference signal and I is the sample signal both measured in watts (W) and A is 
absorbance, a unit less parameter. Once absorbance has been calculated the Beer-Lambert law 
can be applied to calculate the concentration of analyte.  
Equation 2.2 -  𝑨 =  𝜺𝒍𝒄 [111] 
Where ɛ (M-1cm-1) is the molar extinction coefficient, a proportionality constant which allows 
different spectra to be compared. l is the path length of the cuvette (cm) and c is the concentration 
of analyte (moldm -3) [111]. 
In order to measure the change in light absorbance a UV-visible spectrometer requires a light 
source, which is dependent upon the wavelength of light required. Wavelengths that are in the 
UV range require a deuterium bulb, where as to generate wavelengths that are within the visible 
region a tungsten bulb is required [111]. Both bulbs generate a spectrum of wavelengths, which 
are broken into individual wavelengths through a monochromator [111]. The selected wavelength 
passes through the sample, where some of the light is absorbed, to the detector. The detector is 
commonly a photomultiplier tube (PMT) [111]. The basic instrument layout has been described in 
Figure 2.1. 
Figure 2.1 – A schematic diagram displaying the major components of a UV-vis 
spectrometer. Black arrows representing the pathway of light to the detector. 
Fluorescence spectroscopy 
Fluorescence spectroscopy was used in Förster Resonance Energy Transfer (FRET) 
experiments and was integral in the detection of nano-size vesicle phase behaviour. 
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Fluorescence is achieved by electromagnetic radiation being absorbed, through electrons being 
electronically excited, and then subsequently relaxing. The process of excitation and relaxation is 
best described when coupled with the Jablonski diagram presented within Figure 2.2. 
Figure 2.2 – Top: Jablonski diagram, where E is energy with S1, S2, S3 and T1 being 
electronic energy levels. Between the electronic energy levels V1, V2 V3 etc. represent the 
vibrational energy levels. Arrows display energy pathways where: blue; photon 
absorbance, green; internal conversion, red; fluorescence emission; brown-intersystem 
crossing, dark green; vibrational relaxation, dark red; phosphorescence [112]. Bottom: 
Normalised absorbance and emission spectra for 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD PE, FRET donor) and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rhod 
PE, FRET acceptor) at a concentration of 1 µg/ml in Chloroform respectively [113], [114]. 
From the Jablonski diagram it can be seen that the first transition is the excitation of an electron 
from the electronic ground state, to an electronic excited state (blue arrow). This transition is 
achieved through an incident photon of light being greater in energy than the energy gap between 
the ground and excited states [112]. The blue line in the spectra for NBD PE and Rhod PE in 
Figure 2.2 displays experimental data for the absorbance of this energy. Once excited the electron 
will then relax back to its ground state through various pathways: The Jablonski diagram displays 
that the molecule will initially relax through non-radiative intramolecular and intermolecular kinetic 
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movement, an example of this relaxation is represented by the dark green arrow [112]. The next 
option for relaxation is fluorescence; a drop from the energetically higher excited electronic state 
to the ground electronic state, releasing a photon shown by the red arrow. This released photon 
is lower in energy than the incident beam due to energy being previously lost through vibrational 
pathways [111]. The red line in the experimentally determined spectra in Figure 2.2, displays the 
lower energy fluorescent light being emitted. When excitation occurs above the HOMO, the 
possibility of vibrational and electronic energy levels overlapping increases. As a result of the 
states overlapping, internal conversion can take place, where electrons drop down electronic 
energy levels, through a vibrational mechanism, rather than a fluorescence mechanism. Internal 
conversion can be seen in the Jablonski diagram between the electronic energy levels S3 and S2, 
highlighted by the green arrow [111]. 
A less common relaxation route is also available when dissipating energy; named intersystem 
crossing (brown arrow). Intersystem crossing occurs when an electron changes its spin state from 
an excited single state to an excited triplet state [111]. In the excited triplet state molecules can 
undergo vibrational relaxation. However, only when the triple state reverts back to its singlet state 
can the electron electronically drop back to the ground state, whereby it emits a photon via 
phosphorescence (dark red arrow) [111]. Phosphorescence is a less common route of relaxation 
than fluorescence, and is a much slower process, due to the route involving a forbidden energy 
state transition [111]. 
To initiate fluorescence an incident beam of light needs to be generated. This is achieved through 
two commonly used light sources; a low pressure mercury lamp and xenon arc lamp, both 
providing a spectrum of wavelengths across the visible and ultra violet range [111]. Figure 2.3 
displays the light passing through the instrument. Initially light hits the monochromator that selects 
the wavelength of UV-vis radiation desired for excitation. The wavelength enters the sample which 
excites the fluorescent analyte. The collection monochromator enables fluorescence intensity to 
be plotted against emission wavelength, where the 90o positioning to the excitation beam 
significantly reduces incident photons being detected. Light detection is achieved through either; 
PMT’s or silicon photodiodes (PD). Both detectors yield units of counts per second (CPS), 
describing how many photons strike the detector every second [111]. 
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Figure 2.3 – Schematic diagram displaying the major components of a fluorometer. Black 
arrows representing the pathway of light to the detector [115].  
Förster Resonance Energy Transfer (FRET) 
FRET is an acronym for Förster Resonance Energy Transfer. FRET commonly involves using 
two compatible fluorescent dyes simultaneously in the same sample; deemed donor and 
acceptor. In order for FRET to occur spectral overlap between the two dyes must exist, whereby 
the emission of the donor dye must overlap with absorbance of the acceptor dye by ~30% [77]. 
When the donor dye is excited, rather than fluorescing, it passes on its energy through a non-
radiative resonance process, electronically exciting the acceptor dye [73]. Through electronic 
relaxation electrons will re-enter their ground states releasing photons [73]. The emitted photons 
will be lower in energy than the initial resonance excitation and the initial incident beam of light 
due to energy loss through vibrational mechanisms, producing a red shift. The energy transfer 
process can be best understood when again considering a Jablonski diagram. 
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Figure 2.4 - Jablonski diagram displaying FRET, where D, A and D* and A* are the donor, 
acceptor ground states and electronically excited states respectively. Black arrows 
represent excitation transitions, the green arrow represents non-radiative relaxation, 
orange arrows display electron donor relaxation and grey lines define resonance energy 
transfer [116], [117]. 
From Figure 2.4 it can be seen that the acceptor and donor ground and excited states are of the 
same magnitude of energy. The band gap between the ground and excited states for the donor 
and acceptor also overlap in energy; this overlap is necessary in order for FRET to occur. The 
overlap between dyes, combined with the energetically lower excitation bands in the acceptor, 
according to resonance to excite the electrons from the ground state of the acceptor into an 
excited state [118].  
While the energy overlap between probes is vital for energy transfer, probe separation also plays 
a significant role. The further the dyes are from one another the lower the probability of exciting 
an acceptor decreases in an inverse power of six relationship as described in Equation 2.3. 





Where E is energy transfer efficiency, r is the distance between the two dyes and Ro is the Förster 
distance, which is defined as the distance where energy transfer is 50% efficient. Ro is calculated 
through Equation 2.4. 




Where n is the refractive index of the solution, fd is the fluorescence quantum yield of the donor 
dye when the acceptor is not present, k2 is the dipole angular orientation of each dye, and J is the 
spectral overlap integral (discussed in section 3.1.1 page 67) [80].  
The distance dependence of probe FRET efficiency can be used as a useful tool to monitor probe 
separation. To calculate probe separation using Equation 2.3, the FRET efficiency (E) of a sample 
must be experimentally determined in conjunction with Equation 2.5. 
Equation 2.5 - 𝑬 =  𝟏 − 
𝑫𝑫𝑨
 𝑫𝑫
Where DDA is the maximum donor fluorescence intensity when both donor and acceptor dyes are 
present in the sample, and DD is the maximum donor fluorescence intensity when only the donor 
dye is present within a sample. From Equation 2.3 and Equation 2.4 only nano-scale separation, 
typically between 1-10 nm [119], allows for detectable resonance energy transfer. Subsequently, 
separating the dyes further than 10 nm limits energy transfer yielding high experimental error. 
Other methods of quantifying FRET include calculating a FRET ratio.  
Equation 2.6 - 𝑭𝑹𝑬𝑻 𝒓𝒂𝒕𝒊𝒐 =  
𝑨𝑫𝑨
 𝑫𝑫𝑨
Where ADA represents maximum acceptor fluorescence intensity when both donor and acceptor 
dyes are present in the sample. The ratio between the donor and acceptor intensities does not 
directly measure E but exists as a relative measure of FRET. Because of this the FRET ratio 
should only be used for qualitative purposes or for monitoring relative changes in the FRET 
efficiency. 
Additional FRET based experiments where the acceptor does not fluoresce but quenches the 
donor are documented but these will not be discussed here [119]. 
Confocal fluorescence microscopy 
To confirm FRET analysis, images of vesicles were taken using confocal fluorescence 
microscopy. The foundation of fluorescence imaging involves the same fluorescence principles 
discussed in section 2.1.3 page 42. However, to produce a fluorescence image the excitation 
beam requires focusing. To focus the beam, lens’ are implemented similarly to an epifluorescence 
instrument. However, confocal microscopy utilises additional confocal pinholes and a laser to 
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remove unfocused light, producing focused, crisp images. The schematic diagram of the workings 
of a confocal fluorescent microscope have been illustrated in Figure 2.5. 
Figure 2.5 – Schematic diagram displaying the major components of a confocal 
fluorescence microscope. Blue lines show the pathway of light to the sample and back to 
the detector. 
To produce an image, the laser source must be paired with the fluorescent dye’s λmax for reasons 
outlined in FRET detection. Furthermore, in order to detect the fluorescent light a charge-coupled 
device (CCD) is commonly used.  
Dynamic Light Scattering (DLS) 
Dynamic Light Scattering (DLS) was used to measure the hydrodynamic radius of individual 
vesicles and vesicle aggregates. Fundamentally, DLS involves the measurement of the diffusion 
coefficient of the particle of interest. When the diffusion coefficient is applied to the Stokes Einstein 
equation the hydrodynamic radius can be calculated. 




r is the hydrodynamic radius, η is the viscosity of the sample, T is temperature, k is the Boltzmann 
constant and D the diffusion coefficient. To define the diffusion coefficients of particles in solution, 
the instrument measures scattered light in time intervals, tracking particle movement in Brownian 
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motion. Under Brownian motion larger particles move at slower rates than smaller particles, owing 
to solvent molecule bombardment in random thermal motion. DLS therefore measures scattering 
intensity of light off of these particles over time. The application of an auto correlation function 
(Equation 2.8) extracts the time dependence of the scattering signal in the presence of noise. 




Where G(τ) is the auto correlation function with respect to scattering intensity, I is intensity of 
scattered light, t is time and τ is delay time. Through increasing τ, signal is raised above random 
noise. By plotting the auto correlation function against time, a decay curve is produced, which is 
modelled through Equation 2.9. 
Equation 2.9 - 𝑮(𝟐)(𝝉) = 𝑩 + 𝑨 ∑ 𝒆(−𝟐𝒒
𝟐𝑫𝝉) [121] 
Equation 2.9 provides a platform where the diffusion coefficient (D) can be calculated. B is the 
baseline at infinite time, A is the intercept and q is the scattering vector calculated using  
Equation 2.10. 
Equation 2.10 - 𝒒 = (𝟒𝝅 𝒏 𝝀𝒐⁄ ) 𝒔𝒊𝒏(𝜽 𝟐⁄ ) [121]
Where λo is laser wavelength and θ is the detection angle. 
A schematic of a DLS instrument is presented in Figure 2.6 displaying the detector at a >90o angle 
to the sample. Common angles being either at 90o for right angle detection and 173o for back 
angle detection, where back angle offers a preferred choice for smaller nano-sized particles [122]. 
The instrument is also commonly equipped with a He-Ne laser at 633 nm and a PMT 
detector [121].  
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Figure 2.6 - Schematic diagram displaying the major components of a DLS instrument. The 
black arrow represents the pathway of incident light and the grey arrow represents 
scattered light to the detector [121]. 
High Performance Liquid Chromatography (HPLC) 
Reverse phase High Performance Liquid Chromatography (HPLC) was applied in analysis of 
potential lipid-DNA degradation. HPLC separates analytes upon their polarity, specifically through 
the analytes interactions with the column and solvent. Reverse phase denotes the column is 
packed with, typically silica, beads treated with a hydrophobic coating. Through the addition of 
using a polar solvent, polar molecules will have little interaction with the column and will be quickly 
eluted. Moreover, a hydrophobic molecule will be retained by the column through favourable 
hydrophobic interactions to the packing material. The high pressure applied to the solvent enables 
the elution of the hydrophobic molecule but at a much slower rate to the hydrophilic molecule. 
After elution molecules were identified through in-line UV detection. 
Materials 
Lipids 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC), bovine (heart) cardiolipin (CL), cholesterol (ovine wool) powder, 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rhod PE, FRET acceptor) and 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD PE, 
FRET donor) were purchased from Avanti Polar Lipids, lipid structures have been displayed in 
Figure 2.7. 
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Figure 2.7 – Lipid structures, where: Top left - DPPC, top right - cholesterol, central left – 
DOPC, central right –NBD PE, bottom left – CL, bottom right – rhod PE. 
Additionally, 16 carbon chain long saturated 1,2-O-dioctadecylrac-glycerol lipid-DNA conjugates 
were purchased from ATDBio. The DNA sequences were: 
1. lipid-5′-TTT ACA GAC TAC C-3′
2. lipid-5′-TTT GGT AGT CTG T-3′
3. lipid-5’-TTT TTT TTT CCC TAA CCC TAA CCC TAA CCC-3‘
4. lipid-5’-TTT TTT GGG TTA TGG TTA GGA TTA GTG-3’
All other reagents, including analytical grade reagents, were purchased from Sigma-Aldrich and 
Fisher Scientific. 
Solution preparation 
Nano-sized liposome preparation 
0.259 M cholesterol solution was made using 0.05 g of powdered cholesterol which was dissolved 
within 5 ml of chloroform. 1 l HEPES buffer was made from 125 mM NaCl, 10 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) titrated against 260 mM NaOH(aq) until a 
pH of 7.4 was achieved. 
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Phosphorus assay 
8.9 N H2SO4 (aq) was prepared through the slow addition of 123.5 ml of H2SO4 to 376.5 ml of 
deionised water. A stirrer bar was used ensuring the acid was evenly dispersed through the 
solution and that the heat was evenly distributed. 10% ascorbic acid solution was prepared by 
dissolving 2.5 g of ascorbic acid in 25 ml of deionised water, which was then well mixed. 2.5% 
ammonium molybdate (VI) tetrahydrate solution was prepared by dissolving 0.625 g of 
ammonium molybdate (VI) tetrahydrate in 25 ml of deionised water which was then well mixed. 
Giant unilamellar vesicle (GUV) preparation 
A 300 mM sucrose solution was made through dissolving 2.565 g of sucrose into 25 ml of 
deionised water. A 1% albumin from bovine serum was made through dissolving 0.5 g of albumin 
into 50 ml of deionised water. 
Methods 
Nano-sized liposome preparation 
To prepare vesicles, lipids in chloroform were pipetted using Hamilton gastight syringes in 
volumes that reflected their mol% for that particular sample in the phase diagram. Molar ratios 
between lipids were calculated where 100% was equal to 3.5 x 10-6 moles. The lipid samples were 
deposited into glass sample tubes, which were then dried under a 1 x 10-3 torr vacuum, equipped 
with a liquid nitrogen trap overnight. 0.5 ml HEPES buffer at 50 oC was added to the dried lipid 
and vortexed until all visible dried lipid was dissolved. Freeze thaw was then performed, freezing 
the sample in liquid nitrogen and thawing the sample in a water bath at 50 oC, until the sample 
reached above 41 oC, ensuring all lipids were homogeneously distributed across the liposomes. 
Freeze thaw was repeated five times per sample. Liposomes were then extruded through an 
Avanti Polar Lipids Extruder 11 times using 100 nm Whatman nuclepore Track-Etch Membrane 
filter and four Whatman drain disks. The extruder and Hamilton syringes were maintained at 50 oC 
at all times to ensure all lipids were homogeneously distributed. 
Giant Unilamellar Vesicle (GUV) preparation 
50 µl of 1 mM lipid was deposited drop wise onto two platinum wires within an electro chamber. 
The electro-chamber was then dried under vacuum alongside 1% bovine serum albumin coated 
glass slides for two hours. The electro chamber was sealed using the dried glass slides in 
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conjunction with rubber gaskets and then filled with 50 oC 10% sucrose solution. Maintaining the 
50 oC temperature, 1 V was applied at 10 Hz for 40 minutes. The frequency was then dropped to 
3 Hz for 15 minutes, then 1 Hz for 7 minutes and finally 0.5 Hz for 7 minutes, before extraction. 
FRET analysis 
Using the lipid concentration calculated from the phosphorus assay experiments, samples 
containing ~50 µM of lipid were prepared, ensuring that the samples were suitably dilute for FRET 
analysis. This ensured minimal inner filtering effects due to scattering from high concentrations, 
while still recording a strong signal from the sample. 
All FRET experiments were conducted using a Fluoromax-3 fluorometer. To monitor phase 
behaviour, the fluorometer’s sample holder was heated to six different temperatures; 18, 20, 25, 
30, 40 and 50 oC using a heated water bath connected to the sample chamber. To monitor the 
sample holder’s temperature a thermocouple device was placed within a cuvette filled with water. 
Before analysis samples were stored in sealed containers in a heated water bath, at the 
appropriate temperature for analysis for a minimum of 30 minutes. Before analysis samples were 
taken out of the water bath and emptied into an appropriate fluorescence cuvette. The cuvettes 
were then placed within the fluorimeters sample holder, which was left for a further 10 minutes to 
thermally equilibrate. In the analysis the excitation beam was set to 460 nm for direct donor 
(NBD PE) excitation, with the excitation band width maintained at 5 nm [122]. The emission 
spectra were recorded between 490–650 nm with an emission band width of 5 nm and an 
integration time of 0.1 s. The emission maxima for NDB PE and rhod PE used in FRET ratio and 
efficiency calculations were 530 nm and 587 nm respectively.  
Phosphorus assay 
A phosphorus assay experiment was conducted to calculate the total concentration of phosphorus 
within a liposome sample. With lipids having ~one phosphorus atom per lipid molecule it is 
possible to determine a guide number of lipids within a sample (cholesterol has no phosphorous 
atom and CL has two). To calculate an unknown phosphorus concentration, a standard 
phosphorus solution was used to create a calibration of 0 µmoles, 0.0325 µmoles, 0.065 µmoles, 
0.114 µmoles, 0.163 µmoles and 0.228 µmoles. 0.45 ml of 8.9 N H2SO4 (aq) was added to the 
calibration samples and unknown samples. Each test tube was then heated above 200 oC using 
a hot plate and an aluminium block for 25 minutes to perform acid digestion. The test tubes were 
removed and cooled before adding 150 µl of H2O2. The test tubes were then placed back into the 
heated block for a further 30 minutes. Once cooled to an ambient temperature, 3.9 ml of deionised 
water was added to each test tube along with 0.5 ml ammonium molybdate (VI) tetrahydrate 
solution and 0.5 ml of ascorbic acid solution. Each test tube was then vortexed to ensure complete 
mixing before placing in a water bath at 100 oC for 7 minutes. The calibration and unknown 
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samples were cooled before UV-visible spectroscopic analysis. Absorbance was measured at 
820 nm on an Agilent Cary 100 UV-vis spectrophotometer. Using the absorbance vs. moles 
calibration, a guide lipid concentration of the unknown samples could be calculated. 
Confocal fluorescence microscopy 
25 μl of the prepared GUV sample was pipetted onto a bovine serum albumin treated slide along 
with 75 μl of HEPES buffer. To image the samples a Zeiss LSM700 inverted confocal fluorescent 
microscope was used with a 488 nm laser at 10mW, in conjunction with a 555 nm laser at 10 mW 
for NBD PE and rhod PE excitement respectively. Images were produced with a Plan-Apochromat 
SF25 lens capable of 63x magnification under oil with a numerical aperture of 1.4. The resulting 
images were processed using Adobe Photoshop CS6 for brightness and contrast adjustment.  
UV DNA thermal-melt analysis 
1 ml of 1 x10-3 M lipid nano vesicle samples were prepared through the extrusion method and left 
at room temperature for 30 minutes. After this time, the sample was separated in 0.5 ml aliquots. 
Opposing thawed aliquots of complementary 2 x10-5 M lipid-DNA conjugates in pH 7.4 HEPES 
buffer were then pipetted into the 0.5 ml vesicle samples at an equimolar concentration. For 
example, sequence 1 was placed into one of the 0.5 ml vesicle samples and sequence 2 was 
placed in the other 0.5 ml vesicle sample. DNA loadings varied from 10, 25, 50, 75, 100, 150, 200 
and 250 DNA strands per vesicle, which was calculated using Equation 2.11.  
Equation 2.11   𝑫𝑵𝑨 𝒍𝒐𝒂𝒅𝒊𝒏𝒈 = (
𝒕𝒐𝒕𝒂𝒍 𝒍𝒊𝒑𝒊𝒅 𝒄𝒐𝒏𝒄.×𝑵𝑨
𝟏𝟎𝟎𝟎𝟎𝟎
) ×𝒘𝒂𝒏𝒕𝒆𝒅 𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝑫𝑵𝑨 𝒔𝒕𝒓𝒂𝒏𝒅𝒔 
Where NA is Avogadro’s number and there are ~105 lipids per 100 nm vesicle [123]. Once the 
DNA was pipetted into the vesicle aliquots, they were then left a further 30 minutes at room 
temperature for the lipid-DNA to integrate into the vesicles’ membrane. Complementary DNA 
doped vesicles were then mixed at a one to one ratio in termers of vesicle concentration and lipid-
DNA concentration, making a 1 ml 1x10-3 M sample. These sample were then given a final 
20 minutes at room temperature to hybridise together. An Agilent Cary 100 UV-vis 
spectrophotometer was used in thermal analysis, where the wavelength was set at 260 nm. To 
Complete thermal analysis temperature ramps were between 15-75 oC at a rate of 0.4 oC min-1 
were conducted, with measurements being taken every 0.1 oC. Before analysis samples were 
initially heated to and maintained at 75 oC for 10 minutes. Sample temperature was monitored 
using the on-board thermocouple rather than using the heating block temperature, yielding more 
accurate DNA Tm. Melting curves were smoothed and a first derivative was applied to the data. 
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Subsequent DNA Tm calculations were made using Origin Pro 9.1 and the Gaussian peak fitting 
model. During pH examination pH was raised and lowered using aliquots of 1.2 M HCl(aq) and 
NaOH(aq) in accordance with a HEPES pH calibration. Acid/base was added once complementary 
vesicles were mixed and left to stand for 30 minutes. Once the pH adjustment component was 
added samples were left for 20 minutes. 
Dynamic Light Scattering (DLS) of vesicle aggregates 
Sample preparation was carried out as described for UV DNA Thermal-melt analysis in 
section 2.3.6 page 53, with the addition of leaving the sample at 4 oC overnight before analysis. 
DLS was performed using a Malvern Zetasizer Nano ZS where samples were left to thermally 
equilibrate in the instrument for 20 minutes before examination. Aliquots of acid/base were again 
added in accordance with a HEPES pH calibration. pH responsive experiments were allowed to 
equilibrate for a minimum of 30 minutes upon the addition of acid/base, preceding measurement. 
High Performance Liquid Chromatography (HPLC) 
For lipid-DNA separation and detection, an Agilent 1290 series HPLC instrument was used in 
conjunction with an inline Agilent 1290 UV detector, Agilent 1290 autosampler, Agilent 1260 
infinity binary pump and a phenomenex hyperclone C18 250 x 4.6mm 5 μm particle packed 
column. To elute lipid-DNA a solvent gradient was applied, as shown in Table 2.1, under a 
1.0 ml min-1 flow rate. 
Table 2.1 – Solvent gradient applied during HPLC analysis of lipid-DNA conjugates with A 
representing 0.1% ammonium acetate (wt/v in water) and B representing acetonitrile. 
Lipid-DNA preparation 
To prepare the lipid-DNA, the phosphoramidite method used by S. G. Boxer et al. was applied 
with some deviations in purification technique [84], [124], [125]. 0.5 g of 1,2-O-dioctadecylrac-






glycerol (0.83 mmol) and 0.32 ml diisopropylethylamine (1.8 mmol) were dissolved in 10 ml 
anhydrous dichloromethane at 0 °C under a nitrogen atmosphere. 0.25 g 2-cyanoethyl N, N-
diisopropylchlorophosphoramidite (1.3 mmol) was added dropwise to the reaction, with constant 
stirring at 0 °C for 15 min, then at room temperature for 2 h. The crude product solution was 
washed with a saturated solution of sodium bicarbonate and saturated solution of NaCl(aq) to dry 
the reaction mixture. The solvent was removed under vacuum. Purification by silica gel 
chromatography was then attempted using a 90:9:1 hexanes:ethyl acetate:trimethylamine 
mixture. Structures were confirmed through 1H, 31P NMR and mass spectrometry. 
The attachment of DNA to the lipid-phosphoramidite was done as a service using ultra-mild 
protecting reagents by Dr Iain Manfield in the Astbury biomolecular interactions facility. 
Critical Micelle Concentration (CMC) measurement 
The method adopted to analyse the CMC was that laid out by Stef A. J. van der Meulen et al. 
Whereby the method implements the use of 1-(2-pyridylazo)-2-naphthol (PAN) [126], a water 
insoluble inorganic dye [127]. Upon increasing surfactant concentration above the CMC micelles 
form, enabling PAN to partition into the hydrophobic rich domains, leading to an increase in 
absorbance at 470 nm [126]. 20 µl PAN suspension (0.2 mg ml-1 dissolved in hexane), was added 
to 450 µl DNA-lipid samples in HEPES buffer, the concentration of the samples were made across 
the estimated CMC range of the lipid-DNA. Samples were then vortexed and the hexane was left 
to evaporate for 30 minutes. The absorbance of each sample was then measured at 470 nm.  
Synthesis 
DNA is often synthesised through an automated phosphoramidite approach, where each base is 
sequentially added to the next, with the starting base being attached to a solid glass bead [128]. 
To produce lipid-DNA, the lipid tail conjugate must be added as the final “base” in the synthesis. 
While the lipid tail is not a base, the addition of a phosphoramidite functional group enables it to 
follow the same synthesis route used for building a DNA strand. A summary of the lipid-DNA 
synthesis can be seen in the cartoon displayed in Figure 2.8. 
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Figure 2.8 - Schematic diagram of DNA-lipid conjugate synthesis via a lipid-phsphoamidite 
intermediate. 
 Lipid-phosphoramidite synthesis 
The initial stage of the synthesis was to produce the lipid-phosphoramidite intermediate. This was 
carried out by flowing the method laid out by S. Boxer et al. where the reaction mechanism can 
be seen in Figure 2.9. 
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Figure 2.9 – Reaction mechanism dispaying the formation of the lipid-phosphoramidite 
intermediate required for lipid-DNA synthesis. R represents an 18 carbon long alkyl 
chain [128]. 
The reaction mechanism in Figure 2.9 displays hunig's base acting as a nucleophile to the 
hydroxyl group. This activates the “lipid tail” enabling it to perform nucleophile substitution with 
the chlorine on the phosphoramidite. When carrying out the experiment, reaction progress was 
monitored via Thin Layer Chromatography (TLC) and after two hours the reaction was stopped. 
Once the mixture had been dried, and the solvent removed, the products were ready for 
purification on a silica column. However, it was found that the purification step using a silica gel 
column, coupled with the mobile phase of hexane:elthylacetate:triethylamine (90:9:1), was 
ineffective. The separation only eluted an unwanted derivative of the lipid phosphoramidite 
product, with a mass of 744.7 gmol-1 and 766.7 gmol-1 with sodium addition from electrospray 
ionisation (Figure 2.10), not the intended 797 gmol-1 lipid-phosphoramidite intermediate. 
Figure 2.10 – Mass spectra of the purified lipid-phosphoramidite. 
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From the data presented within Figure 2.10 it was assumed that the lipid-phosphoramidite was 
stuck to the silica. Solvent parameters were therefore examined using TLC to drive more 
successful separation (data not shown). Conversely, the original solvent parameters were found 
to be optimal to drive an effective separation between products and reactants via TLC. To analyse 
whether the lipid-phosphoramidite was indeed being formed, the crude product was examined via 
mass spectrometry. 
Figure 2.11 - Mass spectra of the crude lipid-phosphoramidite. 
The mass spectrometry data shown in Figure 2.11 exhibits the crude product having an 
abundance of the wanted lipid-phosphoramidite, with the addition of some impurities. However, 
these impurities are not seen in the “purified” sample in Figure 2.10, indicating that during 
purification a reaction may be taking place. Interestingly between the wanted lipid-
phosphoramidite shown in Figure 2.11 and one of the impurities found in the Figure 2.10 there is 
a 53 gmol-1 mass disparity, telling of an arguable acrylonitrile (CH2CHCN) removal. The removal 
of the protecting leaving group has been outlined in Figure 2.12 
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Figure 2.12 - Suggested pathway for lipid-phosphoramidite degradation through the 
removal of CH2CHCN and consequential change in phosphorus oxidation state. 
Additionally, the reaction pathway outlines that there is a change in the phosphorus oxidation 
state from P 3+ to P 5+. To detect this change in oxidation state and support an argument for 





53.1 gmole -1  
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Figure 2.13 - Phosphorus NMR data for the crude and purified lipid-phosphoramidite 
intermediate: Top – the crude lipid-phosphoramidite (~150 ppm). Bottom – the oxidised 
phosphoramidite intermediate (~15 ppm). 
The phosphorus NMR data displays a peak position shift from ~150 ppm to ~15 ppm. These peak 
positions indicate the presence of phosphorous 3+ and 5+ containing compounds 
respectively [129]. Further evidence for the phosphorous oxidation state change from 3+ to 5+ can 
be found in the proton NMR spectra shown in Figure 2.14.  
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Figure 2.14 - Proton NMR data for lipid-phosphoramidite derivates. Top - crude 3+ lipid-
phosphoramidite intermediate. Bottom – oxidised 5+ lipid phosphoramidite intermediate. 
Through phosphorus 5+ having a spin state of ½ it can couple with the newly attached proton 
shown in Figure 2.12 [130]. The hydrogen–phosphorous splitting at ~5.4 ppm found in the purified 
product is significantly reduced in the crude lipid-phosphoramidite 3+ sample. This indicates that 
there is a much lower oxidised phosphorus 5+ content in the crude product.  
In conclusion it was hypothesised that TLC displayed good separation through the purification 
being over a short time scale. The larger column used for purification takes longer to run, and so 
the lipid phosphoramidite has a longer time frame in which to oxidise, forming the 5+ complex. 
Vanderlick et al. used a similar method to prepare the lipid phosphoramidite, however they did 
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not use a purification step and placed the crude product onto the DNA synthesiser. In light of this, 
moving forward crude product was not purified and was placed directly into the DNA synthesiser. 
Lipid-DNA conjugation 
To generate lipid-DNA conjugates, a lipid-phosphoramidite “base” was added as the “last base” 
to the DNA sequences via phosphoramidite chemistry. This would be achieved through a tetrazole 
catalyst reaction, where the mechanism has been outlined below in Figure 2.15. 
Figure 2.15 – “Last base” phosphoramidite attachment of the lipid tail to the DNA sequence 
through tetrazole cytolysis [128]. R and R1 represent the 18 carbon long alkyl chain and 
the rest of the DNA sequence respectively and P-Base is a protected base pair.  
Upon lipid tail DNA conjugation further work up was required to oxidise the phosphorus from a 3+ 
state to a more stable 5+ state. 
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Figure 2.16 - Oxidation of the phosphorus from 3+ to 5+ [128]. R and R1 represent the 
18 carbon long alkyl chain and the rest of the DNA sequence respectively and P-Base is a 
protected base pair. 
The oxidation initially requires the addition of iodine to produce phosphorus 4+. Iodine, a good 
leaving group, provides a point of access for a hydroxyl substitution; initiated through the addition 
of pyridine. The use of pyridine in excess will further drive phosphorus from its 4+ oxidation state 
to the desired 5+ state. Finally, protection group removal is achieved through the addition of 
warmed ammonia [128].  
However, in this instance using the method outlined above lipid-DNA was not successfully 
yielded. Through mass spectrometry it was observed that only DNA was synthesised for each 
sequence, data shown within Figure 2.17.  
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Figure 2.17 – Mass spectrometry data indicating the presence of just the DNA sequences 
opposed to the desired lipid-DNA conjugates. Graphs are presented in DNA sequence 
order, where the first graph at the top is for DNA sequence 1. 
With respect to Figure 2.17, the measured masses are comparable to the calculated masses of 
the DNA sequences alone without the conjugated lipid tail. The calculated masses for each of the 
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DNA sequences are 3893.60, 3986.63, 8937.84 and 8412.47 gmol-1 for sequences 1, 2, 3 and 4 
respectively.  
Due to the DNA synthesis and subsequent lipid-phosphoramidite attachment being run as a 
service by Dr Iain Manfield in the Astbury biomolecular interactions facility, it was difficult to 
speculate the cause of lack of success. Speculatively, the fault may lie in the difficulty met when 
dissolving the lipid-phosphoramidite, and/or the lipid-DNA may have been lost in salt removal 
column after synthesis. Due to the extended lead time in preparing the lipid-DNA it was 
considered to be more time effective and more in line with the overall project goals to purchase 
the material required.  
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Phase boundary mapping of four component nano 
vesicles via Förster resonance energy transfer 
(FRET) 
To build a Janus liposome capable of forming a controllable, directional, size limited cluster; 
understanding and regulating vesicle lipid composition is key. From the introductory review, it was 
shown that the addition of 10 mol% cardiolipin (CL), significantly influences trace saturated DNA-
lipid bridging conjugate partitioning to the lo phase, by an order of magnitude. This in turn aided 
the formation of size limited vesicle clusters. In this chapter, we aim to fully examine the influence 
10 mol% CL has on the previously established three component DPPC:DOPC:cholesterol phase 
diagram, in the hope of producing a tuneable and adaptable drug delivery platform.  
Taking inspiration from previous studies examining the formation and measurement of lipid 
phase separation by S. Keller et al. and S. Veatch et al., this worked focused on producing a 
nano vesicle four component phase diagram. Specifically, we examined the phase 
diagram of DOPC:DPPC:cholesterol:CL where CL concentration is maintained at       
10 mol%, outlined in Figure 3.1. Through limiting the CL content, it is hoped unwanted 
higher order and more complex four component phase behaviour is avoided, while 
exploiting the aided DNA-lipid partitioning to the lo phase.  
Figure 3.1 – Left: the four component DPPC:DOPD:cholesterol:CL phase diagram with the 
blue line representing the 10 mol% CL slice. Right: The “three” component phase diagram 
slice where vertices represent 90 mol% where CL is maintained at 10 mol%  
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With similar phase diagrams already documented both on a nano and micro scale, our new four 
component phase diagram could be plotted using a previously used vesicle mapping 
technique [72]. Here Förster resonance energy transfer (FRET) was chosen to map the 
DOPC:DPPC:cholesterol:CL phase diagram slice.  
FRET and phase detection 
Fluorescent dyes 
In order to obtain FRET data, the lipid conjugated fluorescent dyes, 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (rhod PE) and 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD PE) were used. The 
selected lipid dyes have two distinct properties required to measure phase separation via FRET 
analysis.  
1. Good spectral overlap of fluorescent probes.
2. Different phase partitioning preferences due to the unsaturated and saturated lipid tails
of rhod PE and NBD PE respectively.
These points are considered in turn. To carry out FRET analysis the two fluorescent probes have 
to have a minimum of 30% spectral overlap between a donor’s emission and acceptor’s excitation 
peaks. The spectral crossover between the two probes used in this analysis are shown within 
Figure 3.2. 
Figure 3.2 – Spectral overlap between FRET donor NBD PE and rhod PE probes used in 
the phase boundary mapping of nano vesicles [131]. 
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Secondly, to detect membrane phase heterogeneity through FRET; rhod PE and NBD PE have 
unsaturated and saturated lipid tails,driving probe partitioning to the ld and lo phases present
respectively. Through phase co-existence and subsequent probe separation into local discrete 
domains, average donor/acceptor probe separation is enhanced. The increase in probe 
separation prevents effective resonant energy transfer between probes. The resulting 
reduction in donor fluorescence quenching leads to a promotion of donor fluorescence 
intensity and a reduction in acceptor intensity. Through this mechanism, a qualitative 
technique was developed. Initially, homogenous membranes have homogenously mixed 
fluorescent dyes and good energy transfer between donor and acceptor probes. Upon 
membrane ld-lo phase separation, inter rhod PE and NBD PE distances will rise significantly, 
reducing acceptor fluorescence intensity. Furthermore, in instances of ld-lgel phase separation 
there will be a significant reduction in probe separation from the homogeneous vesicle. This 
increased level of FRET is through NBD PE’s preferential partitioning into the ld phase in this 
case [132].  
Phase detection 
Using published phase diagrams for DOPC:DPPC:cholesterol vesicles as a guide, three initial 
phase representatives were chosen for the new four component phase diagram containing 
10 mol% CL. These three samples were chosen to examine whether FRET’s energy transfer 
dependence on distance, was suitable for being able to detect the difference between ld, ld-lo 
coexistence and lgel phases, enabling phase boundaries to be recorded on the phase diagram. 
These initial samples had composition probe concentrations maintained at 0.2 mol%/probe. From 
the raw fluorescence data, FRET efficiencies and ratios were calculated using Equation 2.5 and 
Equation 2.6 and processed to give a FRET profile with respect to temperature. Both FRET 
efficiency and ratio, Equation 2.5 and Equation 2.6 respectively, are commonly used 
experimentally. Where the ratio gives a relative measure of energy transfer and the efficiency can 
give a more detailed account of the percentage of energy transferred from the donor to acceptor 
dye. Here both were examined to assess which was most suitable in vesicle samples.  
The first of the three phase representative samples examined was in a suspected ld phase region 
of the phase diagram. The result from the FRET based phase detection technique is outlined in 
Figure 3.3. 
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Figure 3.3 – A: Phase diagram displaying sample composition DOPC:70%, DPPC:10%, 
cholesterol:10% CL:10% in red, sample doped with NBD PE: 0.2% and rhod PE:0.2%. B: 
Cartoon of interpreted data where donor (D) and acceptor (A) lipid dyes are 
homogenously mixed across the vesicle’s surface. C: Example of raw fluorescence data 
initially excited at 460 nm with emission maxima for D at 535 nm and A at 587 nm. D: 
Calculated FRET ratios and efficiencies plotted against temperature. 
For the suspected homogeneous ld phase raw fluorescence data, there is a high acceptor peak 
and low donor peak relative to one another, irrespective of temperature. This profile indicates 
consistent good energy transfer from the donor to the acceptor. This data are consistent with the 
hypothesis of a single phase being present with limited probe separation and homogeneous lipid 
mixing. The decrease present in the overall fluorescence signal, for both the acceptor and donor 
peak intensities with respect to rising temperature, is likely due to a quenching effect. There are 
two main types of fluorescence quenching; dynamic and static.  
1. Dynamic quenching refers to three mechanisms: FRET which has previously been
discussed, Dexter electron transfer and exciplex formation. Dexter electron
transfer/enhanced thermal collisional energy transfer occurs when an excited dye collides
with a dye species with overlapping molecular orbitals [133]. An exciplex is a short lived
excited state dimer complex formed from an excited dye and an unexcited molecule.
2. Static quenching is the process where complexes are formed before excitation occurs,
contrasting with the formation of exciplexs.
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The most probable mechanism causing the quenching seen in this data is through dynamic 
collisional quenching. Heating increases diffusion rates of the lipids, increasing the frequency of 
molecular collisions allowing energy to be lost through a non-radiative pathway, therefore 
decreasing the fluorescent signal [111].  
With regard to whether the FRET ratio or efficiency displays the better FRET temperature 
profile, no significant changes are present within the data, making it difficult to assess which 
method is better. The efficiency did show to be more constant with temperature, however, the 
FRET ratio exhibited a smaller uncertainty in respect of the specific data series.   
The next sample chosen was a previously reported phase separating composition [91]. Using 
this as a reference sample the FRET based technique’s effectiveness to detect phase co-
existence was analysed.  
Figure 3.4 - A: Phase diagram displaying sample composition DOPC:27.5%, DPPC:37.5%, 
Cholesterol:25% CL:10%in red, sample doped with NBD PE:0.2% and rhod PE:0.2%. B: 
Cartoon of interpreted data where donor (D) and acceptor (A) lipid dyes partition into 
separate lo and ld coexisting domains respectively at low temperatures, leading to 
homogenous mixing across the vesicle’s surface at 50 oC. C: Example of raw fluorescence 
data initially excited at 460 nm with emission maxima for D at 535 nm and A at 587 nm. D: 
Calculated FRET ratios and efficiencies plotted against temperature. 
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The suspected ld-lo phase coexisting liposomes show a different FRET regime to what was 
previously reported for the suspected homogeneous ld phase. Here at low temperatures the raw 
fluorescence spectra display a donor peak larger in intensity than the acceptor peak, 
contrastingthat seen for the suspected single phase ld system. Through heating the suspected ld-
lo samples, similar peak intensities to the reported ld phase are displayed, with the FRET ratio at 
50 oC being comparable to that shown for the ld samples. It is clear that heating the samples 
changes lipid phase behaviour from exhibiting a poor FRET regime, where NBD PE and rhod 
PE probes are heterogeneously separated through preferential phase partitioning at low 
temperatures, to an effective FRET regime at higher temperatures. At a temperature above 
the Tm for the highest melting lipid (DPPC 41 oC), lipids form a homogenous vesicle 
surface [134]. In other words, as the temperature is raised, lipids begin to diffuse out of their 
respective domains as the thermal energy rises, forming a homogenous membrane. 
Subsequently the donor probes are mixed with the acceptor probes, allowing for good energy 
transfer as seen for the ld phase sample. Upon forming an ld surface, the donor intensity peak 
decreases and the acceptor peak increases due to the probes becoming closer together, 
enabling energy to be transferred through resonance.  
Upon examining the FRET ratios and efficiency data presented, using the ratio is much clearer 
with error bars significantly smaller than the efficiency errors. This in turn demonstrates and 
implies vesicles moving from a ld-lo phase coexisting state, to a ld phase upon heating. 
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Figure 3.5 - A: Phase diagram displaying sample composition of DOPC:0%, DPPC:80%, 
Cholesterol:10% CL:10%in red, sample doped with NBD PE:0.2% and rhod PE:0.2%. B: 
Cartoon of interpreted data displaying donor (D) and acceptor (A) lipid dyes homogenously 
mixed across the vesicle’s surface, where the vesicle is no longer a smooth sphere but 
rather a gel like distorted sphere. C: Example of raw fluorescence data initially excited at 
460 nm with emission maxima for D at 535 nm and A at 587 nm. D: Calculated FRET ratios 
and efficiencies plotted against temperature. 
The suspected single lgel phase data displays a similarly high and consistent energy transfer 
across the temperatures measured, as seen in the ld phase representatives. However, the lgel 
samples displayed a higher fluorescence profile, suggesting that complementary FRET probes 
are closer in proximity to one another than in ld phase representative samples. Overall from the 
FRET profile, it would appear that liposomes are always in a single phase, where it would be 
expected under heating that they transition from a single lgel phase to single ld phase.  
Once again it was confirmed, through the data presented within Figure 3.5, that the FRET ratio 
offers a better means of processing FRET data than efficiency. Throughout the three phase 
representative samples, the FRET ratio temperature profile was able to distinguish between the 
three different phases more clearly than a FRET efficiency profile. The downfall of calculating 
FRET efficiency here is that it requires two samples; one with just donor dye in vesicles and a 
second with both donor and acceptor dyes. The need for two samples escalates experimental 
uncertainty when calculating FRET, resulting in a significant decrease in data accuracy. Where 
on the other hand, taking the ratio reduces uncertainty as it compensates for slight sample to 
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sample total lipid concentration deviations. A further disadvantage of calculating FRET efficiency, 
is that the need for two samples significantly lengthens experimental procedures, both in terms 
of the formation of samples and the analysis of samples. 
However, neither data processing technique accounts for direct acceptor fluorescence instigated 
through donor excitation. Therefore, new experiments were conducted to gather a background 
measurement for all three samples, where acceptor fluorescence could be adjusted through 
Equation 3.1 and Equation 3.2. 
Equation 3.1 -  𝑨𝒕𝒕𝒆𝒏𝒖𝒂𝒕𝒆𝒅 𝑹𝒂𝒕𝒊𝒐 =  
(𝑨𝑫𝑨 −𝑨𝑨)
 𝑫𝑫𝑨
Equation 3.2 - 𝑨𝒕𝒕𝒆𝒏𝒖𝒂𝒕𝒆𝒅 𝑬𝒇𝒇𝒊𝒄𝒊𝒆𝒏𝒄𝒚 =  𝟏 −  
(𝑫𝑫𝑨− 𝑨𝑨)
 𝑫𝑫
Where; AA is the maximum acceptor fluorescence intensity when only acceptor dye is present 
within a vesicle, DDA is the maximum donor fluorescence intensity when both donor and acceptor 
dyes are present a vesicle, DD is the maximum donor fluorescence intensity when only the donor 
dye is present within a vesicle, and ADA represents maximum acceptor fluorescence intensity 
when both donor and acceptor dyes are present in a vesicle. 
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Figure 3.6 – ld phase representative with a composition of DOPC:70%, DPPC:10%, 
Cholesterol:10% CL:10% A: Example of raw fluorescence acceptor data when excited at 
430 nm doped with 0.2% rhod PE. B: Graph to compare FRET efficiency with FRET 
efficiency with non-resonant fluorescence removed. C: Graph to compare FRET ratios with 
FRET ratios with non-resonant fluorescence removed. 
The initial raw fluorescence graph in Figure 3.6 displays rhod PE is excited through the dye’s wide 
Gaussian excitation peak distribution. This subsequent fluorescence emission from rhod PE 
attributes to the fluorescence seen when both dyes are present in FRET experiments. Through 
subtracting the non-resonance induced fluorescence, measured in Figure 3.6, an attenuated 
efficiency and ratio was calculated. For the attenuated ld phase efficiency, there was little 
improvement in the presented data. Contrastingly the FRET ratio had a significant systematic 
drop coupled with a rise in error.  
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Figure 3.7 - ld-lo phase coexistence phase representative with a composition of 
DOPC:27.5%, DPPC:37.5%, Cholesterol:25% CL:10% A: Example of raw fluorescence 
acceptor data when excited at 430 nm doped with 0.2% rhod PE. B: Graph to compare 
FRET efficiency with FRET efficiency with non-resonant fluorescence removed. C: Graph 
to compare FRET ratios with FRET ratios with non-resonant fluorescence removed. 
A similar trend occurs in Figure 3.7, as displayed for Figure 3.6, whereby attenuated FRET 
efficiency shows little in the way of change, and the FRET ratio displays an overall drop draped 
in higher experimental uncertainty. 
76 
Figure 3.8 - lgel phase representative with a composition DOPC:0%, DPPC:80%, 
Cholesterol:10% CL:10% A: Example of raw fluorescence acceptor data when excited at 
430 nm doped with 0.2% rhod PE. B: Graph to compare FRET efficiency with FRET 
efficiency with non-resonant fluorescence removed. C: Graph to compare FRET ratios with 
FRET ratios with non-resonant fluorescence removed. 
The final experiment, in regard to plotting attenuated FRET shown in Figure 3.8, displays the 
same trends seen for both FRET efficiency and ratio, already discussed. From Figure 3.6,  
Figure 3.7 and Figure 3.8 it is clear that accounting for direct rhod PE excitation does not lead to 
more distinguishable trends but invokes the opposite. This is a result of more experimental 
uncertainty being added through the need for further samples to be made and measured.  
In summary, the most accurate technique to analyse the raw FRET data was to take the FRET 
ratio. Through only requiring one sample the ratio is overall lowest in uncertainty, and to maintain 
low uncertainty, direct acceptor excitation was not removed during future data processing. 
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Fluorescent probe concentration 
Calculating probe separation 
To ensure that the probes are at an appropriate concentration to detect phase transitions and 
phase boundaries, probe separation (r) was calculated for a 100 nm diameter ld liposome. The 
first part of calculating r was to know the number of lipids on the surface of the liposome. To do 
this some assumptions were made:  
• The diameter of the liposomes did not vary.
• There was no inter-liposome probe quenching.
• Only the surface monolayer of the vesicle was considered.
• All lipids had the same 0.71 nm2 head group area [135].







Where Nsurface total is the total number of lipids in the surface monolayer of the liposome, d is the 
liposome diameter and a is the surface area of a lipid. Assuming liposome diameter is 100 nm 
Nsurface total = 44247 lipids. 0.2 mole% of the lipids in the liposome surface are FRET acceptor 
probes and 0.2 mole% are FRET donor probes; therefore, the number of FRET probes within the 
monolayer is 177. Taking the ratio between the number of FRET probes against Nsurface total reveals 
there are 500 lipids per FRET pair. Assuming the FRET pair will be in a disk of 500 lipids, the 
maximum separation can be known once lipid disk diameter is calculated from its area. When 
calculating disk radius some assumptions again have to be made. 
• There is only one acceptor probe and one donor probe per 500 lipids.
• Membrane curvature effects are insignificant.
• No other effects but the donor in question effect acceptor excitation.
• The liposome surface monolayer is in an ld phase.
• There are no non-FRET quenching effects.
Equation 3.4 -  𝒓 = √
𝑵𝒅𝒊𝒔𝒌×𝒂
𝝅
r is the radius of the lipid disk, Ndisk is the number of lipids in the disk, which in this example is 
500. From the calculation the 500 lipid disk was calculated to have a radius of 10.6 nm. In the 500
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lipid disk the FRET pair are randomly separated by distance x. To calculate average probe 
distribution within the disk Equation 3.5 was used.  
Equation 3.5 - 𝒙 =
𝒓
√𝟐
From Equation 3.5 average probe separation for 0.2% NBD PE and 0.2% rhod PE for 100 nm 
vesicles was calculated to be 7.5 nm. This separation is on the larger side of recommended FRET 
analysis limits of 10 nm [73]. However, the collected FRET data for the three phase 
representatives still displays an ability to depict the necessary information, to differentiate the 
phases. To compare this theoretical value of probe separation, an experimentally determined 
value was calculated using Equation 3.6. 







Where x is the probe separation distance and Ro for NBD PE and rhod PE was found to be 
5.2 nm [137]. Through Equation 3.6 and using the experimentally determined ld 18 oC efficiency 
(0.401 from Figure 3.3), the experimental inter probe separation was calculated to be 5.5 ± 0.7 nm 
which is more representative of the 5.2 nm Ro for NBD PE and rhod PE. The disparity in the 
theoretical and experimental probe separation is likely due to three large assumptions made when 
making the theoretical calculation. Firstly, only the exterior monolayer was considered, removing 
any potential interactions across the lower dielectric oily lipid tail interface. Secondly, this analysis 
only reflects two probes, removing the complexity of mapping many probes. And thirdly, the model 
does not consider membrane curvature. 
Raising probe concentration 
Low probe concentrations are vital when mapping out the new phase diagram. If the concentration 
of the probe is too high they will become a major component of the phase diagram, which could 
lead to complex phase behaviour. High probe concentrations could potentially lead to the wanted 
four component phase diagram not being mapped but rather a six component diagram. 
Conversely if the probe concentrations are too low, high noise to signal data will be recorded. To 
ensure that probe concentrations are optimum to detect phase boundaries, where FRET signals 
may be less clear, probe concentrations were raised from 0.2-0.6 mol% for the previously shown 
ld-lo phase coexisting sample (DOPC:27.5, CL:10, DPPC:37.5, cholesterol:25). 
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Figure 3.9 - Comparison of FRET ratios when the concentration of FRET probes is raised 
from 0.2-0.6 mol% in the ld-lo phase coexisting DOPC:27.5, CL:10, DPPC:37.5, 
cholesterol:25 sample. 
Figure 3.9 exhibits higher probe concentrations leading to larger FRET ratios, while still displaying 
the FRET change, attributed to ld-lo phase coexistence melting at high temperatures. However, 
using higher concentrations of fluorescent probes has shown to be problematic. Whereby the 
experimental uncertainty has drastically increased, preventing data trends from being readily 
observed.  
Furthermore, issues have been reported in the literature when using these probes in higher 
concentrations. Specifically, NBD has been discussed to self-quench when in high concentration 
through a static mechanism [133].This is a potential issue at low temperatures, where the donor 
probe partitions preferentially to the lo domain, driving locally high concentrations of NBD. This is 
of major concern especially when domain sizes are small, raising the probability of self-quenching. 
Through self-quenching NBD would not be able to transfer energy through resonance to the 
acceptor, limiting the donor and acceptor fluorescence peak intensity. In the case of rhod PE, 
literature has shown that higher concentrations of the trace probe in solution and in model 
membranes, leads to a decrease in fluorescence emission [138]. In solution, quenching is driven 
through to the formation of aggregates. Conversely, within a ld membrane, the reduced 
fluorescence is through an increase in the probability of dyes dynamically self-quenching, i.e. they 
collided together while in an excited state [138].  
In conclusion, the experimental work illustrates that using lower concentrations of FRET probes 
(0.2 mol%) minimises error in calculating FRET, while still allowing the ld, lgel and ld-lo phases to 
be distinguished from one another. Lower concentrations also aid in minimising potential self-
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quenching effects associated with NBD PE and rhod PE. Moving forward, all experiments used a 
concentration of 0.2 mol% for each fluorescence probe.  
Phase boundary mapping 
 A coarse grain approach 
With the NBD PE/rhod PE based FRET technique displaying the ability to effectively gather data 
to allow reliable interpretation of phase behaviour, coarse grain mapping of the four component 
phase diagram was initiated. Through coarse grain mapping and theoretical knowledge of allowed 
thermodynamic phase diagram topologies, a detailed phase diagram can be constructed while 
minimizing sample selection and analysis lead time. This is opposed to the previous work in 
mapping phase diagrams, whereby small changes in composition were made and analysed with 
no regard to composition error and sample preparation time [67]. 
Coarse grain experimental design relies upon taking samples across the phase diagram that are 
significantly removed from one another, to gain a general overview of the phase diagram. This 
general overview will display rough locations of the different phases. In order to find specific phase 
boundaries new samples were taken half way between the points of the two phases. This process 
was repeated until there was 5 mol% composition discrepancy between the two phases. 5 mol % 
was used as the experimental cut off, due to 3 mol% sample preparation error. Figure 3.10 
displays an early example of coarse grain mapping and resulting FRET data. 
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Figure 3.10 – Example of coarse grain mapping over the DOPC:DPPC:Cholesterol:CL phase diagram where CL was maintained at 10 mol%. The phase 
diagram has been annotated with raw fluorescence and processed FRET data. Blue samples display suspected ld phase behaviour, green samples display 
suspected ld-lo phase behaviour and purple displays suspected lo-HII phase coexistence.  
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To develop the beginnings of the mapped phase diagram as shown in Figure 3.10; the FRET 
melting profiles and raw fluorescence graphs gathered from previously recorded phase 
representatives, were used to categorise new samples into FRET/phase behaviour styles. The 
FRET temperature profiles for samples in a suspected ld phase, always have a FRET ratio above 
one despite raising the temperature. Suspected phase ld-lo co-existence regions, have FRET 
ratios that increase with temperature, where, at low temperatures (~20 oC) the FRET ratio is below 
1 and upon heating (~50 oC) the ratio is higher than one. These designated categories have been 
labelled on the phase diagram shown in Figure 3.10 using colour. Blue has been used to express 
samples with implied ld phase behaviour and green to display suspected ld-lo phase co-existence 
at low temperatures.  
Purple on the other hand, has been used to denote previously unseen phase behaviour. It was 
anticipated from the previously recorded analogous three component phase diagrams, that the 
purple region of the phase diagram in Figure 3.10 would display lo phase behaviour, attributed to 
the high cholesterol saturated lipid composition. Therefore, it was anticipated that these samples 
would have high FRET ratios similar to those recorded for the ld phase. However, the samples 
high in saturated lipid content are unique in that they always maintain a FRET ratio below one, 
irrespective of temperature. To determine the cause of the phase diagram disparity from the 
addition of 10 mol% CL, further FRET investigation was conducted. 
lo-HII phase coexistence 
From the early coarse grain mapping of the phase diagram, samples that contained 0 mol% 
DOPC produced fluorescence spectra and FRET temperature profiles unlike those produced for 
the phase representatives. Figure 3.10 displays samples with 0 mol% DOPC having low acceptor 
fluorescence, which when heated does not rise above the donor fluorescence as seen for ld-lo 
phase coexisting FRET samples. The addition of CL as a fourth component opens up the potential 
for a four phase triangular pyramid, yielding possible HII phase formation at high CL 
concentrations (see Table 1.1) [139]. In other words, rather than centre of the phase diagram 
having three phase coexistence, as shown in Figure 1.8, the extra lipid component, CL, could be 
adding to its complexity, which has been speculatively outlined in Figure 3.11.The extra vertices 
offered by this potentially new four phase triangular pyramid, affords the possibility for new phase 
co-existence regions. 
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Figure 3.11 – Cartoon of the four phase triangular pyramid when CL is added as a fourth 
component and is no longer set at 10 mol%. The cartoon displays the potential phases 
associated with each of the edges and vertices. The 3 phase co-existence regions have 
not been recorded for image clarity. 
It was anticipated that 10 mol% CL would be low enough in concentration to cause minimal 
disturbance to the previously recorded three component phase diagram, and limit the potential 
for additional unwanted phase coexistence beyond what is necessary for Janus vesicle cluster 
building. However, this early coarse gain mapping indicates that this may not be the case. To 
further explore the potential of phase lo-HII coexistence and map the size of this region, coarse 
grain mapping was continued along the 0 mol% DOPC axis where CL concentration is maintained 
at 10 mol%. 
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Figure 3.12 – Top: DOPC:DPPC:Cholesterol: phase diagram where CL is maintained at 10 
mol% displaying sample selection with colour denoting phase behaviour. Purple 
references suspected lo-HII phase behaviour and red the lgel phase. Bottom: Table 
displaying sample composition and calculated FRET ratios at 18 and 50 oC.  
Through coarse grain mapping the 0 mol% DOPC axis displays a trend where FRET ratio rises 
slowly with a decreasing mol% of cholesterol, as seen in Figure 3.12, until crossing into the lgel 
phase at 10 mol% cholesterol. This indicated phase behaviour change along the 0% DOPC axis 
was perhaps linked with cholesterol concentration. To validate the hypothesis that unsuspected 
FRET results were related to the addition of CL, rather than a failing of the FRET analytical 
technique, a comparison of samples, where 30% cholesterol was maintained alongside 10 mol% 













40 50 0.604 0.006 0.775 0.028
30 60 0.608 0.004 0.815 0.018
20 70 0.662 0.004 0.938 0.008
10 80 1.724 0.102 1.519 0.14
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Figure 3.13 – A: comparison of FRET ratios from samples where the unsaturated 
component was changed from 10 mol% CL to DOPC. DPPC and cholesterol were 
maintained at 60 and 30 mol% respectively. B: raw fluorescence data for 
DOPC:DPPC:cholesterol at concentrations of 10:60:30 mol% respectively. C: raw 
fluorescence data for CL:DPPC:cholesterol at concentrations of 10:60:30 mol% 
respectively  
Figure 3.13 displays that the swapping of 10 mol% CL with the alternate DOPC leads to drastically 
different FRET data. Fluorescence results for the DOPC system, fell in line with published data 
by S. Keller et al; indicating that FRET does provide a solid platform to map out phase behaviour 
in this low DOPC environment. The unexpected results must consequently be significant in 
displaying unusual phase behaviour. 
A plausible explanation for the low FRET values, attributed to low DOPC mol%, could be due to 
CL’s polymorphism, whereby CL can form bilayers or hexagonal (HII) phase arrangements. 
Furthermore literature discusses that CL in its polymorphism can swap between phases by nulling 
the head group’s negative charge, specifically through the addition of calcium ions (Ca+2) [140]. 
CL is a lipid that is physically cone shaped with a small polar head group and four large di-
unsaturated hydrophobic tails. However CL’s negative net charge, gained from two acidic protons; 
one with a pka of 1.05-2.8 the second being 7.5-9.5 [141], provides a repulsive force, creating a 
cylindrical shaped molecule in terms of packing arrangement. Through removing the negative 
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charge (shown within Figure 3.14) with sodium, there will be no head group repulsion; and the 
overall shape of the molecule will be a cone. 
Figure 3.14 – The polymorphism cardiolipin: Top - net 2- charge results in cylindrical 
packing arrangement; outlined by the blue cylinder. Right – cardiolipin neutralised through 
sodium addition generates an inverted cone shape, with the purple cone displaying the 
new preferred packing arrangement. 
Upon forming a cone shape where head groups are smaller than their respective hydrophobic tail 
groups, which is achieved when CL is neutralised, HII packing is preferential. 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE) is an analogous lipid to CL, with the ability to form HII 
phases and the potential to form “lipidic particles” (lo-HII coexistence) [142]. DOPE has been 
discussed to enter a lo-HII phase coexisting state, as an intermediate between planar bilayers and 
inverted micelles. Specifically of interest DOPE has shown to display lo-HII phase coexistence 
through increasing the cholesterol concentration to 33 mol% [142]. The authors argue that 
cholesterol stabilises the hydrophobic tails by inserting itself into the free spaces formed once the 
membrane starts to invert [142]. 
87 
Figure 3.15 – Suggested cartoon model for “lipidic” particle/lo-HII phase coexistence: 
Top - Cartoon displaying formation route of the HII phase from a bilayer via lo-HII phase 
coexistence intermediate. Bottom – Cartoon displaying the role of cholesterol stabilising 
HII phase formation [142]. 
Literature therefore indicates that cholesterol may play an important role in polymorphic lipids 
being able to swap their packing arrangements. This model potentially agrees with data presented 
here for CL, whereby FRET signal is reduced with rising cholesterol for samples with limited 
DOPC. In other words, rising cholesterol may encourage lo-HII phase coexistence. Furthermore, 
CL has four times the number of unsaturated bonds than that offered by DOPE, potentially 
proposing an explanation as to why inverted phase behaviour is apparent for CL at lower 
cholesterol concentrations (<33 mol%) as previously reported for DOPE [142]. 
Figure 3.16 – 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). 
To confirm and gain a fuller understand of the potential lo-HII phase coexistence, further 
investigation using complementary techniques was required, as discussed in section 3.2.2 
page 93. However, for the purpose of phase boundary mapping FRET still offered a viable, 
sensitive approach to detect dissimilar lipid phases. Specifically, FRET was still able to provide a 
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method to define phase boundaries, even across this unexpected phase region. Finally, in regard 
to potential lo-HII coexistence, while the full mapping of the phase diagram is of interest, it should 
be recognised that the spirit of the project is directed towards mapping out the ld-lo phase co-
existence region, for practical uses within size limited Janus drug delivery systems.  
FRET interpretations 
Continuing with the coarse grain FRET analytical technique, three phase diagrams of the four 
component DPPC, DOPC and cholesterol across a 10 mol% CL slice were produced. Originally 
lipid composition was plotted against FRET ratio at 20 °C, yielding a 3D FRET ratio plot of the 
phase diagram which is displayed in Figure 3.17. This plot shows the four main areas of interest 
ld, ld-lo, lgel lo-HII phases, each represented by blue, green, red, and purple respectively. Similarly, 
a phase diagram at 50 °C was produced from the FRET data. At this raised temperature, the ld-lo 
phase coexistence region had melted increasing the FRET ratios. However, these 3D FRET ratio 
graphs poorly define phase boundaries and only partially display the phase diagram, making them 
difficult to interpret. Through returning to using FRET data and phase representatives as a 
qualitative technique, a clear, experimentally determined, phase diagram was plotted
(Figure 3.17).  
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Figure 3.17 – Left: Experimentally determined 2D DPPC, DOPC, cholesterol phase diagram with CL set at 10 mol% at 20 °C, dots representing samples 
taken. Top Right: raw FRET ratio data plotted on a DPPC, DOPC, cholesterol phase diagram with CL set at 10 mol% at 20 °C creating a 3D representation 
of the phase diagram. Bottom Right: raw FRET ratio data plotted on a DPPC, DOPC, cholesterol phase diagram with CL set at 10 mol% at 50 oC. 
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The 2D experimentally determined phase diagram was drawn through further FRET 
interpretations and the visualisation of the formation of cholesterol crystals. The latter was readily 
observed, Figure 3.18, with the crystal phase boundary beginning at ~50 mol%. 
Figure 3.18 – Cholesterol crystalsformed at a composition of DOPC 30% DPPC 10%
cholesterol 50% CL10% with NBD PE and rhod PE both being maintained at 0.2 mol% 
respectively. The photograph displays three repeats with crystals being present.  
The formation of crystals produces vesicles with reduced and unknown cholesterol levels in their 
membranes, rendering them unsuitable for further development. Continued mapping above 
50 mol% cholesterol was not carried out due to project focus being about the ld-lo phase 
coexistence region. Previous published phase diagrams for DPPC:DOPC:cholesterol states that 
above 50 mol% cholesterol no further phase changes occur [67]. 
In regards to the other interpreted phases, the lgel phase was shown to be homogeneous through 
not presenting any melting transitions as seen for suspected lo-ld co-existing samples. While a 
lack of a transition does not directly link it with being a lgel phase, the lack of unsaturated lipid and 
wealth of saturated lipid indicate a lgel phase being present. Finally, where cholesterol is ≤0%, 
melting transitions are still observed similar to lo-ld co-existing samples, indicating the melting of 
saturated lipid domains. However, this result is accountable to ld and lgel phase separation, rather 
than ld and lo phase separation as previously shown by J.T. Buboltz et al. in the analogous 
DPPC:DOPPC:cholesterol phase diagram [67].  
The phase diagram presented in Figure 3.17 only marks phase boundaries from the interpretation 
of FRET data. However, not all phases have been recorded that are known to be present. For 
example, while the three phase triangle for DOPC:DPPC:cholesterol is not always recorded, its 
location has been noted to calculate tie line positions, see Figure 1.8 [67], [76], [78]. The 
experimental data gathered through course grain mapping confirms that the three phase triangle 
has not significantly changed its position though CL incorporation, but has so far been ignored in 
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Figure 3.17. The next iteration of the phase diagram’s design was to evolve it to comply with 
phase diagram theory, where theory disclosed details that FRET/coarse grain mapping could not 
determine. 
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Figure 3.19 – The corrected experimentally determined DPPC, DOPC, cholesterol phase diagram with CL set at 10 mol% at 20 °C, dots represent samples 
taken. Numbered fluorescence microscopy images display phase behaviour of lipids in GUV samples. All images were produced in conjunction with 
0.2 mol% NBD PE and rhod PE fluorescent dyes respectively Scale bar represents 20 µm. 
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The phase diagram present in Figure 3.19 has the addition putative phases. The first of these is a 
three phase triangle displaying three phase co-existence. From the top right hand corner of the three 
phase triangle will exist a pure lo phase. This phase will be small and has no strict phase boundary 
with the ld phase, therefore on the diagram no strict distinction between the ld and lo phases has been 
made and is represented through a colour gradient. The lo phase must exist between the ld-lo and lo-
HII phases to comply with the law of adjoining phases [139], where two phase coexisting regions must 
be separated by a single phase region. The final addition to the experimentally determined phase 
diagram was the small lo-lgel phase coexisting region. This will be a very small region due to the small 
size of the three phase triangle’s edge and positioning between the two other phases. While all these 
additions are important to produce a comprehensive phase diagram, the experimentally interpreted 
diagram in Figure 3.17 would suffice to produce Janus nano vesicles. 
The four component phase diagram slice was intentionally plotted using nano-sized vesicles using 
FRET in order to accurately map phase boundaries, rather than interpreting phase behaviour from 
giant vesicles. However, to confirm FRET data were being interpreted correctly, GUVs were prepared 
and imaged to visualise the suspected phase behaviour, as well as the unusual lo-HII phase behaviour 
as hypothesised in section 3.2.1.1 page 86. Figure 3.19 displays compositions of GUV samples taken 
across the phase diagram and resulting imaged structures. Images were gained through confocal 
fluorescence microscopy, once again taking advantage of NBD PE and rhod PE phase partitioning 
preferences. Sample 1 is in the single ld phase part of the phase diagram which is displayed in the 
homogeneous surface shown in the microscopy fluorescence image. Samples 2, 3 and 4 are in the 
direction of the ld-lo phase tie line taken from the DOPC:DPPC:cholesterol phase diagram. It was 
assumed from the overall similar topology of the phase diagram 10 mol% CL would not invoke a large 
change in the overall direction of the three component ld-lo tie line, making it suitable for use as a 
pseudo tie line for the four component lipid system. Through interpreting this pseudo tie line, it was 
expected that the area of green NBD PE would increase with DPPC percentage and conversely the 
area of red, rhod PE, would diminish. Confocal images confirm that positioning on the pseudo tie line 
does affect the proportion of each coexisting phase and the potential size of functionalisable area. 
Sample 5 appears to have a lo-HII  phase coexisting membrane, denoted by the NBD partitioning 
studded with very bright rhod PE groupings. These observations fall in line with the models previously 
presented whereby both lo phase and HII phase are cohabiting the same vesicle. Here it is inferred 
that NBD PE enters the saturated lo domain across the surface of the vesicle and rhod PE partitions 
to the unsaturated HII phase. This hypothesis has been illustrated in the cartoon model depicted in 
Figure 3.20.  
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Figure 3.20 - Cartoon of the suggested model for lo-HII phase coexistence. DPPC, CL, NBD PE 
and rhod PE are represented through the grey, purple, green and red headed lipids 
respectively. Cholesterol has been removed from the cartoon for drawing clarity.  
The model displays how the highly hydrophobic HII phase is encompassed and stabilised through the 
surrounding lo phase. This behaviour would go some way to explain NBD doped saturated membrane 
surrounding pockets of red rhod PE doped inverted micelles, inferred from the confocal image.  
Finally, the last fluorescence confocal image for sample 6, displayed in Figure 3.19, exhibits a 
deformed structure similar to those present in literature. 
Figure 3.21 – Confocal fluorescence microscopy image of a DPPC vesicle in a lgel phase 
labelled with Bodipy-PC [143]. 
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The literature image in Figure 3.21 and the phase representative image of sample 6 in Figure 3.19, 
display very similar morphological characteristics. Both structures are shown to have similar rigid 
non-spherical morphologies due to the tight packing of saturated lipids. The similarity therefore gives 
confidence to the interpretation of sample 6 being in a lgel phase. 
Summary 
Using FRET, nano-size vesicle phase behaviour has been mapped at 20 oC to produce a four 
component phase diagram of DOPC, DPPC, cholesterol and CL, where CL is fixed at 10 mol%. The 
phase behaviour and subsequent phase boundaries have been monitored through the measurement 
and interpretation of raw fluorescence data and FRET ratio temperature profiles, spanning 18-50 oC. 
Multiple methods were scrutinised to develop the best FRET data processing procedure, with the 
FRET ratio providing the best route to minimise uncertainty. While examining phase behaviour 
unexpected lo-HII phase coexistence was observed, where lo-HII phase coexistence has been 
rationalised to be connected to cholesterol concentration. This connection has previously been shown 
in literature with analogous DOPE. All phases were confirmed through complementary confocal 
fluorescence microscopy images of GUV samples.  
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Thermal examination of lipid-DNA conjugates 
incorporated into vesicles 
To form controlled vesicle dimers a DNA “glue” needed to be incorporated into the previously 
established heterogeneous liposome surface. To provide the “sticky” patch on the vesicle’s surface, 
lipid-DNA was integrated into vesicles. The purchased lipid-DNA consisted of two 16 carbon length 
saturated lipid tails attached to previously designed DNA sequences, constructed via 
phosphoramidite chemistry. The basic structure of a lipid-DNA molecule has been drawn in 
Figure 4.1.
Figure 4.1 – Lipid structure of lipid-DNA conjugates. R1 denotes the DNA rest of the 
oligonucleotide and BP represents the first BP attached to the lipid tail.  
Expanding on the lipid-DNA structural template outlined in Figure 4.1, the complete four sequences 
purchased were: 
1. lipid-5′-TTT ACA GAC TAC C-3′
2. lipid-5′-TTT GGT AGT CTG T-3′
3. lipid-5’-TTT TTT TTT CCC TAA CCC TAA CCC TAA CCC-3‘
4. lipid-5’-TTT TTT GGG TTA TGG TTA GGA TTA GTG-3’
The first two short 13 base pair (BP) long sequences are fully complementary to one another with the 
exception of the three thymine (T) spacers. These spacers ensure there is a gap between the vesicle 
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surface and the incoming binding DNA of ~1 nm, thereby reducing membrane surface effects on 
hybridisation. Sequences 3 and 4 are 30 mer and 27 mer BP long sequences respectively, and have 
been designed to provide pH sensitivity as i-motif sequences. Each strand has thymine spacer groups 
and three BP mismatches. These mismatches lower the binding free energy of the hybridised duplex 
aiding inter strand dehybridisation and intra molecular i-motif folding at low pH. The three mismatches 
between the two i-motif sequences have been displayed in Figure 4.2.  
Figure 4.2 – i-motif DNA sequences aligned as they would be in vesicle hybridisation. Blue 
boxes display three complementary BPs and red denotes a mismatching base pair. Top: 
sequence 3. Bottom: sequence 4. 
Through the incorporation of i-motif sequences into the Janus vesicles a pH sensitive switchable 
device could be produced. The resulting switchable device would greatly improve the scope of this 
Janus vesicle sized limited cluster drug delivery platform, into a realm of stimuli responsive 
applications. 
Lipid-DNA self-assembly 
Before incorporating the lipid-DNA into vesicles, the Critical Micelle Concentration (CMC) was 
measured. Through measuring the CMC and comparing results with literature, the lipid tail and DNA 
would be shown to be conjugated together. Furthermore, the CMC would give a working 
concentration to be below in future experiments, giving a twofold benefit. Firstly, micelle formation 
would lower the concentration of free lipid-DNA and membrane integrated lipid-DNA. Secondly, it 
ensures lipid-DNA micelles do not significantly interfere in later dynamic light scattering experiments. 
To measure the CMC of the DNA-lipids 1-(2-pyridylazo)-2-naphthol (PAN) [126], a water insoluble 
organic dye [127], was dissolved in hexane and added to DNA-lipid solutions. Upon increasing 
surfactant concentration above the CMC micelles form, which enabled PAN to partition into the 
hydrophobic rich domains, increasing absorbance at 470 nm [126]. 
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Figure 4.3 - Detecting the CMC for lipid-DNA using UV-vis spectroscopy. Wavelength was set 
to 470 nm. Solid straight lines display the vertices at which the CMC values were measured. 
Curved lines are a guide for the eye.  
From the data presented in Figure 4.3 a CMC was obtained for both sequences. The 13 base pair 
sequence was calculated to have a CMC of 6.4 mM and the 27 base pair sequence was calculated 
to have a CMC of 7.3 mM. These values are in the range of those presented by Stef A. J. van der 
Meulen et al., indicating that the lipid and DNA are conjugated together and ready for liposome 
incorporation. However, no clear distinction can be made to argue that the length of the DNA 
sequence affects the CMC, due to a lack of repeats and associated large uncertainty. No repeats 
were performed due to the high volume of sample required by this analytical method. Likewise Stef 
A. J. van der Meulen et al. did not display error bars on their data, suggesting that sample volume 
may have also been a limitation for them [126]. 
Ultraviolet absorption spectroscopy and calculating the melting temperature 
of lipid-DNA 
Experiments were conducted to determine the appropriate loading of lipid-DNA per vesicle. To do 
this the melting temperature of integrated lipid-DNA (Tm) was measured through ultraviolet absorption 
spectroscopy, where two wavelengths could be used to measure the Tm. The first at 260 nm displays 
UV DNA absorption where the BPs in single stranded DNA (DNAss) are able to perform electronic 
π – π* transitions, which are quenched once hybridised to form double stranded DNA (DNAds) [96]. 
The second wavelength is 320 nm where turbidity changes are recorded. In other words, when 
99 
vesicles hybridise together the resulting clusters become larger than the incident light, and therefore 
scatters light more effectively than single vesicles [96]. Specifically, at low temperatures vesicles are 
hybridised together (high turbidity), and upon the DNA melting, the turbidity drops as more single 
vesicles are formed [96]. These turbidity changes in vesicle samples likely also swamp the π 
transitions seen at 260 nm. However, both experiments record a sigmoidal DNA transition curve, 
where half way up the curve is the point at which half of the DNA is hybridised to its complementary 
strand, signifying the melting temperature of the DNA. 
Furthermore, using the experimentally determined Tm a van’t Hoff derived thermodynamic model can 
be applied, allowing the changes in entropy and enthalpy to be calculated.  
pH non-responsive lipid-DNA vesicle incorporation 
pH 7.4 
This thesis has so far primarily focused on heterogeneous mixtures of lipids to investigate phase 
separation. However, to assess DNA Tm and lipid-DNA suitability, homogeneous vesicles of 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) were loaded with lipid-DNA. Through
using a homogeneous vesicle, only DNA interactions between vesicles will be measured when the 
vesicles are heated/cooled. Measurements on heterogenous vesicles would be subject to the effects 
of both DNA melting and cooling, combined with the melting and condensing of lo patches in phase 
coexisting vesicles.  
Six loadings were initially chosen from 10 DNA strands per vesicle to 250/vesicle to examine the 
effect of DNA loading on Tm. DNA loadings in vesicles were kept at equimolar concentrations. For 
example, vesicles doped with 10 DNA stands/vesicle of sequence 1 were mixed with vesicles doped 
with 10 DNA strands/vesicle of sequence 2. To complete the sample for UV analysis, the 0.5 ml 
aliquot of vesicles doped with sequence 1 was mixed with the 0.5 ml aliquot containing vesicles doped 
with sequence 2, to make up a total volume of 1 ml. Lipid concentrations were maintained at 1x10-3 M 
and lipid-DNA loading were calculated using Equation 2.11. 
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Figure 4.4 – Thermal-melt data of hybridised DNA loaded vesicles temperature controlled at a 
ramp rate of 0.5 °C min-1 with absorbance taken every 10 seconds. A and B are loadings of 10 
and 50 lipid-DNA/vesicle respectively; C and D are loadings of 100 and 150 lipid-DNA/vesicle 
respectively, and finally; E and F are loadings of 200 and 250 lipid-DNA/vesicle respectively. 
The data in Figure 4.4 displays that above a DNA concentration of 10 DNA/vesicle heating ramps 
lead to sharp uncontrolled transitions. Contrastingly cooling cycles gave more reliable sigmoidal 
curves. Furthermore, higher DNA loading affords more hybridisation between vesicles and therefore 
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yields higher temperature stability. These larger flocculates of vesicles formed a sediment at the 
bottom of the cuvette, leading to unpredictable absorption at lower temperatures for higher DNA 
concentrations.  
To calculate the Tm of samples the melting ramps were discounted as they yielded unrepresentative 
results. Once removed, first derivatives were calculated from the cooling ramps in Figure 4.4. The 
cooling ramp first derivatives were then taken and plotted against temperature as shown in 
Figure 4.5. The data in Figure 4.5 displays temperature ramps for single samples, not separate
sample repeats. 
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Figure 4.5 – First derivative plots of thermal-melt data of hybridised DNA loaded vesicles, 
temperature cycled at 0.5 oC min 1 with absorbance taken every 10 seconds. To the data a 
Gaussian peak fitting was applied in Origin Pro 9.1. A and B are loadings of 10 and 50 lipid-
DNA/vesicle respectively; C and D are loadings of 100 and 150 lipid-DNA/vesicle respectively, 
and finally; E and F are loadings of 200 and 250 lipid-DNA/vesicle respectively. 
Using the first derivative plots in Figure 4.5, the DNA Tm could be obtained from the peak maxima, 
for POPC vesicles doped with increasing concentrations of pH non-responsive DNA. These Tm data 
were accumulated and plotted in Figure 4.6. 
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Figure 4.6 – Left: table to show average Tm of DNA calculated from first derivative plots 
presented in Figure 4.5. Right: graph to show how rising lipid-DNA loading per vesicle 
increases Tm of vesicle aggregates, line to guide the eye. 
The rise in Tm with increased DNA concentration is driven through a higher number of DNA strands 
favouring duplex formation. The preference towards duplex formation is a consequence of 
constructive base stacking interactions [144]. Base stacking interactions are an amalgamation of 
attractive Van der Waals dispersive forces, dipole induced dipole and induced-dipole-induced dipole 
interactions across the flat π BP system. As the DNA concentration increases there is a considerable 
energetic gain leading to a higher Tm.  
The data within Figure 4.6 clearly demonstrate that a DNA loading of 10 DNA/vesicle dehybridises at 
~37 oC (body temperature). As a consequence of being at 37 oC, there would be a high population of 
single vesicles and subsequently low population of aggregated vesicles. This in turn would limit a 
10 DNA/vesicle concentration in reaching this project’s specific aims. Positively, 50-250 DNA/vesicle 
loadings present Tm considerably higher than body temperature. The high narrow melting 
temperature transitions for 50-250 DNA/vesicle loadings, have no overlap around 37 oC. This ensures 
that only a very small population of tethered vesicles would dehybridise in and above (~5 oC) normal 
body temperatures.  
pH 5 
To gain a greater picture of vesicle cluster stability, the 13 BP sequences were thermally examined 
at pH 5, a physiologically relevant pH in late endosome/lysosome encapsulation [145]. Moving 
forward additional samples using DNA at concentration of 25 and 75/vesicle were measured as 
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previous data displayed large increases in Tm, specifically within the range of 10 to 50 and 50 to 
100 DNA/vesicle loadings, ~10 oC and ~5 oC respectively at pH 7.4. 
Figure 4.7 - Left: table to show average Tm of DNA calculated from first derivative plots for 
samples held at pH 5. Right: graph to show how rising lipid-DNA loading per vesicle increases 
Tm of DNA in the sample, line to guide the eye. 
Data in Figure 4.7 display a rise in DNA instability gained by being at pH 5. The Tm of vesicle 
aggregates with loadings of 25 lipid-DNA/vesicle were still stable significantly above body 
temperature. However, reducing the pH from 7.4 to 5 resulted in a small drop in Tm across all loadings 
in the order of ~2 oC, suggesting that a lower pH does somewhat destabilise DNA binding between 
vesicles. To examine whether the difference in Tm at pH 7.4 and 5 is systematic with concentration, 
a plot of the difference between Tm of pH 7.4 and 5 was produced. 
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Figure 4.8 – The plotted difference between Tm for DNA loadings at pH 7.4 and 5 . 
Figure 4.8 displays there is no systematic Tm change in regards to DNA concentration between pH 
7.4 and 5, across all DNA loadings examined. While there is an overall reduction in stability at pH 5, 
it is insufficient for significant DNA to dehybridise in late endosome/lysosome encapsulation.  
Thermodynamic data extrapolation 
With the calculation of average Tm for DNA mediated hybridised vesicle samples, it was possible to 
construct a van’t Hoff plot. Through this plot entropy and enthalpy changes of the lipid-DNA melting 
could be calculated to further characterise the system. 
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Figure 4.9 - van’t Hoff plot of data presented in Figure 4.6 and Figure 4.7 for lipid-DNA loaded 
into POPC vesicles.  
At pH 5, 10 and 25 DNA/vesicle loadings gave nonlinear results (data not shown in Figure 4.9) as 
required for van’t Hoff thermodynamic modelling. The disparity from the trend is likely due to sample 
preparation errors, when pipetting small volumes of DNA-lipid, and lack of repeats. It is worth noting 
that previous analogous experiments by other groups did not run repeats, therefore do not show error 
bars [96]. This is likely due to a limited lipid-DNA supply. 
In conjunction with the van’t Hoff derived thermodynamic model presented in Equation 1.8, the 
gradient and intercept in Figure 4.9 are equal to R/∆H and ∆S/∆H respectively. ∆H and ∆S were 
extracted from Figure 4.9 and are shown in Table 4.1. 
Table 4.1 – Thermodynamic data derived from the van’t Hoff plot presented in Figure4.9 for 
the hybridisation of pH non-responsive lipid-DNA tethered POPC vesicles. 
pH ΔH / kJ mol-1 error / kJmol-1 ΔS / J mol-1 error / Jmol-1
7.4 -129.37 1.26 -280.73 0.91
5 -120.62 1.91 -275.02 2.09
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The thermodynamic energies shown in Table 4.1 display that pH does play a role in DNA binding 
strength, presenting that a reduction in pH decreases binding energy by ~8 kJmol-1. Furthermore, the 
reduction in entropy mirrors the pH destabilisation argument through there being a smaller change in 
order of the system. These results are comparable with 10 BP cholesterol-DNA counterparts 
previously studied [96].  
Vesicle stability vs salt concentration 
Salt/sodium concentration is closely linked with DNA stability and the melting temperature of DNA. A 
reduction in salt has well documented negative effects on hybridisation, limiting the screening counter 
ions of the charged phosphate backbone of DNA. Without screening, there is a net negative repulsion 
between DNA strands and a drop in successful hybridisation. With this sensitivity to salt concentration 
the lipid-DNA linked clusters were again examined through UV thermal analysis.  
To examine the effect of salt concentration on DNA vesicle tethering, two DNA loadings were chosen; 
250 and 75 copies of 13 BP sequence DNA/vesicle respectively. These concentrations were chosen 
as they both showed reliable hybridisation irrespective of the tested pH. The salt concentrations 
examined were factors of the 120 mM salt concentration i.e 0, 0.5x, 1x, 2x, 5x and 10x. Furthermore, 
to accurately account for the salt concentration after the HEPES buffer was made to pH 7.4, the 
osmolality of each solution was measured. 
Table 4.2 – Calculated Tm of pH non-responsive DNA linked POPC vesicles with loading of 75 
and 250 DNA/vesicle at pH 7.4 and 5.  
From the DNA Tm data set presented within Table 4.2 a plot of the data was constructed, shown 
within Figure 4.10. To the data a decay exponential (y = A1*exp(-x/t1) + y0) was fitted in Origin 
Pro 9.1.  
Tm  / 
oC error / oC Tm  / 
oC error / oC Tm  / 
oC error / oC Tm  / 
oC error / oC
7.00 30.49 0.25 39.58 2.21
67.67 51.27 0.11 37.68 0.36 55.08 0.16 49.14 0.24
126.50 - - 48.67 0.02 58.09 0.18 55.67 0.01
252.50 56.62 0.08 55.84 0.10 62.70 0.69 61.91 0.28
693.33 58.40 1.09 56.69 0.12 64.57 0.19 65.66 0.61
1196.67 57.51 0.26 55.49 0.28 64.85 0.55 63.74 0.56
No hybridisation detected No hybridisation detected 
NaCl Conc 
/ mM
pH 5 75 DNA / Vesicle pH 7.4 250 DNA / Vesicle pH 5 250 DNA / VesiclepH 7.4 75 DNA / Vesicle
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Figure 4.10 – log salt concentration against Tm for pH non-responsive DNA linked POPC 
vesicles with loading of 75 and 250 DNA strands/vesicle at pH 7.4 and 5. Insert displays the 
same data on a log temperature scale.  
As expected sodium concentration was shown to play a vital role in modifying the Tm of hybridised 
vesicles. 250 mM sodium concentration further promoted negative screening and subsequently 
hybridisation, raising the Tm ~5 oC across all samples. Further increasing salt beyond a ~250 mM 
sodium concentration had no effect in raising the Tm, displaying that maximum screening for the 
13 BP sequence is achieved after the addition of ~250 mM sodium. Furthermore, DNA sequences 
were shown to have a lower DNA Tm as sodium level decreased. The decrease in DNA melting 
temperature associated with lower salt also shows to be more significant for samples at pH 5 than 
pH 7.4, where low sodium (7 mM) and pH (5) prevented DNA hybridisation.  
In summary, the 13 BP sequence has been shown to be effective in maintaining POPC cluster 
formations in relatively extreme pH, salt and temperature environments. However, in order to further 
develop the cluster forming drug delivery platform, the in house designed i-motif DNA sequences 
were substituted for the pH non-responsive sequence.  
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pH responsive lipid-DNA vesicle incorporation 
pH 7.4 and 5 
The same methodology used for the pH non-responsive sequences was carried out to analyse the 
i-motif counterparts. Initially, the DNA Tm of i-motif lipid-DNA doped POPC vesicles in HEPES buffer,
at pH 7.4 and 5 at 125 mM sodium, was measured. 
Figure 4.11 - Top: table to show average Tm of pH responsive DNA calculated from first 
derivative plots for samples held at pH 7.4 and 5. Bottom: graph to show how rising lipid-DNA 
loading per vesicle increases Tm of DNA in the sample. 
Tm / 
oC error / oC Tm / 
oC error / oC
10
25
50 40.38 0.13 40.32 0.42
75 40.69 0.04 41.00 0.27
100 42.48 0.05 41.32 0.22
150 45.25 0.03 42.74 0.07
200 47.37 0.02 49.43 0.08
250 48.11 0.02 49.95 0.07







The thermal-melt data presented here in Figure 4.11 displays a significant drop in Tm for the i-motif 
sequence, in comparison with the previously studied pH non-responsive sequence. This decrease is 
consistent across loadings and pH by ~10 oC. Unexpectedly, results show a discontinuous transition 
in Tm for 200 and 250 DNA/vesicle loadings at pH 5. While this is a small transition (~2 oC), future 
van’t Hoff analysis will not use these data points. The rest of the DNA Tm data were converted and 
plotted in a van’t Hoff plot. 
Figure 4.12 - van’t Hoff plot of i-motif thermal-melt data presented in Figure 4.11 for lipid-DNA 
loaded into homogenous POPC vesicles. 
Figure 4.12 shows Tm data for pH 5 to be unreliable, therefore it was not sensible to apply van’t Hoff 
analysis to calculate thermodynamic values for this data. However, van’t Hoff analysis was employed 
to extract thermodynamic values for pH 7.4.  
Table 4.3 - Thermodynamic data derived from the van’t Hoff plot presented in Figure 4.12 for 
pH responsive lipid-DNA tethered POPC vesicles at pH 7.4. 
pH ΔH / kJ mol-1 error / kJmol-1 ΔS / J mol-1 error / Jmol-1
7.4 -134.02 26.16 -298.11 81.77
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Between the pH non-responsive and i-motif sequences, the longer i-motif at pH 7.4 has shown to 
have a higher change in enthalpy and entropy than the shorter, pH non-responsive sequence 
measured at pH 7.4. The larger enthalpy and entropy changes are due the larger number of BPs 
present per sequence on the i-motif.  
Vesicle stability vs salt concentration 
The DNA melting temperatures for the i-motif sequences have so far indicated that these sequences 
are able to maintain hybridisation between vesicles at pH 5, despite not being able to sensibly apply 
van’t Hoff analysis. At pH 5 the DNA i-motif sequences were expected to display a significant 
reduction in DNA Tm. To encourage DNA dehybridisation, lipid-DNA doped POPC vesicles were 
made in the presence of low salt concentration buffer. Through reducing the DNA’s sodium exposure, 
it was expected that electrostatic repulsion between phosphate backbones would disfavour duplex 
formation. To measure a change in DNA Tm in varying salt concentrations, the previous procedure 
used in Figure 4.10 was repeated for vesicles doped with 75 and 250 DNA/vesicle loadings. 
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Figure 4.13 – Top: table to show calculated Tm of pH responsive DNA linked POPC vesicles 
with loadings of 75 and 250 DNA/vesicle at pH 7.4 and 5. Bottom: plot of measured log of salt 
concentration against Tm for DNA i-motif linked POPC vesicles, with loadings of 75 and 
250 DNA/vesicle at pH 7.4 and 5, with a decay exponential applied. Insert displays the same 
data on log temperature scale. 
Unexpectedly, Figure 4.13 displays 75 DNA/vesicle loading as having a higher thermal stability at 
pH 5 than pH 7.4, for salt concentrations greater than 126.5 mM. Conversely the opposite is true for 
250 DNA/vesicle loading above 252.5 mM salt. However, while results are outside of the standard 
deviation, the first derivative data in Figure 4.14 displays that there is higher error in plotting a curve 
for samples at pH 5 than pH 7.4, through the increased data scatter.  
Tm / 
oC error / 
oC Tm / 
oC error / 
oC Tm / 
oC error / 
oC Tm / 
oC error / 
oC
7.00 28.97 0.17 36.97 0.38
67.67 36.33 0.28 47.59 0.58
126.50 39.86 0.36 40.99 0.40 48.14 0.31 50.18 0.44
252.50 47.67 0.31 49.35 0.58 54.43 0.53 51.43 0.73
693.33 50.70 0.57 51.98 0.32 58.18 0.36 56.05 1.32
1196.67 52.57 0.39 53.96 0.12 61.21 0.30 57.52 1.46
NaCl conc / 
mM
pH 5 75 DNA / vesicle pH 7.4 250 DNA / vesicle pH 5 250 DNA / vesicle
No hybridisation detected No hybridisation detected 
pH 7.4 75 DNA / vesicle
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Figure 4.14 – First derivative plots of thermal-melt data of hybridised i-motif lipid-DNA loaded 
vesicles, the temperature was cycled at a ramp rate of 0.5 °C min -1 with absorbance taken 
every 10 seconds. To the data a Gaussian peak fitting was applied in Origin Pro 9.1. A and B 
are loadings of 75 and 250 lipid-DNA/vesicle respectively at 126.5 mM salt and pH 7.4; C and 
D are loadings of 75 and 250 lipid-DNA/vesicle respectively at 126.5 mM salt and pH 5. 
Nevertheless, across all salt concentrations in Figure 4.13 the i-motif sequence Tm is below that 
reported for the pH non-responsive sequence. Furthermore, samples at pH 5 at low salt 
concentrations (<126.50 mM) have been shown to have no measurable hybridisation, displaying the 
i-motif’s sensitivity in forming a duplex in low pH and salt environment. Through this sensitivity and
further DNA development, it could be possible that a triggered vesicle cluster release could be 
exhibited through reduced salt and i-motif lipid-DNA integration. However, this project will focus on 
using pH as a trigger for vesicle release.  
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A pH switchable device 
i-motif DNA sequences form reversible inter and intra hybridised structures; using this technology it
was hoped that a pH switchable vesicle cluster device could be produced. In this instance in the 
presence of a low pH, a dimer drug carrier would separate into its constituent single liposomes. 
Through increasing the pH back to its original higher pH, vesicles would reform into a dimer.  
To measure this responsivity, POPC vesicles were once again separated into two aliquots and loaded 
with opposing complementary DNA sequences in equimolar concentrations using the previously 
outlined lipid-DNA series of 10 to 250 DNA/vesicle. Opposing aliquots of DNA doped vesicles were 
then recombined ensuring the DNA loadings were of the same concentration. This procedure was 
used for both the i-motif and non-responsive DNA. Initially samples were prepared and measured at 
pH 7.4 where UV data were captured across the usual temperature ramps. The pH was then dropped 
to pH 3 using 1.2 M HCl(aq). Once the pH was lowered UV thermal analysis was continued as 
previously detailed. 
Figure 4.15 – A typical UV spectroscopy graph displaying no thermal-melt activity at pH 3. 
This behaviour is seen across all loadings irrespective of DNA sequence type at pH 3. 
The UV data shown in Figure 4.15, displays that at pH 3 there are no features indicative of integrated 
lipid-DNA melting. Irrespective of loading or DNA sequence the sigmoidal melting curve was not 
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observed, demonstrating a lack of hybridisation between DNA and tethering between vesicles. The 
rising trend with temperature is likely due to thermal expansion of vesicles scattering more light. Upon 
collecting data at pH 3 aliquots of 1.2 M NaOH(aq) were added to the samples to raise the pH back to 
7.4 and thermal melt scans were resumed. 
Figure 4.16 – A Typical UV spectroscopy graph displaying no thermal-melt activity at pH 7.4. 
This behaviour is seen across all loadings irrespective of DNA sequence type, after pH was 
risen back to pH 7.4. 
Once the pH was raised back to 7.4, both sequences in all concentrations showed no signs of 
hybridisation; an example of this behaviour can be seen in Figure 4.16. The lack of hybridisation 
points to DNA being irreversibly damaged by the pH drop, preventing tethering. The likely route for 
this damage was thought to be through depurination. Whereby the glycosidic linkage to the G and A 
BPs is broken, liberating the BP from the DNA structure and leaving behind an apurinic site, as shown 
within Figure 4.17 [146].  
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Figure 4.17 – The acid catalysed SN1 reaction mechanism for the depurination of guanine 
from DNA leaving behind an apurinic site (red box) [146], [147]. B represents the addition of 
base.  
The depurination reaction mechanism in Figure 4.17 is shown to continue to progress to opening the 
sugar ring, which if base is further added leads to DNA sugar phosphate breakage. Specifically, after 
the formation of the apurinic site there exists an equilibrium mixture of the ring-closed acetal (99%) 
and the ring-opened aldehyde, which leads to DNA backbone breakage with the addition of 
base [147]. This may have happened in experiments presented here where the pH was initially 
dropped to pH 3 through the addition of hydrochloric acid.  
Pyrimidine based cytosine and thymine groups undergo a slight variation of the depurination reaction 
mechanism. Instead T and C BPs undergo depyrimidination, a less common form of base loss. The 
preference towards A and G removal is rationalised through them having an easier removal route 
than T, and C [147].  
HPLC of acid catalysed DNA break up 
The hypothesis put forward, for a lack of pH switch ability, describes the DNA sequences succumbing 
to a thermally influenced acid catalysed degradation. High Performance Liquid Chromatography 
(HPLC) coupled with UV detection was therefore implemented to measure the potential retention time 
shifts due to DNA break down. 
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Figure 4.18 – HPLC data of pH non-responsive lipid-DNA . A: Control DNA sequence 1 (TTT 
ACA GAC TAC C). B: DNA sequence 1 at 70 °C for one hour at pH 3. C: DNA sequence 1 at 
70 °C for 24 hours at pH 3. D: Control DNA sequence 2 (TTT GGT AGT CTG T). E: DNA 
sequence 2 at 70 °C for one hour at pH 3. F: DNA sequence 2 at 70 °C for 24 hours at pH 3. 
(HPLC conditions in section 2.3.8 page 54) 
Initially Figure 4.18 outlines that extreme environmental conditions led to DNA instability. Across both 
pH non-responsive sequences UV absorption is low for all eluted compounds in the control samples. 
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The data displays lipid-DNA likely being resolved at ~32 minutes, with DNA that is not attached to 
the lipid tail being present at 19 minutes.  
When the pH was dropped to pH 3 and the sample was left in a water bath at 70 oC for an hour, two 
distinct peaks were recorded at ~14.2 and ~18.8 minutes. As previously discussed, depurination is 
the loss of purine BPs from DNA and occurs at a faster rate than depyrimidination [147]. Therefore, 
it has been interpreted that the new peaks would be produced through the liberation of more 
hydrophilic G and A BPs from DNA and not T and C. Due to the two non-responsive sequences being 
fully complementary, chromatograms could be used to calibrate relative BP concentrations and 
identify the peaks to specific BPs. For example, sequence 1 is rich in adenine with 4 BPs per 
sequence, where sequence 2 is deficient in adenine with 1 per sequence. Therefore, in sequence 1 
it is most likely that adenine is the largest peak after an hour at 70 oC at pH 3, with a retention time 
of 18.8 minutes. The peak resolved at 18.8 minutes in sequence 2 should therefore be a quarter in 
area of that reported for sequence 1, due to there being 75% less adenine in sequence 2. The data 
shown in Figure 4.18 reflects this hypothesis with the peak in sequence 1 having a peak area of 
34.615 mAU*min and sequence 2 having a peak area of 8.469 mAU*min. A similar approach was 
used in an effort to verify that the peak with a retention time of 14.2 minutes was guanine. Where a 
recorded peak area ratio of 1:4 (3.956 and 15.817 mAU*min) reflected the DNA guanine base pair 
ratio of 1:4, for sequence 1 and sequence 2 respectively. Even if the hypothesis of depurination being 
more likely than depyrimidination is rejected, the peak areas in regards to T make little sense. T has 
a 1:~2 ratio with respect to sequence 1 and 2, and no peak area ratio fits that pattern. Additionally, 
the results displayed here were comparable to published HPLC elusion times for free BPs under 
similar solvent condition [148].  
Continued 24 hour heating could possibly lead to further BP liberation, including T and C, but in these 
extreme conditions it is likely that BP breakdown is occurring alongside DNA backbone breakage, as 
seen in the reaction mechanism present within Figure 4.17. It is thought that these continued 
reactions go some way to explaining the rise in the number of peaks recorded through extended 
overnight heating. 
A similar HPLC approach was used for examining the pH responsive i-motif sequences. 
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Figure 4.19 - HPLC data of pH responsive i-motif lipid-DNA. A: Control DNA sequence 3 (TTT 
TTT TTT CCC TAA CCC TAA CCC TAA CCC). B: DNA sequence 3 at 70 °C for one hour at pH 
3. C: DNA sequence 3 at 70 °C for 24 hours at pH 3. D: Control DNA sequence 4 (TTT TTT GGG
TTA TGG TTA GGA TTA GTG). E: DNA sequence 4 at 70 °C for one hour at pH 3. F: DNA 
sequence 4 at 70 °C for 24 hours at pH 3. (HPLC conditions in section 2.3.8 page 54) 
Once again HPLC data displays evidence of DNA BP liberation as previously shown for the short 
fully complementary sequences after 24 hours of heating, indicated by peaks being present at ~18.8 
minutes and ~14 minutes for BPs A and G respectively. 
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The data within Figure 4.19 display the controls having a larger peak separations than previously 
seen for the shorter DNA sequences. It has been rationalised that the lipid-DNA elutes at ~33 minutes 
and the larger peaks with shorter retention times are DNA sequences missing the hydrophobic lipid 
tail (free DNA). The rise in free DNA absorbance for sequences 3 and 4 in comparison with sequences 
1 and 2 is thought to be due to DNA BP attachment efficiencies. When building DNA there is a 
coupling efficiency of 98.5% per BP, meaning for each BP attachment cycle 1.5% of the all the DNA 
strands are missing that particular cycle’s BP. In the result of a BP not been added to a sequence, a 
capping step in the synthesis prevents the continuation further BP addition. Predictably, longer 
sequences have more BP addition cycles, resulting in consecutive losses of 1.5% DNA per BP. 
Through the i-motifs being ~15 BPs longer than the non-responsive sequences, there will be a 
conservative 20% drop in successfully lipid-DNA production [149]. However, sequence 4’s control 
has two peaks in the DNA resolution area (~18 minutes and ~19 minutes), each thought to be 
denoting a DNA substructure. Sequence 4 has been previously discussed to have the ability to form 
guanine quadruplex [150]. A quadruplex is similar to the i-motif where intra-hybridisation occurs along 
a strand of DNA, but in place of C*-C hydrogen bonding, G rich sequences can hybridise without the 
need for hemi-protonation [151].    
Figure 4.20 – A model of intra-hydrogen bonding of a guanine rich DNA forming a G 
quadruplex substructure of DNA [151]. A – cartoon displaying guanine base pair arrangement 
around a positively charged ion. B - cartoon displaying stacked hydrogen bonded guanine 
base pair layers. 
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Figure 4.20 displays that in a quadruplex the DNA contorts to form four hydrogen bonds between G 
BPs, rather than the usual three which is often aided by a metal centre such as potassium or 
sodium [151]. Intra-hybridised DNA would likely be separated from free DNA and in HPLC 
experiments, potentially giving rise to the two starting peaks in the HPLC sequence 4 control. 
However, literature displays that quadruplex formation and disassembly is complex with three 
intermediate structures [152], where the final quadraplex can either form a monomolecular, 
bimolecular or tetramolecular substructure [153]. Furthermore, literature demonstrates that these final 
quadraplex substructures have been separated via HPLC [153]. This highlights that more work needs 
to be done here to fully determine the peaks in HPLC data for the sequence 4 control and pH 3 70 oC 
heating study. Nevertheless, the change indicated by the 70 oC 24 hour pH 3 study in Figure 4.19 
demonstrates there is some structural changes in the DNA that are likely contributing the lack of 
rehybridization when the pH is raised back to pH 7.4 (shown in Figure 4.16).  
Figure 4.19 also shows a definitive peak shift from 19 minutes to 12.8 minutes for sequence 3 after 
being held at 70 oC for an hour at pH 3. This shift is likely due to minimal depurination when heated 
and the formation of the i-motif, which is promoted in the presence of a low pH environment and lower 
temperature during analysis. This change in DNA structure from unhybridised to intra-hybridised 
would likely result different elution times. In other words, when the DNA was held at 70 oC for an hour, 
any intra-strand hybridisation would likely melt as 70 oC is well above any pervious recorded Tm using 
sequence 3. At these high temperatures, the unhybridised DNA would expose BPs to potential 
depurination. However, over this short period of time, relative to the 24 hour heating, depurination 
would be minimal, enabling the prospect of the i-motif to form when the sample was cooled. 
Furthermore because of suspected i-motif formation, the reduced peak at 19 minutes could be 
attributed to residual non i-motif folded DNA. With regard to sequence 4 the addition of acid could 
remove intra-strand hybridisation through nitrogen/free-proton hydrogen bonding, resulting in the 
large now single peak seen after 18 minutes. It is important to note that no peaks at ~18.8 and 
~14 minutes have been recorded after 1 hour of heating, indicative of no A and G BPs being removed 
via depurination. 
However, HPLC analysis of samples heated for 24 hours display that sequences 3 and 4 may become 
susceptible to acid catalysed BP removal. Chromatograms for both sequences reveal a distinctive 
peak at ~18.7 minutes suggesting adenine removal. Interestingly, no peaks at ~14 minutes for 
sequence 3 are present, this coincides with the fact no G BPs are in DNA sequence 3. This data 
therefore adds significant weight behind the hypothesis that the peaks seen at ~14 minutes for other 
sequences after being heated 70 oC are guanine. Nevertheless, the reoccurrence of peaks at 14 and 
~18.7 minutes seem to be linked with the data previously recoded from POPC lipid-DNA thermal-
melt analysis.  
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In summary HPLC has been an effective tool in describing why pH switching was not observed 
through UV thermal-melt analysis. To monitor a potential pH switch a technique where temperature 
could be kept at a lower 25 oC would be beneficial.  
Summary 
The data gathered in this chapter describe how UV temperature ramping cycles can be used to 
measure vesicle bound lipid-DNA melting temperatures. Initially three experiments were run for two 
sets of complementary DNA sequences, a fully complementary short sequence and a pH responsive 
i-motif:
1. Measurement of Tm for lipid-DNA bound POPC vesicles, at physiological salt and pH, across
10-250 DNA strand loadings/vesicle.
2. Measurement of Tm to gauge stability in lower pH conditions
3. Measurement of Tm to examine the effect of sodium on vesicle binding
Through these experiments, it was found that DNA concentration plays a large role in the thermal 
properties of vesicle bridging, allowing van’t Hoff plots to interpret thermodynamic properties of the 
system for both sets of sequences. Furthermore, it was found that the sequence dictates the Tm of 
hybridised vesicles, where the i-motif forming DNA had a lower Tm independent of loading. A 
reduction in pH from 7.4 to 5 gave a lower Tm across all DNA loadings. Salt concentrations below 
~125 mM for the fully complementary sequences were found to lower DNA binding at pH 7.4, through 
reducing the screening of the negative charges on the phosphate backbone of samples. The same 
effect was not recoded for the i-motif sequences at pH 5 due to high error in the data.  
Finally, the potential for a pH switchable tethered vesicle devise was investigated. However, it was 
found that using a UV temperature ramp based experimental method led to potential depurination of 
BPs from the DNA. If occurring the reduced number of BPs would prevent hybridisation when the pH 
was raised back to a physiological pH 7.4. HPLC data also so signs for confirming DNA depurination. 
Moving forward, the lipid-DNA sequences examined here were coupled with the four-component 
phase diagram of DPPC:DOPC:cholesterol:CL. Through this integration, it was hoped that controlled 
size limited clusters could be formed. 
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Measuring the size of vesicle clusters tethered 
together through lipid-DNA conjugates 
Once controlled DOPC:DPPC:cholesterol:CL (where CL is set at 10 mol%) phase separation was 
achieved through the newly constructed phase diagram, and suitable DNA sequences were chosen; 
specific liposome compositions could be tuned to control average liposome aggregate size. Initially 
to investigate controlled aggregation two fundamental questions were explored. 
1. Does the size of the lo patch influence the average cluster size?
2. Does the concentration of DNA influence the average cluster size?
To address the former, the suspected “pseudo” tie line across the ld-lo phase coexistence region was 
used as a guide for sample selection. It must be emphasised that the real tie line for the four-
component phase diagram would not be limited to the 10 mol% CL plane. However, it has been 
shown that moving across the pseudo tie line provides the ability to control membrane heterogeneity. 
Using this tie line, it was hoped the controllable lo surface area would potentially lead to the control of 
average cluster size. With regard to the second question, the concentration of DNA was expected to 
change the number of hybridised vesicles in a cluster, dependent upon the position in the tie line. 
Three representative phase positions on the pseudo tie line were carried forward from Figure 3.19, 
where 2, 3 and 4 represent tie line positions T1, T2, T3. 
Cluster formation and measurement 
To examine whether DNA concentration influences Janus liposome clustering, 75 and 250 DNA 
strands/vesicle were chosen as representative of low and high concentrations respectively. Previous 
data displayed that concentrations below 75 DNA strands/vesicle provided unreliable turbidity 
detection for small hybridised clusters.  
In order to monitor cluster size, Dynamic Light Scattering (DLS) was implemented. Through 
measuring the diffusion of the vesicles by Brownian motion and the use of the Stokes-Einstein 
equation, it is possible to determine liposome hydrodynamic diameters [154]. Smaller particles exhibit 
faster diffusion coefficients than larger particles therefore it is possible to determine the difference in 
hydrodynamic diameter and therefore cluster size. The hydrodynamic diameter is not the true 
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diameter of a particle’s size but is an average diameter across the entirety of the sample and a 
particle’s shape. The hydrodynamic diameter therefore assumes spherical particles. In the case of 
individual vesicles this does not raise an issue due to their already spherical shape. However, for 
tethered liposomes this does raise an issue that needs to be addressed in reference with Figure 5.1. 
Figure 5.1 -  A cartoon of vesicle cross sections to show models A and B; where A displays a 
false hypothesis of how DNA doped Janus vesicles hybridise together with a subsequently 
inaccurate hydrodynamic diameter. B displays a more accurate representation of how Janus 
DNA doped liposomes hybridise together with a deformed adhesion plaque and more accurate 
hydrodynamic diameter. 
If liposomes were solid spheres they would link together as displayed in example A within Figure 5.1, 
where they would have a long aggregated vesicle length (2d) and a shorter vesicle width (d). Through 
using DLS to measure the aggregate’s size, the hydrodynamic radius would be reported as the 
average between the aggregate’s length and the aggregate’s width, resulting in an inaccurate 
hydrodynamic diameter reading. However, previous work has shown that when liposomes are 
tethered using DNA they deform due to their soft membranes, forming a flat adhesion plaque [91]. In 
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this model (B) the cluster diameter is significantly less than 2d, resulting in a more overall spherical 
particle. Membrane flexibility therefore gives rise to more accurate DLS measurement of the clusters, 
raising the accuracy of the calculated hydrodynamic diameter of the tethered vesicles. Individual 
larger vesicle clusters may not form an overall spherical shape, but due to the random tethering in 
these clusters, throughout the sample, an average hydrodynamic diameter would be calculated which 
would be representative of the physical diameter. 
Diameter recording via DLS enabled the volume of vesicles to be readily calculated. Using the 
calculated volume of a cluster and that of a single vesicle, a coarse number of vesicles within a 
tethered cluster could be interpreted with reference to Equation 5.1.  
Equation 5.1 -  𝑨𝒗𝒆𝒓𝒂𝒈𝒆 𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒕𝒆𝒕𝒉𝒆𝒓𝒆𝒅 𝒗𝒆𝒔𝒊𝒄𝒍𝒆𝒔 =  
𝒂𝒗𝒆𝒓𝒂𝒈𝒆 𝒗𝒐𝒍𝒖𝒎𝒆 𝒐𝒇 𝒂 𝒄𝒍𝒖𝒔𝒕𝒆𝒓
𝒂𝒗𝒆𝒓𝒂𝒈𝒆 𝒗𝒐𝒍𝒖𝒎𝒆 𝒐𝒇 𝒂 𝒔𝒊𝒏𝒈𝒍𝒆 𝒗𝒆𝒔𝒊𝒄𝒍𝒆
In Equation 5.1 large assumptions have been made when calculating the volume of the clusters. As 
discussed there is an error in the DLS calculated hydrodynamic diameter, where it is assumed that 
what is being measured is strictly spherical or a dense cluster rather than fractal aggregates. 
Furthermore, there is a space between vesicles taken up by the DNA bridge which through this 
calculation is incorporated into the vesicle volume. Additionally, it is also assumed that vesicle 
volumes are equivalent whether they are discrete or clustered. However, the calculated coarse 
number of vesicles, while carrying significant error, gave an insight to the levels of vesicle 
hybridisation in samples.  
Phase diagram led cluster formation 
pH non-responsive DNA mediated cluster assembly 
To ensure that observed aggregation was due to tie line effects rather than unforeseen properties of 
a DNA sequence, the fully complementary 10 base pair (BP) pH “non-responsive” sequences were 
investigated to begin with.  
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Across tie line examination 
To examine whether controlled DNA vesicle tethering was being observed, 100 nm diameter phase 
separated T1, T2 and T3 vesicles, loaded with 75 and 250 lipid-DNA/vesicle were examined via DLS. 
As disused for UV thermal melt analysis, the sample’s vesicle population was separated into two, 
separately doped with the opposing complementary lipid-DNA conjugates and recombined to 
complete the sample. Additionally, a positive control experiment examining mass hybridisation when 
DNA is not localised via phase separation (hybridised DNA POPC) was prepared and run alongside 
a negative control experiment, where POPC vesicles were doped with only sequence 1 (unhybridised 
DNA POPC). 
Table 5.1 – Average hydrodynamic diameter across the DPPC:DOPC:Cholesterol:CL (CL set 
at 10 mol%) ld-lo phase coexistence tie line with positive and negative POPC controls, with 75 
and 250 non-responsive DNA loadings. Errors calculated using individual repeats. Readings 
were taken at 25 oC. 
Composition 
75 DNA strands/vesicle 250 DNA strands/vesicle 
Average 
hydrodynamic 












- - - 2554.56 0.53 97.00 
T1 149.67 0.11 1.95 189.73 0.13 1.07 
T2 166.20 0.20 5.80 181.03 0.11 0.59 
T3 132.30 0.09 0.75 149.27 0.09 0.83 
Unhybridised DNA 
POPC 
119.90 0.05 1.47 123.53 0.31 1.14 
Average number of 
vesicles 
Error 
Average number of 
vesicles 
Error 
Hybridised POPC - - 9256.17 1027.28 
T1 1.94 0.01 3.96 0.11 
T2 2.66 0.26 3.44 0.06 
T3 1.34 0.04 1.93 0.05 
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The data were then processed from Table 5.1 into line graphs, to clearly define how liposome 
composition changes vesicle aggregation.  
Figure 5.2 – Line graphs to show the data presented in Table 5.1. Left: average hydrodynamic 
diameter of clusters. Right: average number of vesicles. Readings were taken at 25 oC. 
The data presented within Figure 5.2 display that phase separation on the 250 non-responsive DNA 
loading has a dramatic effect on decreasing the hydrodynamic diameter of a single cluster. 
Specifically, phase separation has been shown to reduce cluster diameters by over an order of 
magnitude relative to homogenous POPC vesicle clusters. Furthermore, it can be seen that tie line 
position and DNA concentration influence the hydrodynamic diameter and consequently the number 
of tethered vesicles within a cluster. This significant drop in hybridisation enables the formation of 
clusters <200 nm, qualifying them to be large enough to take advantage of the EPR effect when 
administered in drug delivery. Furthermore, the chosen DNA concentrations per vesicle gave cluster 
sizes appropriate for designing small clusters of vesicles as desired; with T1 75 loading and T3 250 
loading displaying particular promise in dimer formation.  
At T1 there is a difference in cluster diameter between the two loadings. This can be explained 
through considering the partitioning of many DNA lipids into the small lo domain. In the case of the 
250 DNA loading, there may be a significant number of lipid-DNAs that begin to partition into the ld 
phase as the small lo domain becomes saturated with lipid-DNA. Furthermore, between the two 
phases a lipid-DNA partition coefficient will exist which describes the ratio of lipid-DNA present within 
each phase. While the lipid-DNA preferentially partitions into the saturated lo domain, there will be 
some lipid-DNA that partitions to the ld phase. Increasing lipid-DNA concentration will therefore 
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promote the number of DNA strands in the ld phase available for ld directed vesicle aggregation. 
Continuing with T1, the 75 DNA loading displays a significant decrease in hydrodynamic diameter. 
With over three times less DNA, the number of strands present with ld phase is limited and the average 
cluster size is smaller by ~40 nm. Interestingly the T1 lo patch size is shown to be sufficiently small 
enough to sterically block multiple liposomes from hybridising. 
Tie line position 2 (T2) again has two rivalling effects, dependent upon lipid-DNA concentration. For 
the T2 250 loading there is a larger lo domain than was present in T1, allowing more lipid-DNA to 
partition within it. This therefore reduces the number of lipid-DNAs in the ld domain and subsequent 
tethered vesicles. Conversely there is a subtle rise in the hydrodynamic diameter for the 75 lipid-DNA 
loading from T1 to T2 by ~15 nm. This growth is suspected to be caused by the larger area on 
vesicles’ surface granting enough room for more than one vesicle to bind. Additionally, the increase 
in saturated DPPC dilutes the lipid-DNA in the lo domain. This reduces the number of available lipid-
DNAs in close proximity for strong hybridisation, between a pair of A and B vesicles. The 250 lipid-
DNA loading provides a “stickier” lo patch than the 75 DNA/vesicle loading, resulting in superior lo 
patch to patch tethering between a pair of 250 lipids-DNA doped vesicles. In other words, once two 
T2 250 lipid-DNA loaded vesicles collide, the close proximity of all the DNA strands enable the 
liposomes to “zip” tightly together. The T2 75 loading on the other hand does not have its DNA lipids 
in such close proximity to one another; therefore, it weakly hybridises to its counterpart, preventing 
the “zipping” action. Without fast and strong hybridisation between liposomes potential sites for further 
tethering with other liposomes are available in the lo phase. 
Finally, at T3, the hydrodynamic diameter drops significantly for both concentrations of lipid-DNA, 
where the 250 lipid-DNA loading can fully partition to the large lo patch. Without random ld phase 
hybridisation, a stable average AB dimer conformation is formed. With regard to the T3 
75 lipid DNA/vesicle loading the DNA has become too dilute across the lo domain, resulting in poor, 
unstable hybridisation between vesicles. Through this dilution, the zippering action is limited resulting 
in weak hybridisation between vesicles, decreasing the hydrodynamic diameter. A cartoon model of 
the discussed hybridisation conjecture across the tie line has been drawn in Figure 5.3. 
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Figure 5.3 – A cartoon summary of vesicle hybridisation across the assumed 
DPPC:DOPC:Cholesterol:CL (CL set at 10 mol%) ld-lo phase coexistence tie line. Green 
represents the lo phase and DNA hybridisation, red displays the ld phase.   
From the initial tie line aggregation data, samples could be selected to confirm dimer tethering through 
cryo-EM. To capture dimer formation a sample of T3 250 DNA/vesicle loading was chosen, frozen 
under liquid nitrogen and then imaged. 
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Figure 5.4 – Cryo-EM image of T3 250 pH non-responsive DNA loaded vesicles. Scale bar 
representing 100 nm. 
The cryo image clearly displays two ~100 nm vesicles forming a dimer. The straight adhesion plaque 
between the vesicles (enlarged in the insert) signifies the difference between liposome adhesion and 
vesicles that are just in close proximity. The data gathered by cryo imaging therefore complements 
and supports both the DLS based technique and the hypothesis that vesicles are indeed aggregating 
together via DNA hybridisation. 
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Thermal-melt of vesicle aggregates 
From the promising initial experimental data, 75 and 250 DNA/vesicle loadings were continued as 
the representative concentrations of DNA, to form potential size limited clusters. Due to the desired 
medical applications of these Janus vesicles, experiments were carried out examining whether 
biological temperatures affected the number of liposomes tethered within a cluster. Conditions were 
then later set to the extreme of 60 oC where the DNA should have melted, displaying single vesicles. 
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Figure 5.5 – Top insert: example of raw thermal-melt data of Janus DNA linked vesicles (T1 
250 non-responsive DNA/vesicle loading). Samples were left for 30 minutes at each 
temperature before measurement. Top: Thermal-melt hydrodynamic diameter of Janus DNA 
linked liposomes across the assumed tie line, with 75 and 250 pH non-responsive DNA/vesicle 
loadings. Bottom: graph displaying the average number of vesicles tethered in a cluster, 
calculated from the hydrodynamic diameter. Lipid concentration was 1x10-3 M. 
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All samples within Figure 5.5 show growth when heated from 25 oC to biologically relevant 37 oC. 
This behaviour was expected as the recorded phase diagram at 20 oC will not be accurate to these 
raised temperatures. Furthermore, through heating the lo patch will be reduced in area as the 
temperature nears that of the Tm of highest melting lipid (DPPC 41 oC). In other words, at 37 oC 
saturated lipids will begin to mix with the ld domain. This has a profound effect on lipid-DNA 
partitioning. Firstly, the lipid-DNA has a saturated chain and will therefore behave similarly to DPPC 
and begin to partition to the ld phase, allowing ABB tethering etc. subsequently increasing the 
hydrodynamic diameter of clusters. Secondly the diminished area of the lo phase will mean that not 
all the lipid DNA will be able to partition to the reduced lo phase. In both of these models the 250 DNA 
loading will be more significantly affected, raising the hydrodynamic diameter which is seen in the 
data.   
60 oC has been shown to be sufficiently warm enough to melt both hybridised DNA and lipid domains, 
resulting in homogeneous membrane formation and DNA dehybridisation. From the data, hybridised 
vesicle clusters at 60 oC should form single vesicles. This hypothesis is consistent with the DLS data 
presented within Figure 5.5. Moreover, 60 oC heating was shown to meaningfully increase the 
hydrodynamic diameter of vesicles as seen with the POPC control, resulting from thermal expansion 
of the membranes surface.  
Long term thermal stability 
All the samples heated to 60 oC for thirty minutes showed little discrepancy from one another in terms 
of hydrodynamic diameter. This leads to the conclusion that thirty minutes should be long enough for 
all 60 oC samples to reach a hydrodynamic equilibrium. However, it would not be safe to assume 
samples held at 37 oC reach a hydrodynamic equilibrium, due to slow lipid diffusion. To account for 
the lipid diffusion at 37 oC, an investigation was conducted where samples were held at 37 oC for 24 
hours before DLS measurement.  
134 
Figure 5.6 – Top: graph to show hydrodynamic diameter growth between samples held at 
37 °C for 30 minutes and 24 hours. Bottom: graph to show the average number of vesicles per 
cluster tethered together, calculated from the hydrodynamic diameter.  
Heating the samples for extended periods of time does lead to an upsurge in hydrodynamic diameter 
for vesicles who’s lo domain size is saturated in lipid DNA. T2 75 DNA/vesicle and T3 75 DNA/vesicle 
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have low DNA loadings in comparison to the area of the lo domain, therefore when heated it is less 
probable for lipid-DNA to diffuse out of the lo domain, and enable successful non-AB vesicle 
hybridisation.  
As discussed, in medical applications it would be undesirable for a small cluster to mass aggregate 
through lipid-DNA surface migration, as shown in the presented data by T1 250 DNA/vesicle. 
However, the rate of DNA migration out of the lo patch will have to compete with liposome sample 
dilution when transported around the blood stream. Explicitly, the significance of liposomes being 
open to mass hybridisation would be lessened by there being no available liposomes in reach, once 
quickly diluted in the blood stream. 
Vesicle ageing stability 
A liposome’s period of usefulness, with regards to aging, is very variable dependent upon cargo type, 
cargo concentration, lipid composition, temperature and other external effects. However, this thesis 
only considered ageing for samples across the pseudo tie line with 75 and 250 lipid-DNA loadings. 
Only when in future development for specific treatments will further stability testing be required.  
Figure 5.7 – Ageing study of Janus DNA linked liposomes across the pseudo tie line with 75 
and 250 non-responsive DNA/vesicle loadings. Left: graph displaying the average 
hydrodynamic diameter of clustering. Right: graph displaying the number of vesicles tethered 
in a cluster, calculated from the hydrodynamic diameter. Reading was taken at 25 oC. 
Figure 5.7 shows that clusters form stable aggregates over a week across the tie line regardless of 
lipid-DNA concentration. One week of cluster stability is a significant amount of time when typical 
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vesicle drug carrier stability is usually measured over a period of 24 hours [155]. Therefore, if small 
liposome clusters were to be used within medical applications, it would not be the liposome DNA 
bridging scaffold that would lead to a limited shelf life, it would be the drug leakage from the vesicles. 
Data shows longer storage would be subject to tie line position. Over a two-week period, the lower 
75 DNA/vesicle loading did show signs of long term instability, specifically at T3 but conversely T2 
displayed negligible cluster growth over the two weeks.  
pH responsive DNA mediated assembly 
pH switching 
To maximise the number of treatments this liposome DNA mediated clustering platform could be 
applied to, the in-house pH responsive sequence developed by Zhou et al. was incorporated into 
vesicles [107]. Initially to test liposome pH switching viability, homogeneous POPC liposomes were 
doped with 250 lipid-DNA/vesicle and analysed through DLS. Vesicles doped with the pH non-
responsive sequence were used as a control.  
Figure 5.8 – pH switching of POPC vesicles tethered together using 250 lipid-DNA pH non- 
responsive strands and pH responsive sequence/vesicle respectively. Left: Graph displaying 
the average hydrodynamic diameter of clustering on a logarithmic scale to the base of ten. 
Right: graph displaying the number of vesicles tethered in a cluster calculated from the 
hydrodynamic diameter on a natural logarithmic scale. The left-hand side on the x axis 
displays the initial starting pH. Samples were incubated for an hour after pH switching before 
measurement. Reading was taken at 25 oC. 
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At the starting pH 7.4, there is disparity between the binding affinity of the pH non-responsive 
sequence and the pH responsive sequence even at the same DNA loading/vesicle, by an order of 
magnitude in hydrodynamic diameter. This discrepancy can be accounted to the stability of each of 
the sequences. By design, the pH responsive mismatched sequence forms less stable duplexes than 
the fully complementary sequences. This instability consequently reduces the number of vesicles 
able to successfully hybridise together in a cluster. The reduction in pH to 4.5, leads to a noteworthy 
reduction in hydrodynamic diameter for both sequences. Because of the pH non-responsive 
sequences being fully complementary, they are more stable at lower pH, hindering the release of 
single vesicles from clusters. On the other hand, through design the pH responsive i-motif sequence 
incorporates BP mismatching. By lowering the pH the duplex is destabilised, enabling the release of 
single vesicles. Upon increasing the pH back to 7.4 the non-responsive sequence does not increase 
the hydrodynamic radius, indicating that there is no increase in vesicle clustering. In reaction to these 
results it was hypothesised that the sequences again may have been damaged through acid 
depurination, greatly reducing hybridisation. The disparity between the i-motif and fully 
complementary sequences is illustrated in Figure 4.18 and Figure 4.19, where the non-responsive 
sequence is found to degrade after one hour at low pH and high temperature, in contrast to the i-motif. 
In addition, the disparity in reforming clusters may also be due to the greater overall percentage of 
damage to the short non-responsive sequence, over the long pH response sequence. In other words, 
if a BP is damaged/removed, longer DNA sequences are more likely to be able to still hybridise 
together, due to the large number of supporting BPs as shown in Figure 5.8. Shorter sequences have 
less hybridising BPs; resulting in an overall larger proportion of the molecule unable to hydrogen bond 
with a correlating sequence, preventing duplex formation.  
With both sets of sequences displaying promising results in the formation of clusters, a study 
examining phase separated vesicles was conducted. 
Phase diagram led cluster formation 
The same experimental conditions to those used in Figure 5.2 were repeated, but in place of the non-
responsive DNA sequence the i-motif sequence was implemented.  
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Figure 5.9 – Average hydrodynamic diameter of pH responsive DNA tethered vesicle clusters, 
and the resulting calculated apparent number of vesicles in said clusters, changes with 
positioning on the tie line of the ld-lo phase coexistence region. Readings were taken at 25 oC. 
Concerns whether the i-motif sequence would provide suitable “stickiness” for small cluster formation 
in phase separated liposomes was put to rest by the data displayed in Figure 5.9. The data show 
composition T1 with a 75 DNA/vesicle loading forming size limited clusters. The results here are akin 
to the data presented in Figure 5.2 and the subsequent model presented in Figure 5.3. At composition 
T2 there is an increase in the hydrodynamic radius of clusters, equating to a larger hydrodynamic 
radius than previously shown for the non-responsive sequence. There may be a contribution to this 
from the longer sequence promoting the distance between vesicles. Between the two lipid-DNA 
sequences the i-motif is averaged to be 15.5 BPs longer which equates to a 5.27 nm extension, when 
BP separation is 0.34 nm [156]. This extension affords more space for binding vesicles enabling the 
potential for further hybridisation with other vesicles. 
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Figure 5.10 – Cartoon of a liposome cross section model displaying how DNA sequence length 
affects the average vesicle cluster size. Cartoon spheres representing phase separated 
vesicles with green highlighting the lo domain and the red the ld domain. On the left, the light 
green straight lines represent the short non-responsive 13 mer. On the right, vesicles are 
connected through the longer pH responsive 30 mer sequence, represented by the conjoined 
light and dark green line, with the dark green displaying the 5.3 nm extension. Cartoon not to 
scale.  
The model shown within Figure 5.10 displays the shorter sequence (left hand side) providing 
unfavourable hybridisation of more than three vesicles, where the longer sequence (right hand side) 
affords potential for four vesicles to cluster tether. 
Data thus far have shown that small size limited clusters can be formed through careful selection of 
both the lipid composition and the lipid-DNA concentration. Further experiments in this chapter are to 
improve upon this foundation to ensure a reliable drug delivery platform and to display further 
potential uses as a medical device. 
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Lipid-PEG addition with phase diagram led cluster formation 
Lipid-PEG 
For successful longer term intravenous circulation of vesicle clusters, it is essential that polyethylene 
glycol (PEG) or another non fouling polymer coating is added to the liposomes’ surface. PEGylating 
NPs produces “stealth” NPs, preventing recognition by the body’s mononuclear phagocyte 
system [157]. Without NPs being PEGylated vesicles display short circulation times and rapid burst 
release, limiting the potential effectiveness of the drug delivery platform and therefore the patient’s 
treatment and outcomes.  
Figure 5.11 – Structure of unsaturated PEGylated lipid, 2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]. 
Lipid-PEG concentration 
Initially lipid-PEG was introduced into POPC homogeneous vesicles to examine the effect PEG may 
have on DNA hybridisation. POPC vesicles doped with 250 and 75 strands of pH responsive and 
non-responsive DNA/vesicle were tested against 0-6% PEG loading, data shown in Figure 5.12. 
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Figure 5.12 – Membrane lipid-PEG mol% showing decreasing hybridisation between vesicles 
in POPC doped lipid-DNA vesicles. Red line is a guide for the eye. Reading was taken at 25 oC. 
The addition of PEG results in a sizeable reduction in vesicle hybridisation, reducing clustering from 
the thousands to single vesicles, with a 4% lipid-PEG addition to the membrane. This was achieved 
through PEG chains providing an effective physical blocking action to DNA. This was likely 
accomplished through the length of PEG being comparable in length to that of the longest used 
30 mer DNA sequence, when PEG is in a brush state. In its fully extended form PEG 2000 has been 
shown to equal 11.5 nm in length whereas the 30 mer DNA sequence is 10.2 nm [156]. However 
when PEG percentage is raised from 4% to 6%, passing through 5%, the mushroom to brush PEG 
transition, data show no significant difference in hybridisation between the two PEG states [158].  
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Figure 5.13 – Left: PEG concentration <5 % forming a mushroom shapeon the surface of a 
vesicle outlined by the blue semicircle. Right: PEG concentration >5 % presenting an 
extended brush shape on the surface of a vesicle outlined by the red cone [158].  
While PEG randomly partitioning to the phase separated surface of the Janus vesicle could have 
drastic effects on size limited cluster formation, this can be controlled through the tailoring of the lipid 
tail. The use of an unsaturated lipid tail promotes partitioning of DNA to the ld region in a phase 
separated liposome. Additionally, once vesicles are hybridised into an AB structure the lo area with 
limited lipid-PEG would be concealed through membrane deformation. Thereby the exterior of the 
vesicle surface would be fully PEGylated as described in Figure 5.14. 
Figure 5.14 – Cross sectional cartoon of dimer phase separated vesicles tethered together 
using lipid-DNA partitioned to lo phase (green), with lipid-PEGs (black) partitioned to the ld 
phase.  
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The lipid-PEG integration to the ld phase offers potential in further developing liposome hybridisation 
specificity. While CL has significantly helped to drive size limited cluster formation, significant 
proportions of the phase diagram, dependent upon DNA concentration, still provide unwanted 
nonspecific hybridisation. To prevent the nonspecific hybridisation PEG would sterically block any 
approaching ld phase partitioned DNA. 
Moving forward, 2% lipid-PEG loading was selected as there was no significant difference between 
this and a higher PEG loading. Furthermore, a higher concentration of lipid-PEG would result in the 
addition of another component within the phase diagram; potentially perturbing the mapped phase 
space plotted in chapter 3. Under these circumstances the lower 2 mol% PEG maximises 
hybridisation blocking with minimal phase interference.  
pH non-responsive DNA mediated cluster assembly 
Across tie line examination 
To measure the effect of lipid-PEG addition has on phase separated vesicles, the first experiment 
conducted was to use DLS to measure the hydrodynamic diameter of lipid nanoparticles across the 
pseudo tie line. 
Figure 5.15 – Data to show the effect on hydrodynamic diameter (left) and calculated number 
of vesicles tethered together with pH non-responsive DNA (right) with the addition of 2 mol% 
lipid-PEG to the phase separated membrane. Reading was taken at 25 oC. 
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The first striking observation is that 2 mol% lipid-PEG significantly lowers the hydrodynamic diameter 
across the tie line. The data show that neither of the lipid-DNA concentrations at any of the positions 
on the tie line led to more than average dimer formation. This significant reduction in number of bound 
vesicles highlights that lipid-PEG in the ld phase, proactively prevents unwanted random tethering, 
while also showing some signs of preventing wanted hybridisation in order to form clusters. T1 75 
DNA/vesicle loading has the same level (within error) of hybridisation as the control. Furthermore, 
Figure 5.15 displays the 250 DNA/vesicle loading as always having higher vesicle tethering than the 
75 DNA/vesicle loading (significant when uncertainty is allowed for). This is likely contributable to the 
increased lipid-DNA forming a “stickier” domain; promoting tethering.    
Thermal-melt of vesicle aggregates 
Continuing with the lipid-PEG pH non-responsive DNA system, melting studies were performed to 
observe whether higher/more biologically relevant temperatures still gave rise to an elevated 
hydrodynamic diameter.  
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Figure 5.16 – Heating study of hybridised vesicles with 2 mol% PEG integration loaded with 
75 and 250 pH non-responsive lipid-DNA/vesicle. Samples were held at respective 
temperatures for 30 minutes. Top: Measured hydrodynamic diameters from phase separated 
vesicles, Bottom: Calculated average number of hybridised phase separated vesicles in a 
cluster from the measured hydrodynamic diameter heating study.  
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Once heated to 37 oC the PEGylated pH non-responsive sequence gave a larger hydrodynamic 
diameter, behaving similarly to samples where PEG is not present, with the advantage of never rising 
above average dimer formation after being held at 37 oC for 30 minutes. Through these initial studies 
DNA linked Janus vesicles assure, upon injection into the patient, there would be no subsequent 
architectural changes with body temperature. The data again show that through further heating to 
60 oC the DNA sequence melts and single vesicles are formed, demonstrating clustering is mediated 
by reversible lipid-DNA interactions.  
Counterintuitively, data for T3 250 DNA/vesicle when heated from 25 oC to 37 oC show an increase 
in hydrodynamic diameter where there is a reported decrease the number of tethered vesicles in 
sample. This apparent discrepancy can be explained with reference to vesicle thermal expansion. 
The number of vesicles hybridised in a cluster is calculated from the ratio between the un-hybridised 
single vesicle control and the clustered vesicle sample. In the case of T3 250 DNA/vesicle the control 
has thermally expanded more than the clustered sample giving rise to an apparent decrease in the 
number of tethered vesicles. However, this is likely not the case due to a significant rise in uncertainty 
in the number of tethered vesicles in that particular sample.  
Vesicle ageing stability 
2% lipid-PEG addition has demonstrated a reduction in random ld tethering over short periods of time 
for 250 and 75 DNA/vesicle loadings, across the pseudo tie line. For effective use within hospital 
treatments the longer the shelf life that can be afforded the better. An extended shelf life opens up 
avenues for new treatments to be taken outside of the hospital in the home. To measure vesicle aging 
stability with PEG addition, experiments were conducted where PEGylated samples were refrigerated 
for two weeks to examine cluster growth rates.  
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Figure 5.17 – Across tie line study for pH non-responsive DNA linked vesicles with 2 mol% 
lipid-PEG doping. All samples were stored in the fridge between measurements. 
Measurements taken at 25 °C.Top: A plot of the measured average hydrodynamic diameter. 
Bottom: A plot of the calculated average number of hybridised vesicles/cluster.  
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The first week of ageing shows unanimously across both DNA loading and tie line, that there is a 
small increase in hydrodynamic diameter. Again, the same rationale for sample aging that was used 
for samples that contain no lipid-PEG can be used here. For example, T1 250 DNA/vesicle loading 
as discussed has a small lo domain and large DNA loading that cannot fully partition to the lo patch. 
While initially the ld non-specific hybridisation is blocked by PEG, over time hybridisation likelihood 
will grow causing the rise in hydrodynamic diameter seen experimentally in Figure 5.17.  
Over the two weeks there is further aggregation of samples, specifically T3 75 DNA/vesicle loading, 
which was previously seen for samples without the introduction of lipid-PEG in Figure 5.7. This pattern 
can be attributed to the low concentration of DNA strands in the lo domain and the resulting weak 
bond between vesicles. Over time the prospect of numerus weak tethering between liposomes 
becomes more likely. Two properties that enhance this effect are the large lo domain enabling the 
space for high local concentrations of vesicles, and low concentration of DNA; prohibiting a tight 
zippering action between two deformable Janus particles. 
Additionally, over the two weeks samples T2 and T3 250 DNA/vesicle loading displayed average 
dimer formations remaining largely undisturbed, making them prospective candidates for future dimer 
treatment development. T1 and T2 75 DNA/vesicle loading form ~50% dimers with little change over 
the two weeks. Over a longer ageing study these preparations may provide long term average dimer 
stability. However, over considerable time scales combined with the type of cargo, leakage may 
become significant. This would need further study when the Janus vesicle platform is applied to a 
specific treatment. 
To maximise the drug delivery platform’s potential, 2 mol% lipid-PEG was introduced to Janus 
liposome clusters, tethered together using pH responsive i-motif sequences. 
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pH responsive DNA mediated cluster assembly 
 Across tie line examination 
A similar study to that done for the non-pH responsive sequences (Figure 5.15) was carried out to 
investigate the i-motif sequences.  
Figure 5.18 - Data to show the effect of 2 mol% lipid-PEG addition on i-motif DNA tethered 
vesicles. Left displays the recorded hydrodynamic diameter and right the calculated number 
of vesicles tethered together. Readings were taken at 25 oC. 
The data present in Figure 5.18 closely mirrors its pH non-responsive counterpart, preventing mass 
aggregation of samples across the tie line as shown in samples lacking lipid-PEG in Figure 5.9. PEG 
2000 is therefore shown to be long enough to counteract the 30 mer sequence non-specific binding 
in the ld phase.  
pH switching 
Vesicles across the tie line were pH switched to examine whether the PEG would interfere with the 
formation of single vesicles and reformation of dimers when acid and base were added, respectively. 
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Figure 5.19 – pH switching response for 250 pH responsive DNA/vesicles across the assumed 
tie line in the ld-lo region. Readings were taken at 25 oC. Left hand side pH 7.4 is the starting 
pH. 
The data shown in Figure 5.19 describe a system where the i-motif DNA sequence is suitable to link 
vesicles together alongside PEG stabilisation. The data denote dimer formation at pH 7.4, where a 
decrease in pH dehybridises linking DNA; creating single liposomes. Through the addition of 1.2 M 
NaOH (aq) base dimer clusters reform, creating a sophisticated switchable device independent from 
tie line position. This new highly specific pH switchable devise unlocks potential for new medical 
based treatments.  
Thermal-melt of vesicle aggregates 
Similarly, to previous work, small cluster thermal stability experiments were carried out across all tie 
line positions with 75 and 250 DNA/vesicle loadings.  
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Figure 5.20 – Top: Heating study showing measured hydrodynamic diameters from phase 
separated vesicles with a 2 mol% PEG integration and 75 and 250 pH responsive DNA/vesicle 
loadings. Samples held at respective temperatures for 30 minutes. Bottom: Calculated 
average number of hybridised phase separated vesicles in a cluster from the measured 
hydrodynamic diameter heating study.  
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The pH responsive sequence across all tie line positions and DNA/vesicle loadings displayed good 
agreement with the pH non-responsive sequence, with the addition of 2 mol% lipid-PEG. The lipid-
PEG acts as a positive tethering stabilising agent irrespective of the sequences tested here, opening 
up avenues to more sophisticated DNA sequences of a similar 30 mer length. Having longer strands 
of DNA that are not proportionate in length to the PEG polymer may result in a reduction in PEG 
effectiveness. Alternatively, a longer PEG 6000 polymer incorporated into the vesicle may allow for 
a longer DNA sequence while still enabling a ld hybridisation phase block.  
Again counterintuitively, data for T3 250 DNA/vesicle when heated from 25 oC to 37 oC show an 
increase in hydrodynamic diameter where there is only a small reported increase in the number of 
tethered vesicles in sample. This apparent discrepancy can be again explained with reference to 
vesicle thermal expansion. The number of vesicles hybridised in a cluster is calculated from the ratio 
between the un-hybridised single vesicle control and the clustered vesicle sample. In the case of T3 
250 DNA/vesicle the control has thermally expanded more than the clustered sample giving rise to 
only a small increase in the number of tethered vesicles with respect to the hydrodynamic diameter.  
Vesicle ageing stability 
The hybridisation seen within Figure 5.20 is representative of vesicles 24 hours after preparation. 
The i-motif sequence has mismatching base pairs that could lead to reduced hybridisation kinetics 
and over time lipid-PEG may not be as effective at blocking ld hybridisation as first suspected for the 
longer sequence [159].  
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Figure 5.21 - Across tie line aging study for pH responsive DNA linked vesicles with 2 mol% 
lipid-PEG. All samples were stored in the fridge between measurements. Measurements read 
at 25 oC. Top: Measured average hydrodynamic diameter plot. Bottom: Calculated number of 
hybridised vesicles per cluster plot.    
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Again, over the week long period, PEG provided sufficient blocking power to prevent uncontrolled ld 
enabled vesicle hybridisation. However over the week, with the exception of T2 250 DNA/vesicle, 
clusters dehybridised releasing single vesicles. The reduction in vesicle tethering for the majority of 
the samples is likely due to lipid-PEG slowly partitioning into the lo domain and disrupting the weak 
hybridisation. Conversely in the second week, specifically for the 75 DNA/vesicle loading, there is a 
trend whereby the larger the lo domain area the more vesicles hybridise together. This growth could 
be attributed to three simultaneous effects accruing after the first week.  
When the low levels of lipid-PEG partition to the lo domain its disruptive forces are relative to lipid-DNA 
to lipid-PEG separation. In small lo patches PEG effects will be more prominent than in larger lo 
domains, T1 to T3 respectively. In turn the disruptive forces of the PEG are therefore reduced, 
commanding an order of magnitude difference with more vesicles being tethered together in T3 over 
T2, when doped with 75 i-motif/vesicle. Furthermore, as previously discussed, T3 has a very large 
surface area allowing for multiple tethering as described in Figure 5.3. And finally, a longer i-motif 
sequence affords larger vesicle aggregates as suggested in Figure 5.10. 
Lipid-PEG doped liposome stability 
Long term thermal stability 
Lipid-PEG has shown that it is capable of significantly reducing nonspecific hybridisation both at room 
and ~body temperature. However, as previously discussed, samples were only heated at 37 oC for 
30 minutes. Therefore, to test how effective PEG was against nonspecific hybridisation, at raised 
temperatures over extended periods, samples were prepared and placed in a water bath at 37 oC for 
24 hours before DLS examination. Through examining the long term thermal stability, it could be 
possible to select an appropriate universal composition that could be safely used in long circulation 
formulations.  
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Figure 5.22 – Phase separated T1 samples with 2 mol% lipid-PEG doped with 75 and 250 pH 
non-responsive and pH responsive DNA/vesicle. Left: Graph displaying time held at 37 °C 
against hydrodynamic diameter. Right: Calculated average number of vesicles for 
hydrodynamic diameter. Both graphs have been presented on a log Y scale.   
As expected a 250 DNA/vesicle loading, where lo is fully saturated with lipid-DNA, leads to high levels 
of clustering, accentuated through an extended heating time. Over time at a raised temperature, more 
saturated lipids will be able to diffuse out of the lo domain reducing lo domain size, promoting 
nonspecific hybridisation. 75 DNA/vesicle loading maintains low vesicle hybridisation, with the pH 
responsive sequence dehybridising through extended heating. This is not to be unexpected when 
considering the initial low levels of successful hybridisation. 
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Figure 5.23 - Phase separated T2 samples with 2 mol% lipid-PEG doped with 75 and 250 pH 
non-responsive and pH responsive DNA/vesicle. Left: Graph displaying time held at 37 oC 
against hydrodynamic diameter. Right: Calculated average number of vesicles for 
hydrodynamic diameter. Both graphs have been presented on a log Y scale.   
The larger lo patch in T2 affords more controlled hybridisation when the raised temperature is held 
for longer periods of time than T1. Nevertheless the 250 DNA/vesicle loading resulted in cluster sizes 
on average five times greater than dimer formation. Both 75 DNA/vesicle loadings showed potential 
in being able to prevent extended clustering. However, for both 75 DNA/vesicle loadings there are 
only low numbers of small clusters, which if introduced as a treatment would lead to poor cluster yield 
once single and dimer vesicles were separated.  
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Figure 5.24 - Phase separated T3 samples with 2 mol% lipid-PEG doped with 75 and 250 pH 
non-responsive and pH responsive DNA/vesicle. Left: Graph displaying time held at 37 oC 
against hydrodynamic diameter. Right: Calculated average number of vesicles for 
hydrodynamic diameter. Both graphs have been presented on a log Y scale.   
Further DPPC addition improves size limited cluster formation relative to T2 and T1 compositions. 
250 lipid-DNA/vesicle doping proves to be unsuitable when heated for long periods of time. However, 
a 75 loading of pH non-responsive DNA/vesicle is shown to improve dimer formation. This sample 
therefore would provide a potential drug delivery platform that would be stable in warmer 
environments for extended periods of time. Similarly, the 75 loading of i-motif sequence displayed 
high binding specificity after extended heating. These extended heating studies have exposed Janus 
vesicles to be a versatile concept, capable of satisfying the demands for safer, highly specific 
treatments.  
Liposome stability after 24 hours 37 oC heating 
Heating to 37 oC for 24 hours does raise further interesting questions. Once the system has been 
heated to 37 oC if placed back in the fridge, for example 24 hours, would this render smaller vesicle 
clusters once again? In other words, once uncontrolled weak DNA bridges have been formed, would 
these fall apart once saturated lipids condense? If this was the case a more versatile, safer delivery 
platform could be modelled. The first DNA set of sequences examined were the complementary pH 
non-responsive sequence.  
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Figure 5.25 – Vesicles across assumed tie line doped with 2% PEG and pH non-responsive 
DNA at concentration of 75 and 250 DNA/vesicle, heated to 37 °C for 24 hours then refrigerated 
for two weeks. Y axes are presented on a log scale. Top: Measured hydrodynamic diameter 
Bottom: Calculated average number of vesicles in a single cluster. Remeasured at 25 oC. 
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Over the two weeks hydrodynamic diameter remains constant for each respective sequence. 
Refrigeration has therefore not been shown to enable cluster reversibility once heated to 37 oC. 
Sample T3 75 DNA/vesicle loading has not shown the mass hybridisation that has come to be 
expected on the second week of ageing. This is perhaps due to a rise in lipid-PEG in the lo domain 
upon heating, which still resides in the more solid lo domain two weeks later, prohibiting aggregation. 
The same experiment was then carried out for the pH responsive sequence. 
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Figure 5.26 - Vesicles across tie line doped with 2% PEG and pH responsive DNA at 
concentration of 75 and 250 DNA/vesicle, heated to 37 °C for 24 hours then refrigerated for 
two weeks. Y axes are presented on a log scale Top: Measured hydrodynamic diameter 
Bottom: Calculated average number of vesicles in a single cluster. Remeasured at 25 oC. 
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In contrast to the data presented in Figure 5.25, the data for 250 DNA/vesicle loading in Figure 5.26 
do show a drop in hybridisation over a week, most notably T1 250 DNA/vesicle. It is hypothesised 
that the small lo domain begins to diffuse at 37 oC enabling lipid-DNA to diffuse across the surface 
where it can weakly, non-specifically hybridise with other vesicles. Upon cooling the weak bonds are 
broken through stronger lipid-PEG lipid-DNA interactions significantly reducing vesicle aggregation. 
T2 and T3 250 DNA/vesicle loadings have larger lo domains reducing the number of lipid-DNA strands 
diffusing out of the domain, resulting in aggregates more controlled in size than T1. Because 
hybridisation is still essentially being directed by the lo domain there is only a small drop upon cooling 
and aging. 75 DNA/vesicle loading fundamentally stays consistent with ageing, but with the exception 
of T3 75 DNA/vesicle. This is the opposite of the trend set out by the non-responsive sequence in 
Figure 5.25. It is therefore hypothesised after two weeks the rise in vesicle hybridisation will be a 
result of the longer sequence of DNA and the larger lo domain as previously discussed.    
Summary 
Throughout the chapter, vesicle clustering between lipid-DNA doped vesicles was monitored using 
DLS. The study found that liposome composition and DNA concentration had critical effects on 
vesicle aggregation, summerised in Figure 5.27. 
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Figure 5.27 – Summary graph of how changes in liposome composition lead to a change in 
the hydrodynamic diameter of clusters i.e. a change in the average number of vesicles able to 
hybridise together using 250 DNA/vesicle pH non-responsive lipid-DNA conjugates with lipid 
maintained at a concentration of 1x10-3 M. All samples measured at 25 oC. 
Figure 5.27 displays that the use of the developed phase diagram in chapter 3 and the introduction 
of low levels of PEG, as to not disturb phase behaviour, reduces random nonspecific tethering. 
Through these added layers of sophistication, stable size limited vesicle clusters can be modelled. 
Furthermore, depending on application, membrane composition can be adapted to improve thermal 
stability and aging capacity. The platform also enables changes in the lipid-DNA bridge to grant 
additional properties. Through using an i-motif sequence a pH responsive mechanism was built into 
the clusters. This addition to the structure affords this platform a bio-relevant stimuli responsive 




Controlled size limited assembly of Janus DNA hybridised nano vesicles was shown to be made 
possible through selective DOPC:DPPC:cholesterol lipid compositions and the introduction of 
10 mol% cardiolipin. Where cardiolipin was found to have an affinity to significantly influence 
saturated lipid partitioning. Fundamentally this project added a fourth lipid component, 10 mol% CL, 
to the established DOPC, DPPC, cholesterol phase diagram, while maintaining vesicle diameter at 
~100 nm. To measure the impact of CL in nano vesicle lipid phase behaviour, Förster Resonance 
Energy Transfer (FRET) was employed as the phase detection technique. From FRET heating 
profiles, using trace complementary FRET probes rhod PE and NBD PE, the 10 mol% CL slice 
through the four component phase diagram was mapped at 20 oC. From this phase diagram the ld-lo 
phase co-existence region was plotted, which was later used to modify the lo patch size on the surface 
of the vesicle. Furthermore, while examining the phase behaviour of these vesicles an unexpected 
lo-HII phase coexistence region was demonstrated. The formation of this phase coexistence region 
was argued to be linked to cholesterol concentration, in line with what has previously shown in 
literature with DOPE. The phase diagram was then verified using complementary confocal 
fluorescence microscopy images of GUV samples.  
Before the application of lipid-DNA to phase separated vesicles UV spectroscopy was coupled with 
temperature ramping, to measure vesicle bound thermal lipid-DNA bridge stability. Experiments 
involved examining two DNA sequences, a short fully complementary sequence and a longer pH 
responsive i-motif sequence. Through the measurement of DNA Tm and the generation of van't Hoff 
plots, thermodynamic properties of membrane bound DNA in physiological HEPES buffer were 
measured. This was continued to further examine DNA stability in lower pH conditions and in variable 
salt conditions. Results showed the DNA sequence type and concentration dictated Tm, furthermore 
pH reduction gave a lower Tm across all samples. Additionally, salt concentration was found to greatly 
affect DNA binding through screening the negative charges on the phosphate backbone. Finally, UV 
temperature ramp experiments were used to investigate the potential for DNA bridged vesicles to 
become pH switchable devices. However, it was found that temperature ramping led to the 
depurination of BPs on the DNA, preventing hybridisation when the pH was raised back to 
physiological pH. DNA depurination was then confirmed via HPLC analysis. 
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Once lipid-DNA bridged POPC vesicle stability was examined and they were found to be suitable, 
the DNA-lipids were introduced to phase separated vesicles. Three appropriate ld-lo phase separating 
compositions were selected, where the size of the lo patch was increased from T1 to T3. From the 
two DNA strand types, DNA concentration and tie line position, a comprehensive study of vesicles 
aggregate size was made via DLS. The vesicle cluster diameters were then interpreted into coarse 
average number of vesicles in clusters. From the data, it was found that membrane phase separation 
considerably reduced aggregate size from 2500 nm to < 200 nm, enabling potential Janus DNA 
vesicle aggregates to take advantage of the EPR effect. Further study displayed that the position on 
the pseudo tie line further influenced the size of hybridised clusters. Continuing with DLS 
experiments, the impact of PEG addition on vesicle aggregates was monitored. Again, PEG addition 
was found to reduce vesicle aggregation size in homogeneous POPC liposomes and phase 
separated vesicles. PEG therefore provides a twofold beneficial influence to Janus DNA hybridised 
clusters. Firstly, PEG provides the means to form size limited clusters across the pseudo tie line. 
Secondly, longer circulation times are afforded to PEGylated NPs when introduced into the body due 
to PEG’s “stealth” properties. Finally, pH responsiveness was observed across the pseudo tie line 
using the i-motif sequences. Through this study, it was found that vesicles hybridised in clusters could 
be dehybridised at pH 4 and once again self-assemble when the pH was raised back to 7.4. These 
data display the potential for DNA hybridised vesicles to be used in a triggered release application, 
whereby vesicles are released from a cluster or surface during drug delivery. This diversity widens 
the scope for these materials as a potential drug delivery platform, which can be tailored to form new 
chemotherapy treatments. 
Future work 
It may be suggested that effort should be made to examine the rest of the four component phase 
diagram. However, this would not be in line with the overall project goal of producing a drug delivery 
platform. While full mapping of the phase diagram would be of academic interest, it would not 
significantly impact the developed carrier and thus would be an unnecessary large expenditure of 
resources. In addition, 10 mol% CL was already found to be sufficient to direct lipid partitioning in 
order to produce < 200 nm clusters and dimers with and without PEG addition. However, in the short 
term continued work in studying Janus DNA vesicle clusters through Cryo TEM would be of value. 
Through this sustained research, a fuller picture of the number of vesicles hybridised in a cluster 
could be put together which would be more accurate than the DLS interpretation put forward here. 
Also, fluorescence cross-correlation spectroscopy (FCCS) could be implemented as a further 
complementary technique, that could be used to measure the number of vesicles in a cluster. 
Additionally, Cryo TEM would enable an average distance between hybridised vesicles to be 
measured, through the unique pattern displayed between two hybridised vesicles.   
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Future research more in line with the original project goals would be tailored towards studying 
additional DNA sequences, specifically in respect to using other i-motifs. Through the integration of 
further BP mismatches in the DNA i-motif sequence, it would be possible to aid the pH-triggered 
i-motif formation. In other words, added BP mismatches would increase inter-strand dehybridisation
susceptibility to a pH trigger. 
In the long term of the development cycle, effort should be made to move away from making a broad-
spectrum drug delivery platform, to one which focuses on a specific application. Primarily this would 
entail examining Janus vesicles in terms of loading potential, drug release kinetics and monitoring 
the membrane’s structural integrity. Each drug would have its own loading efficiency and leakage 
rate dependant on the individual species’ structure and resulting hydrophobicity. Long term stability 
in regard to leakage would be dependent upon the drug’s partition coefficients, both in the liposome 
core and across the membrane [160]. The next step would be to integrate these materials into cell 
culture experiments, where a comparison of single vesicles against clustered vesicles in prodrug and 
combinational therapies would be undertaken. However, the experiments are well beyond the scope 
for this first principle examination of DNA bridged Janus vesicle cluster design.  
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